
<html lang="en"     class="pb-page"  data-request-id="c4af31ac-d634-4a3c-a4ed-e2ad1764b2cf"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2017.60.issue-20;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.7b01269;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Enzymatic Generation of Highly Anticoagulant Bovine Intestinal Heparin" /></meta><meta name="dc.Creator" content="Li  Fu" /></meta><meta name="dc.Creator" content="Kevin  Li" /></meta><meta name="dc.Creator" content="Daisuke  Mori" /></meta><meta name="dc.Creator" content="Makoto  Hirakane" /></meta><meta name="dc.Creator" content="Lei  Lin" /></meta><meta name="dc.Creator" content="Navdeep  Grover" /></meta><meta name="dc.Creator" content="Payel  Datta" /></meta><meta name="dc.Creator" content="Yanlei  Yu" /></meta><meta name="dc.Creator" content="Jing  Zhao" /></meta><meta name="dc.Creator" content="Fuming  Zhang" /></meta><meta name="dc.Creator" content="Murat  Yalcin" /></meta><meta name="dc.Creator" content="Shaker A.  Mousa" /></meta><meta name="dc.Creator" content="Jonathan S.  Dordick" /></meta><meta name="dc.Creator" content="Robert J.  Linhardt" /></meta><meta name="dc.Description" content="Unlike USP porcine heparin, bovine intestinal heparin (BIH) has a low anticoagulant activity. Treatment with 6-OST-1, -3, and/or 3-OST-1 afforded two remodeled heparins that met USP heparin activit..." /></meta><meta name="Description" content="Unlike USP porcine heparin, bovine intestinal heparin (BIH) has a low anticoagulant activity. Treatment with 6-OST-1, -3, and/or 3-OST-1 afforded two remodeled heparins that met USP heparin activit..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 16, 2017" /></meta><meta name="dc.Type" content="rapid-communication" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01269" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01269" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01269" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01269" /></link>
        
    
    

<title>Enzymatic Generation of Highly Anticoagulant Bovine Intestinal Heparin | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01269" /></meta><meta property="og:title" content="Enzymatic Generation of Highly Anticoagulant Bovine Intestinal Heparin" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01269/20171020/images/large/jm-2017-01269a_0006.jpeg" /></meta><meta property="og:description" content="Unlike USP porcine heparin, bovine intestinal heparin (BIH) has a low anticoagulant activity. Treatment with 6-OST-1, -3, and/or 3-OST-1 afforded two remodeled heparins that met USP heparin activity and Mw specifications. We explored the pharmacodynamics and pharmacokinetics in a rabbit model. We conclude that a modest increase in the content of 3-O-sulfo groups in BIH increases the number of antithrombin III binding sites, making remodeled BIH behave similarly to pharmaceutical heparin." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01269"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01269">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01269&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01269&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01269&amp;href=/doi/10.1021/acs.jmedchem.7b01269" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 8673-8679</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01216" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Brief Article</span><a href="/doi/10.1021/acs.jmedchem.7b01452" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Enzymatic Generation of Highly Anticoagulant Bovine Intestinal Heparin</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Li++Fu">Li Fu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin++Li">Kevin Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daisuke++Mori">Daisuke Mori</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Makoto++Hirakane">Makoto Hirakane</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lei++Lin">Lei Lin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Navdeep++Grover">Navdeep Grover</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Payel++Datta">Payel Datta</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yanlei++Yu">Yanlei Yu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jing++Zhao">Jing Zhao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fuming++Zhang">Fuming Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-2803-3704" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Murat++Yalcin">Murat Yalcin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∇</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shaker+A.++Mousa">Shaker A. Mousa</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jonathan+S.++Dordick">Jonathan S. Dordick</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+J.++Linhardt">Robert J. Linhardt</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-2219-5833" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1.0"><span class="aff-text"><sup>†</sup>Center for Biotechnology and Interdisciplinary Studies, <sup>‡</sup>Department of Chemical and Biological Engineering, <sup>§</sup>Department of Biomedical Engineering, <sup>∥</sup>Department of Biology, and <sup>⊥</sup>Department of Chemistry and Chemical Biology, Rensselaer Polytechnic Institute, Troy, New York 12180, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">#</span> <span class="aff-text">The Pharmaceutical Research Institute, Albany College of Pharmacy, Rensselaer, New York 12144, United States</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∇</span> <span class="aff-text">Department of Physiology, Veterinary Medicine Faculty, Uludag University, Gorukle 16059, Bursa, Turkey</span></div><div class="corresp-info"><strong>*</strong>Phone: 1-518-276-3404. E-mail: <a href="/cdn-cgi/l/email-protection#91fdf8fff9f0e3d1e3e1f8bff4f5e4"><span class="__cf_email__" data-cfemail="c8a4a1a6a0a9ba88bab8a1e6adacbd">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01269&amp;href=/doi/10.1021%2Facs.jmedchem.7b01269" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 8673–8679</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 3, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>28 August 2017</li><li><span class="item_label"><b>Published</b> online</span>16 October 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 October 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01269" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01269</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8673%26pageCount%3D7%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DLi%2BFu%252C%2BKevin%2BLi%252C%2BDaisuke%2BMori%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D20%26contentID%3Dacs.jmedchem.7b01269%26title%3DEnzymatic%2BGeneration%2Bof%2BHighly%2BAnticoagulant%2BBovine%2BIntestinal%2BHeparin%26numPages%3D7%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8679%26publicationDate%3DOctober%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01269"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">532</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">12</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01269" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Enzymatic Generation of Highly Anticoagulant Bovine Intestinal Heparin&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Li&quot;,&quot;last_name&quot;:&quot;Fu&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Daisuke&quot;,&quot;last_name&quot;:&quot;Mori&quot;},{&quot;first_name&quot;:&quot;Makoto&quot;,&quot;last_name&quot;:&quot;Hirakane&quot;},{&quot;first_name&quot;:&quot;Lei&quot;,&quot;last_name&quot;:&quot;Lin&quot;},{&quot;first_name&quot;:&quot;Navdeep&quot;,&quot;last_name&quot;:&quot;Grover&quot;},{&quot;first_name&quot;:&quot;Payel&quot;,&quot;last_name&quot;:&quot;Datta&quot;},{&quot;first_name&quot;:&quot;Yanlei&quot;,&quot;last_name&quot;:&quot;Yu&quot;},{&quot;first_name&quot;:&quot;Jing&quot;,&quot;last_name&quot;:&quot;Zhao&quot;},{&quot;first_name&quot;:&quot;Fuming&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Murat&quot;,&quot;last_name&quot;:&quot;Yalcin&quot;},{&quot;first_name&quot;:&quot;Shaker&quot;,&quot;last_name&quot;:&quot;A. Mousa&quot;},{&quot;first_name&quot;:&quot;Jonathan&quot;,&quot;last_name&quot;:&quot;S. Dordick&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;J. Linhardt&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;16&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;8673-8679&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01269&quot;},&quot;abstract&quot;:&quot;Unlike USP porcine heparin, bovine intestinal heparin (BIH) has a low anticoagulant activity. Treatment with 6-OST-1, -3, and/or 3-OST-1 afforded two remodeled heparins that met USP heparin activity and Mw specifications. We explored the pharmacodynamics and pharmacokinetics in a rabbit model. We conclude that a modest increase in the content of 3-O-sulfo groups in BIH increases the number of antithrombin III binding sites, making remodeled BIH behave similarly to pharmaceutical heparin.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01269&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01269" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01269&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01269" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01269&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01269" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01269&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01269&amp;href=/doi/10.1021/acs.jmedchem.7b01269" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01269" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01269" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01269%26sid%3Dliteratum%253Aachs%26pmid%3D28972371%26genre%3Darticle%26aulast%3DFu%26date%3D2017%26atitle%3DEnzymatic%2BGeneration%2Bof%2BHighly%2BAnticoagulant%2BBovine%2BIntestinal%2BHeparin%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D20%26spage%3D8673%26epage%3D8679%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291445" title="Chemical structure">Chemical structure</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a>,</li><li><a href="/action/doSearch?ConceptID=291774" title="Nuclear magnetic resonance spectroscopy">Nuclear magnetic resonance spectroscopy</a>,</li><li><a href="/action/doSearch?ConceptID=291833" title="Heparin">Heparin</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/jmcmar.2017.60.issue-20/20171026/jmcmar.2017.60.issue-20.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01269/20171020/images/medium/jm-2017-01269a_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01269/20171020/images/large/jm-2017-01269a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01269&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Unlike USP porcine heparin, bovine intestinal heparin (BIH) has a low anticoagulant activity. Treatment with 6-OST-1, -3, and/or 3-OST-1 afforded two remodeled heparins that met USP heparin activity and Mw specifications. We explored the pharmacodynamics and pharmacokinetics in a rabbit model. We conclude that a modest increase in the content of 3-<i>O</i>-sulfo groups in BIH increases the number of antithrombin III binding sites, making remodeled BIH behave similarly to pharmaceutical heparin.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51554" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51554" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Heparin is a glycosaminoglycan that is obtained from animal tissues and is widely used as a clinical anticoagulant drug.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Heparin is biosynthesized in the Golgi of certain animal cells through the stepwise action of de-<i>N</i>-acetylase-<i>N</i>-sulfotransferase, C5-epimerase, 2-<i>O</i>-, 6-<i>O</i>-, and 3-<i>O</i>-sulfotransferases on the heparosan polysaccharide precursor.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3-5)</a> Incomplete modification at each biosynthetic step leads to a large variety of chain structures. The heparin polysaccharide (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) is composed of disaccharide repeating units, including a major repeating unit that is trisulfated (TriS), →4) α-L-IdoA2S (1→4) α-D-GlcNS6S (1→, where IdoA is iduronic acid, GlcN is glucosamine, and S is sulfo. Heparin contains lesser amounts of glucuronic acid (GlcA) and <i>N</i>-acetyl glucosamine (GlcNAc) residues having varying numbers of <i>O</i>-sulfo groups.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> Heparin contains a pentasaccharide sequence (i.e., →4) GlcNAc6S (1→4) GlcA (1→4) GlcNS3S6S (1→4) IdoA2S (1→4) GlcNS6S (1→) that allows it to interact with antithrombin III (AT) and inhibit blood coagulation proteases, such as factor IIa (FIIa or thrombin) and factor Xa (FXa).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> There is some allowable structural variation in the AT-binding pentasaccharide sequences,<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> but all have unique, well-conserved residues, such as a central 3-<i>O</i>-sulfoglucosamine, critical for anticoagulant activity. Some unsubstituted AT precursor sites remain in heparin due to incomplete action of the 3-<i>O</i>-sulfotransferase.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01269/20171020/images/medium/jm-2017-01269a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01269/20171020/images/large/jm-2017-01269a_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of heparins and their remodeled structures. a + d ∼ 20, b = 1, c ∼ 8 for MW weight average 20 000. X or X′ = SO<sub>3</sub><sup>–</sup>, H; Y or Y′ = SO<sub>3</sub><sup>–</sup>, COCH<sub>3</sub>, H; Z = SO<sub>3</sub><sup>–</sup>, H. (A) Schematic structure of an average chain present in PI heparin. (C) Schematic structure of an average chain present in BI heparin. (B) Schematic structure of an average chain present in BI 3S6S heparin. (D) Schematic structure of an average chain present in BI 3S heparin. See <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.7b01269/suppl_file/jm7b01269_si_001.pdf" class="ext-link">Supporting Information Table S1 and Figure S1</a> for detailed MW data.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01269/20171020/images/large/jm-2017-01269a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01269&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Nearly 100 metric tons of heparin is annually produced worldwide primarily from porcine intestine (PI).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Small amounts of bovine intestinal (BI), bovine lung, and ovine (sheep) intestinal heparins are also prepared but are not approved for clinical use in most countries. These heparins, sourced from bovine and ovine tissues, exhibit physiochemical, biological, and pharmacological differences from pharmaceutical porcine intestinal heparin.<a onclick="showRef(event, 'ref11 ref12 ref13 ref14 ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13 ref14 ref15 ref16 ref17">(11-17)</a></div><div class="NLM_p">There has been growing concern about the stability and safety of the pharmaceutical heparin supply chain.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> In 2007–2008 a heparin contamination crisis resulted from the adulteration of crude porcine intestinal heparin with a toxic semisynthetic glycosaminoglycan, oversulfated chondroitin sulfate.<a onclick="showRef(event, 'ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21 ref22">(19-22)</a> This contamination crisis was associated with multiple deaths and severely disrupted the heparin supply chain for a period of time.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Porcine diseases, including blue ear disease and porcine diarrhea, have also resulted in market disruptions.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Recently, concerns regarding illegal blending of bovine or ovine heparin products with porcine heparin have led to drug recalls.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><div class="NLM_p">These issues have led researchers and regulatory agencies to consider alternative supplies of heparins, either the development of bioengineered heparins,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> synthetic heparins,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> or the reintroduction of bovine heparin into the pharmaceutical market.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Bovine lung heparin was successfully used in the U.S. until the 1990s when it was voluntarily withdrawn following the outbreak of bovine spongiform encephalopathy (BSE) in Europe,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and BI mucosa heparin has been more recently used in South America.<a onclick="showRef(event, 'ref14 ref16 ref26'); return false;" href="javascript:void(0);" class="ref ref14 ref16 ref26">(14, 16, 26)</a></div><div class="NLM_p">Recently, our laboratory<a onclick="showRef(event, 'ref11 ref13 ref15 ref27'); return false;" href="javascript:void(0);" class="ref ref11 ref13 ref15 ref27">(11, 13, 15, 27)</a> and others<a onclick="showRef(event, 'ref12 ref14 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref12 ref14 ref16 ref17">(12, 14, 16, 17)</a> have been examining the physicochemical, biological, and pharmacological differences in heparins prepared from different tissues of food animals. Moreover, there have even been efforts reported to prepare low molecular weight heparin products from bovine-derived heparins.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a></div><div class="NLM_p">Some concerns have recently arisen about the reintroduction of bovine heparin, as it is clearly different from porcine intestinal heparin.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> From a commercial standpoint, it appears that BI is a preferred source over bovine lung heparin. Since there are substantial differences between porcine intestinal heparin and BI heparin, new pharmacopeia monographs will be required. Most concerning, however, is that the substantial differences in the specific anticoagulant activities (units/mg) of BI heparin (∼100–130 U/mg) and porcine intestinal heparin (∼180–210 U/mg) will make these products difficult for clinicians to use and potentially interchange. For example, heparin, administered on a unit basis, is frequently neutralized with protamine sulfate (an antidote given on a weight basis), thus requiring complex calculations by surgeons if heparins with very different potencies were used. Moreover, while pharmaceutical heparin is generally considered a safe and effective drug, it does exhibit side effects in a small percentage of patients.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Of particular concern is heparin-induced thrombocytopenia (HIT) in which heparin binds, through primarily electrostatic interaction, to platelet factor IV (PF4), resulting in an immunologically active complex, resulting in aggregation and loss of platelets. The PF4 binding site in heparin is believed to be a dodecasaccharide or longer site rich in the highly sulfated TriS sequence.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Thus, there is concern that any new heparin products introduced into the market may not show enhanced PF4 binding leading to HIT, but unfortunately extensive in vivo studies are required to determine the prevalence of HIT.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><div class="NLM_p last">In the current study we extend our understanding of the structural differences between PI and BI heparins, particularly their differences in the levels of 3-<i>O</i>-sulfo and 6-<i>O</i>-sulfo content, to understand how these differences impact their anticoagulant activities. Moreover, we use recombinant 3-<i>O</i>- and 6-<i>O</i>-sulfotransferases to prepare enzymatically modified BI heparin and compare this remodeled heparin to pharmaceutical porcine intestinal heparin.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17713" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17713" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2-1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Enzymatic Modification of BI Heparin</h3><div class="NLM_p">Heparin biosynthetic enzymes 6-OST-1, 6-OST-3, 3-OST-1 and PAPS regeneration enzyme AST-IV were prepared and immobilized as previously reported.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> 6OST-1 and 6OST-3 were prepared as maltose binding protein (MBP) fusions, and 3OST-1 and arylsulfotransferase-IV (AST-IV) were prepared as His-tagged fusions. These proteins were immobilized on amylose and Ni-Sepharose resins, respectively. BI heparin was treated with a mixture of immobilized 6-OST-1, 6-OST-3, and 3-OST-1 or with only 3-OST-1. The sulfation reaction was coupled with a PAPS recycling system consisting of potassium <i>p</i>-nitrophenyl sulfate (PNPS as a sacrificial sulfo donor), 3′-phosphoadenosine 5′-phosphosulfate (PAPS), and AST-IV. After the reaction was complete, the mixtures were filtered to remove enzyme resin, dialyzed using 5K Da molecular weight cutoff (MWCO) centrifugal membrane units with distilled water to remove PNP, PAPS, MES salt, and other small molecule impurities, and the retentate containing remodeled BI heparins was lyophilized for further analysis.</div><div class="NLM_p">Disaccharide compositional analysis of the heparin polysaccharide relies on its exhaustive treatment with a cocktail of heparinases to afford primarily disaccharide products. These disaccharides are then analyzed by strong anion exchange (SAX) high performance liquid chromatography (HPLC) and their identity and concentrations determined based on disaccharide standards.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The disaccharide compositions of a typical PI mucosal heparin and a BI mucosal heparin are shown in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>. There are major compositional differences in these two heparins. In particular, PI heparin has a higher level of fully modified TriS sequence (66% and 55% TriS in PI and BI, respectively), →4) α-L-IdoA2S (1→4) α-D-GlcNS6S (1→, the result of greatly reduced 6-<i>O</i>-sulfo group content and a higher <i>N</i>-acetyl content, resulting in enriched levels of 0S + 2S + 6S + 2S6S (8.6% and 2.9% in PI and BI, respectively). The disaccharide compositions of PI and BI heparins compare well to previously published analyses.<a onclick="showRef(event, 'ref11 ref13 ref15 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref11 ref13 ref15 ref28 ref29">(11, 13, 15, 28, 29)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Properties of Remodeled BI Heparins Compared to PI USP Heparin</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="8" align="center">disaccharide composition (mol %)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">activity (U/mg)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">heparin</th><th class="colsep0 rowsep0" align="center">0S</th><th class="colsep0 rowsep0" align="center">NS</th><th class="colsep0 rowsep0" align="center">6S</th><th class="colsep0 rowsep0" align="center">2S</th><th class="colsep0 rowsep0" align="center">NS6S</th><th class="colsep0 rowsep0" align="center">NS2S</th><th class="colsep0 rowsep0" align="center">2S6S</th><th class="colsep0 rowsep0" align="center">TriS</th><th class="colsep0 rowsep0" align="center">sulfo groups per disaccharide</th><th class="colsep0 rowsep0" align="center">Mw<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">anti-Xa</th><th class="colsep0 rowsep0" align="center">anti-IIa</th><th class="colsep0 rowsep0" align="center">Xa/IIa</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">USP specs</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2.5–2.7</td><td class="colsep0 rowsep0" align="left">15000–19000</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>180</td><td class="colsep0 rowsep0" align="left">0.9–1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PI (USP) heparin</td><td class="colsep0 rowsep0" align="left">4.0</td><td class="colsep0 rowsep0" align="left">3.2</td><td class="colsep0 rowsep0" align="left">3.7</td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">10.2</td><td class="colsep0 rowsep0" align="left">7.8</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">67.7</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">17000</td><td class="colsep0 rowsep0" align="left">200</td><td class="colsep0 rowsep0" align="left">200</td><td class="colsep0 rowsep0" align="left">1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BI heparin</td><td class="colsep0 rowsep0" align="left">3.3</td><td class="colsep0 rowsep0" align="left">5.9</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">8.2</td><td class="colsep0 rowsep0" align="left">32.2</td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="left">46.8</td><td class="colsep0 rowsep0" align="left">2.3</td><td class="colsep0 rowsep0" align="left">18500</td><td class="colsep0 rowsep0" align="left">110</td><td class="colsep0 rowsep0" align="left">105</td><td class="colsep0 rowsep0" align="left">1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BI heparin 3S</td><td class="colsep0 rowsep0" align="left">3.9</td><td class="colsep0 rowsep0" align="left">6.3</td><td class="colsep0 rowsep0" align="left">0.0</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">5.7</td><td class="colsep0 rowsep0" align="left">32.1</td><td class="colsep0 rowsep0" align="left">0.0</td><td class="colsep0 rowsep0" align="left">49.5</td><td class="colsep0 rowsep0" align="left">2.3</td><td class="colsep0 rowsep0" align="left">18500</td><td class="colsep0 rowsep0" align="left">231</td><td class="colsep0 rowsep0" align="left">268</td><td class="colsep0 rowsep0" align="left">0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BI heparin 3S6S</td><td class="colsep0 rowsep0" align="left">3.6</td><td class="colsep0 rowsep0" align="left">5.4</td><td class="colsep0 rowsep0" align="left">0.0</td><td class="colsep0 rowsep0" align="left">2.4</td><td class="colsep0 rowsep0" align="left">6.1</td><td class="colsep0 rowsep0" align="left">15.3</td><td class="colsep0 rowsep0" align="left">0.0</td><td class="colsep0 rowsep0" align="left">67.2</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">17900</td><td class="colsep0 rowsep0" align="left">289</td><td class="colsep0 rowsep0" align="left">301</td><td class="colsep0 rowsep0" align="left">1.0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">The systematic errors of disaccharide compositional values are less than 0.1%.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Systematic errors of bioactivity assays are less than 5%.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">Some of the larger chains may remain bound to the enzymes, reducing the average molecular weight of the resulting products.</p></div></div></div><div class="NLM_p last">Treatment of BI heparin with 6-OST-1, 6-OST-3, and 3-OST-1 afforded a disaccharide composition that was similar to PI heparin. In particular, the TriS content of BI 3S6S was 71%, higher than the PI heparin used in this study but comparable to many previously analyzed heparins (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01269/suppl_file/jm7b01269_si_001.pdf" class="ext-link">Table S2 in Supporting Information</a>).<a onclick="showRef(event, 'ref11 ref13 ref15 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref11 ref13 ref15 ref28 ref29">(11, 13, 15, 28, 29)</a> Finally, the disaccharide analysis of BI heparin with only 3-OST-1 was very similar to BI heparin and quite dissimilar to PI heparin. The subtle differences between BI and BI 3S heparins result from the increased levels of 3-<i>O</i>-sulfo groups resulting in a greater quantity of resistant tetrasaccharide, containing a reducing end GlcNS3S6S residue,<a onclick="showRef(event, 'ref7 ref8 ref34'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref34">(7, 8, 34)</a> impacting the compositional makeup of the remaining disaccharides.</div></div><div id="sec2-2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> NMR Analysis of BI Heparin and Remodeled BI Heparin</h3><div class="NLM_p">NMR analysis<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> was performed to assess the monosaccharide composition of the starting and modified BI heparins (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.7b01269/suppl_file/jm7b01269_si_001.pdf" class="ext-link">Supporting Information Figure S2 and Table S3</a>). Instead of using the very sophisticated quantitative 2D NMR recently developed by the Guerrini laboratory,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> the 1D <sup>1</sup>H NMR quantification method applied indicated the types and amounts of sulfo groups. This method had been validated in our previous report to have standard deviation of 0.7%. The <sup>1</sup>H NMR of the starting BI heparin closely resembled that of more than 20 other BI heparins examined in our laboratory.<a onclick="showRef(event, 'ref11 ref13 ref15 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref11 ref13 ref15 ref28 ref29">(11, 13, 15, 28, 29)</a> The anomeric signals in the partial <sup>1</sup>H NMR spectrum shown in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A could be clearly assigned and integrated (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01269/suppl_file/jm7b01269_si_001.pdf" class="ext-link">Table S3 in Supporting Information</a>). As expected, treatment of BI heparin with 6-OST-1, 6-OST-3, and 3-OST-1 increased the content of 6-<i>O</i>-sulfo and 3-<i>O</i>-sulfo groups (62–81% and 5–19%, respectively). While the increase in 3-<i>O</i>-sulfo groups in both enzyme treated BI heparins could be clearly demonstrated, it is much harder to demonstrate the increase in 6-<i>O</i>-sulfo groups because of the structural heterogeneity of these polysaccharides. To that end, 1D distortionless enhancement by polarization transfer (DEPT)-135 <sup>13</sup>C NMR spectra were obtained to examine definitively the change in 6-<i>O</i>-sulfo group content of the BI heparin treated with 6-OST-1, 6-OST-3, and 3-OST-1 (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>B and in <a href="/doi/suppl/10.1021/acs.jmedchem.7b01269/suppl_file/jm7b01269_si_001.pdf" class="ext-link">Supporting Information Table S3</a>). DEPT spectroscopy results in a negative signal for the primary C6 carbon allowing the clear assignment of the C6 of GlcNS6S and GlcNS resonances. These experiments confirm that only the sample treated with 6-OST-1 and 6-OST-3 showed increased GlcNS6S content and with decreased GlcNS content (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>B).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01269/20171020/images/medium/jm-2017-01269a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01269/20171020/images/large/jm-2017-01269a_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. NMR analysis of BI heparin and modified BI heparins: (A) 1D <sup>1</sup>H NMR spectra of bovine heparins BI, BI 3S, BI 3S6S; (B) 1D DEPT-135 <sup>13</sup>C NMR spectra of bovine heparins BI, BI 3S, BI 3S6S.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01269/20171020/images/large/jm-2017-01269a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01269&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2-3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Tetrasaccharide Mapping Analysis</h3><div class="NLM_p">Tetrasaccharide mapping analysis was next undertaken by treating each heparin sample with heparinase II followed by analysis of the resulting resistant tetrasaccharides<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> with reverse phase ion pairing (RPIP) HPLC and mass spectral (MS) detection (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>).<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> Standard tetrasaccharides carrying a GlcNS3S6S residue at their reducing end have been prepared through heparinase II treatment of heparin, purified and characterized.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> Analysis of PI heparin affords the major resistant tetrasaccharides (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a> T1, T2, T3, and T4) expected, while BI heparin shows lower amounts of these and minor amounts of unidentified resistant tetrasaccharides (T5 and T6). Treatment of BI heparin with either 6-OST-1, 6-OST-3 and 3-OST-1 or 3-OST-1 alone enhances the content of tetrasaccharides (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>) but to different degrees. The presence of 6-OST-1 and 6-OST-3 increases the sulfation level of the resulting resistant tetrasaccharides as evidenced from the higher intensity of the peaks eluting later (having greater net charge) and their molecular mass (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01269/20171020/images/medium/jm-2017-01269a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01269/20171020/images/large/jm-2017-01269a_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Extracted ion chromatogram of tetrasaccharide mapping on BI heparins and PI heparin. T1 (<i>m</i>/<i>z</i> 477) is ΔUA-GlcNAc6S-GlcA-GlcNS3S. T2 (<i>m</i>/<i>z</i> 517) is ΔUA-GlcNAc6S-GlcA-GlcNS3S6S. T3 (<i>m</i>/<i>z</i> 536) is ΔUA-GlcNS6S-GlcA-GlcNS3S6S. T4 (<i>m</i>/<i>z</i> 557) is ΔUA-GlcNAc2S6S-GlcA-GlcNS3S6S. T5 (<i>m</i>/<i>z</i> 536) and T6 (<i>m</i>/<i>z</i> 536) have unknown structures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01269/20171020/images/large/jm-2017-01269a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01269&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2-5" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Binding Analysis</h3><div class="NLM_p">Heparin anticoagulant activity results from the binding of heparin to the AT site on its blood factor targets. There are a number of approaches for determining AT binding site content. These include activity assays, AT-based affinity fractionation of heparin chains, fluorescence binding assays, and competitive SPR. The competitive binding assay was recently developed by our laboratory<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> and was found to be a very specific method correlating well with anti-Xa activity and AT binding site content. Thus, we compared the protein binding of the modified BI heparins to BI and PI heparins based on a competitive binding study using surface plasmon resonance (SPR) (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>). Since the resistant tetrasaccharide content increased on treatment with 6-OST-1, 6-OST-3 and 3-OST-1, or 3-OST-1 alone, we expected that the AT-binding activity would be similarly enhanced.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Unmodified BI heparin required over 3-fold higher concentration to compete with USP heparin than did PI heparin (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A). In contrast, BI heparin treated with 3-OST-1 alone or 6-OST-1, 6-OST-3 and 3-OST-1 showed 3-fold and 5-fold lower concentrations than PI heparin to displace AT from surface-bound USP heparin. These results clearly demonstrate that competent AT binding sites had been generated in BI heparin with both treatments, consistent with the results obtained in the tetrasaccharide mapping experiment.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01269/20171020/images/medium/jm-2017-01269a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01269/20171020/images/large/jm-2017-01269a_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Surface plasmon resonance IC<sub>50</sub> measurement of bovine heparins using surface competition SPR: (A) IC<sub>50</sub> for AT binding of heparins; (B) IC<sub>50</sub> for PF4 binding of heparins.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01269/20171020/images/large/jm-2017-01269a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01269&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">SPR competition studies performed with PF4 (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B) showed that PI and BI heparins had comparable binding in terms of IC<sub>50</sub>, but the shapes of the binding curves were dissimilar, with BI heparin showing much more PF4 binding at high concentrations than PI heparin. This is particularly concerning since much higher concentrations of BI heparin are required compared to PI heparin for the anticoagulant activity effect. The 6-OST-1, 6-OST-3 and 3-OST-1 treated BI heparin had significantly higher affinity for PF4 consistent with its higher level of sulfation and its particularly high TriS content (74% compared to 66% for PI and 50% for BI heparin, respectively) (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). In contrast, the 3-OST-1 treated BI heparin showed considerably weaker binding to PF4. This is consistent with the fact that 3-OST-1 treatment cannot increase TriS content (TriS has no 3-<i>O</i>-sulfo group and can only be enhanced by treatment with 6-OST-1 and/or 6-OST-3, which can convert →4) α-L-IdoA2S (1→4) α-D-GlcNS (1→ into →4) α-L-IdoA2S (1→4) α-D-GlcNS6S (1→ (TriS)). It is noteworthy that while 3-OST-1 treatment slightly alters the relative TriS content based on disaccharide analysis (55% for BI heparin compared to 54% for BI 3S (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), this increase is an artifact of the increased level of resistant tetrasaccharides (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>), corresponding to AT-binding sites (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A).</div></div><div id="sec2-6" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Anticoagulant Activity</h3><div class="NLM_p last">The anticoagulant activity of the remodeled BI heparins was next measured using the methods described in the current USP heparin monograph and compared to those of PI and BI heparins (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). As expected, PI heparin showed an anti-FXa activity of 200 U/mg, an anti-FIIa activity of 200 U/mg with an anti-FXa/anti-FIIa ratio of 1.0, consistent with USP requirements of >180 U/mg with an anti-FXa/anti-FIIa ratio of 0.9–1.1.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> BI heparin showed considerably lower anti-FXa activity of 110 U/mg, an anti-FIIa activity of 105 U/mg with an anti-FXa/anti-FIIa ratio of 1.0. BI 3S, and BI3S6S heparins both showed activities greatly enhanced over PI heparin. Although remodeled BI heparin shows relatively higher anticoagulant activity, it meets all current USP criteria for pharmaceutical grade heparin. Two possible approaches to reduce activity closer to 180 U/mg are less exhaustive treatment of BI heparin with 3-OST-1 or blending untreated BI heparin with 3-OST-1-treated BI heparin.</div></div><div id="sec2-7" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Pharmacodynamics and Pharmacokinetics</h3><div class="NLM_p">Finally, in vivo pharmacodynamics/pharmacokinetics analysis (PD/PK)<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> was undertaken in the rabbit model (<i>n</i> = 3) with intravenous administration of BI 3S heparin at a dose of 6.4 mg/kg (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A). The blood was sampled prior to dosage and up to 2 h after administration. PD analysis showed BI 3S heparin had a <i>t</i><sub>1/2</sub> of 28 and 44 min based on anti-FXa activity and anti-FIIa activity, respectively. The area under the curve (AUC) for these activities was 665 and 826 U·min/mL, respectively. PK was next determined using disaccharide analysis relying on multiple reaction monitoring (MRM) as previously described.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> The concentration of heparin in the plasma was calculated and afforded a <i>t</i><sub>1/2</sub> of 30 min and an AUC of 714 μg·min/mL. The PD data compared favorably with historic data from our laboratory in rabbits (by the same route and same dose) that examined eight different contemporary USP (PI) heparins (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>B). PI heparin had a <i>t</i><sub>1/2</sub> of 105 and 45 min, AUC of 1925 and 1164 U·min/mL, respectively, based on anti-FXa activity and anti-FIIa activity.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01269/20171020/images/medium/jm-2017-01269a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01269/20171020/images/large/jm-2017-01269a_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Pharmacodynamics/pharmacokinetics (PK/PD) of heparins in the rabbit: (A) BI 3S heparin (in triplicate, ±SD); (B) PI heparin (<i>n</i> = 7 USP PI heparins, each in triplicate, ±SD).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01269/20171020/images/large/jm-2017-01269a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01269&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07078" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07078" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The current study provides proof-of-concept experiments that bovine heparin of low activity can be remodeled to meet USP specifications. The results of this study show that it is possible to increase the activity of BI heparin to that of PI heparin through its treatment with 6-OST-1, 6-OST-3 and 3-OST-1. Surprisingly, treatment of BI heparin with 3-OST-1 alone also afforded a remodeled heparin that met the ant-FXa and anti-FIIa activity requirements of PI heparin. While treatment with 6-OST-1, 6-OST-3 and 3-OST-1 provided BI 3S6S heparin that was closer in composition to PI heparin and had the highest anticoagulant activity, this approach had two limitations. First, the resulting heparin had a very high level of sulfation and was particularly rich in the fully modified TriS sequence. This sequence, known to be responsible for PF4 binding, showed enhanced binding to PF4 and thus might increase the incidence of the HIT side effect associated with the intravenous use of heparin. Second, the use of three enzymes each requiring PAPS cofactor would significantly increase the cost of remodeling BI heparin to meet the USP activity specifications. Thus, we undertook a more selective remodeling strategy that relied only on 3-OST-1 and PAPS to enhance only the AT-binding activity without enhancing the PF4 binding and also decreasing the cost and complexity of the remodeling process. The result was a remodeled BI 3S heparin that met USP activity specifications without enhanced PF4 binding. Preliminary PD/PK studies showed that this remodeled BI heparin behaved similarly to PI (USP) heparins. Cautionary notes are required for this study. The authors are aware that heparin, particularly crude unprocessed raw heparin, is under continued risk from illegal blending, adulteration, and processing. Remodeling of BI heparin for human use (alone or blended with other heparins) is not acceptable without appropriate regulatory oversight and approval. Additional in vivo evaluation of remodeled BI heparin is required prior to human use. Remodeled BI heparin is structurally different from PI heparin. Ultimately, the avoidance of animal-sourced heparins might be the only way to prevent future contamination and secure the heparin supply.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25403" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25403" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="secz" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Enzymatic Sulfation of Bovine Heparins</h3><div class="NLM_p last">Two BI heparin samples (20 mg each) were treated in parallel either with both 6-OST-1, -3 and 3-OST-1 or with only 3-OST-1. The sulfation reaction was coupled with a PAPS recycling system that consisted of potassium 4-nitrophenyl sulfate (PNPS), PAPS, and AST-IV. The detailed reaction conditions are as follows: substrate concentration of 1 mg/mL, each enzyme concentration of 0.5 mg/mL for 50% slurry, PNPS and PAPS concentrations of 10 mM and 250 μM, respectively. All reactions were incubated at 37 °C for 40 h in 50 mM 2-(<i>N</i>-morpholino)ethanesulfonic acid (MES) buffer (pH 7.2). After the reaction was complete, the mixtures were filtered to remove enzyme resin, dialyzed using 5K Da molecular weight cutoff (MWCO) centrifugal membrane units with distilled water to remove PNP, PAPS, MES salt, and other small molecule impurities, and the retentates were lyophilized for further analysis. NMR and disaccharide compositional analysis confirmed the purity of each polysaccharide product to be ≥95%.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01269">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55086" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55086" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01269" class="ext-link">10.1021/acs.jmedchem.7b01269</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Heparin sources, enzyme expression and immobilization, disaccharide and tetrasaccharide analysis, NMR spectroscopy, molecular weight and concentration determinations, surface plasmon resonance binding analysis, in vitro anticoagulant activity measurement, purity and quality analysis of modified bovine intestinal heparins, animal studies and determination of PD, PK studies, supplementary tables, and supplementary figures (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01269/suppl_file/jm7b01269_si_001.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01269/suppl_file/jm7b01269_si_001.pdf">jm7b01269_si_001.pdf (1.17 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b01269" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17025" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17025" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin Li</span> - <span class="hlFld-Affiliation affiliation">†Center for Biotechnology and Interdisciplinary Studies, ‡Department of Chemical
and Biological Engineering, §Department of Biomedical Engineering, ∥Department of Biology, and ⊥Department of
Chemistry and Chemical Biology, Rensselaer
Polytechnic Institute, Troy, New York 12180, United States</span>; 
    <span class="hlFld-Affiliation affiliation">The Pharmaceutical
Research Institute, Albany College of Pharmacy, Rensselaer, New York 12144, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Physiology, Veterinary Medicine Faculty, Uludag University, Gorukle 16059, Bursa, Turkey</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lei Lin</span> - <span class="hlFld-Affiliation affiliation">†Center for Biotechnology and Interdisciplinary Studies, ‡Department of Chemical
and Biological Engineering, §Department of Biomedical Engineering, ∥Department of Biology, and ⊥Department of
Chemistry and Chemical Biology, Rensselaer
Polytechnic Institute, Troy, New York 12180, United States</span>; 
    <span class="hlFld-Affiliation affiliation">The Pharmaceutical
Research Institute, Albany College of Pharmacy, Rensselaer, New York 12144, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Physiology, Veterinary Medicine Faculty, Uludag University, Gorukle 16059, Bursa, Turkey</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert J. Linhardt</span> - <span class="hlFld-Affiliation affiliation">†Center for Biotechnology and Interdisciplinary Studies, ‡Department of Chemical
and Biological Engineering, §Department of Biomedical Engineering, ∥Department of Biology, and ⊥Department of
Chemistry and Chemical Biology, Rensselaer
Polytechnic Institute, Troy, New York 12180, United States</span>; 
    <span class="hlFld-Affiliation affiliation">The Pharmaceutical
Research Institute, Albany College of Pharmacy, Rensselaer, New York 12144, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Physiology, Veterinary Medicine Faculty, Uludag University, Gorukle 16059, Bursa, Turkey</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2219-5833" title="Orcid link">http://orcid.org/0000-0003-2219-5833</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2e424740464f5c6e5c5e47004b4a5b"><span class="__cf_email__" data-cfemail="b5d9dcdbddd4c7f5c7c5dc9bd0d1c0">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Li Fu</span> - <span class="hlFld-Affiliation affiliation">†Center for Biotechnology and Interdisciplinary Studies, ‡Department of Chemical
and Biological Engineering, §Department of Biomedical Engineering, ∥Department of Biology, and ⊥Department of
Chemistry and Chemical Biology, Rensselaer
Polytechnic Institute, Troy, New York 12180, United States</span>; 
    <span class="hlFld-Affiliation affiliation">The Pharmaceutical
Research Institute, Albany College of Pharmacy, Rensselaer, New York 12144, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Physiology, Veterinary Medicine Faculty, Uludag University, Gorukle 16059, Bursa, Turkey</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daisuke Mori</span> - <span class="hlFld-Affiliation affiliation">†Center for Biotechnology and Interdisciplinary Studies, ‡Department of Chemical
and Biological Engineering, §Department of Biomedical Engineering, ∥Department of Biology, and ⊥Department of
Chemistry and Chemical Biology, Rensselaer
Polytechnic Institute, Troy, New York 12180, United States</span>; 
    <span class="hlFld-Affiliation affiliation">The Pharmaceutical
Research Institute, Albany College of Pharmacy, Rensselaer, New York 12144, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Physiology, Veterinary Medicine Faculty, Uludag University, Gorukle 16059, Bursa, Turkey</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Makoto Hirakane</span> - <span class="hlFld-Affiliation affiliation">†Center for Biotechnology and Interdisciplinary Studies, ‡Department of Chemical
and Biological Engineering, §Department of Biomedical Engineering, ∥Department of Biology, and ⊥Department of
Chemistry and Chemical Biology, Rensselaer
Polytechnic Institute, Troy, New York 12180, United States</span>; 
    <span class="hlFld-Affiliation affiliation">The Pharmaceutical
Research Institute, Albany College of Pharmacy, Rensselaer, New York 12144, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Physiology, Veterinary Medicine Faculty, Uludag University, Gorukle 16059, Bursa, Turkey</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Navdeep Grover</span> - <span class="hlFld-Affiliation affiliation">†Center for Biotechnology and Interdisciplinary Studies, ‡Department of Chemical
and Biological Engineering, §Department of Biomedical Engineering, ∥Department of Biology, and ⊥Department of
Chemistry and Chemical Biology, Rensselaer
Polytechnic Institute, Troy, New York 12180, United States</span>; 
    <span class="hlFld-Affiliation affiliation">The Pharmaceutical
Research Institute, Albany College of Pharmacy, Rensselaer, New York 12144, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Physiology, Veterinary Medicine Faculty, Uludag University, Gorukle 16059, Bursa, Turkey</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Payel Datta</span> - <span class="hlFld-Affiliation affiliation">†Center for Biotechnology and Interdisciplinary Studies, ‡Department of Chemical
and Biological Engineering, §Department of Biomedical Engineering, ∥Department of Biology, and ⊥Department of
Chemistry and Chemical Biology, Rensselaer
Polytechnic Institute, Troy, New York 12180, United States</span>; 
    <span class="hlFld-Affiliation affiliation">The Pharmaceutical
Research Institute, Albany College of Pharmacy, Rensselaer, New York 12144, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Physiology, Veterinary Medicine Faculty, Uludag University, Gorukle 16059, Bursa, Turkey</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yanlei Yu</span> - <span class="hlFld-Affiliation affiliation">†Center for Biotechnology and Interdisciplinary Studies, ‡Department of Chemical
and Biological Engineering, §Department of Biomedical Engineering, ∥Department of Biology, and ⊥Department of
Chemistry and Chemical Biology, Rensselaer
Polytechnic Institute, Troy, New York 12180, United States</span>; 
    <span class="hlFld-Affiliation affiliation">The Pharmaceutical
Research Institute, Albany College of Pharmacy, Rensselaer, New York 12144, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Physiology, Veterinary Medicine Faculty, Uludag University, Gorukle 16059, Bursa, Turkey</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jing Zhao</span> - <span class="hlFld-Affiliation affiliation">†Center for Biotechnology and Interdisciplinary Studies, ‡Department of Chemical
and Biological Engineering, §Department of Biomedical Engineering, ∥Department of Biology, and ⊥Department of
Chemistry and Chemical Biology, Rensselaer
Polytechnic Institute, Troy, New York 12180, United States</span>; 
    <span class="hlFld-Affiliation affiliation">The Pharmaceutical
Research Institute, Albany College of Pharmacy, Rensselaer, New York 12144, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Physiology, Veterinary Medicine Faculty, Uludag University, Gorukle 16059, Bursa, Turkey</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fuming Zhang</span> - <span class="hlFld-Affiliation affiliation">†Center for Biotechnology and Interdisciplinary Studies, ‡Department of Chemical
and Biological Engineering, §Department of Biomedical Engineering, ∥Department of Biology, and ⊥Department of
Chemistry and Chemical Biology, Rensselaer
Polytechnic Institute, Troy, New York 12180, United States</span>; 
    <span class="hlFld-Affiliation affiliation">The Pharmaceutical
Research Institute, Albany College of Pharmacy, Rensselaer, New York 12144, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Physiology, Veterinary Medicine Faculty, Uludag University, Gorukle 16059, Bursa, Turkey</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2803-3704" title="Orcid link">http://orcid.org/0000-0003-2803-3704</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Murat Yalcin</span> - <span class="hlFld-Affiliation affiliation">The Pharmaceutical
Research Institute, Albany College of Pharmacy, Rensselaer, New York 12144, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Physiology, Veterinary Medicine Faculty, Uludag University, Gorukle 16059, Bursa, Turkey</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shaker A. Mousa</span> - <span class="hlFld-Affiliation affiliation">The Pharmaceutical
Research Institute, Albany College of Pharmacy, Rensselaer, New York 12144, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jonathan S. Dordick</span> - <span class="hlFld-Affiliation affiliation">†Center for Biotechnology and Interdisciplinary Studies, ‡Department of Chemical
and Biological Engineering, §Department of Biomedical Engineering, ∥Department of Biology, and ⊥Department of
Chemistry and Chemical Biology, Rensselaer
Polytechnic Institute, Troy, New York 12180, United States</span>; 
    <span class="hlFld-Affiliation affiliation">The Pharmaceutical
Research Institute, Albany College of Pharmacy, Rensselaer, New York 12144, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Physiology, Veterinary Medicine Faculty, Uludag University, Gorukle 16059, Bursa, Turkey</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>L.F. carried out synthesis, purification, and NMR characterization of modified bovine heparins. P.D. prepared enzymes. K.L. and N.G. purified and immobilized enzymes. D.M. did disaccharide and Mw assays for the modified bovine heparins. M.H. prepared PAPS. Y.Y. and M.H. did anticoagulant assays. L.L. did tetrasaccharide analysis. F.Z. and J.Z. did SPR analysis. M.Y. and S.A.M. did animal studies, and J.S.D. helped plan the studies and write the manuscript. R.J.L. designed and supervised the project and wrote the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07180" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07180" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by U.S. NIH Grants HL096972, HL62244, HL094463, and GM38060.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i16" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i16"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i17" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i17"> Abbreviations Used</h2><tr><td class="NLM_term">USP</td><td class="NLM_def"><p class="first last">United States Pharmacopeia</p></td></tr><tr><td class="NLM_term">6-OST-1 and -3</td><td class="NLM_def"><p class="first last">6-<i>O</i>-sulfotransferase isoform-1 and -3</p></td></tr><tr><td class="NLM_term">3-OST</td><td class="NLM_def"><p class="first last">3-<i>O</i>-sulfotransferase isoform-1</p></td></tr><tr><td class="NLM_term">IdoA</td><td class="NLM_def"><p class="first last">iduronic acid</p></td></tr><tr><td class="NLM_term">GlcN</td><td class="NLM_def"><p class="first last">glucosamine</p></td></tr><tr><td class="NLM_term">S</td><td class="NLM_def"><p class="first last">sulfo</p></td></tr><tr><td class="NLM_term">GlcA</td><td class="NLM_def"><p class="first last">glucuronic acid</p></td></tr><tr><td class="NLM_term">GlcNAc</td><td class="NLM_def"><p class="first last"><i>N</i>-acetyl glucosamine</p></td></tr><tr><td class="NLM_term">TriS</td><td class="NLM_def"><p class="first last">trisulfated</p></td></tr><tr><td class="NLM_term">AT</td><td class="NLM_def"><p class="first last">antithrombin III</p></td></tr><tr><td class="NLM_term">FIIa</td><td class="NLM_def"><p class="first last">factor IIa or thrombin</p></td></tr><tr><td class="NLM_term">FXa</td><td class="NLM_def"><p class="first last">factor Xa</p></td></tr><tr><td class="NLM_term">BSE</td><td class="NLM_def"><p class="first last">bovine spongiform encephalopathy</p></td></tr><tr><td class="NLM_term">HIT</td><td class="NLM_def"><p class="first last">heparin-induced thrombocytopenia</p></td></tr><tr><td class="NLM_term">PF4</td><td class="NLM_def"><p class="first last">platelet factor IV</p></td></tr><tr><td class="NLM_term">API</td><td class="NLM_def"><p class="first last">active pharmaceutical ingredient</p></td></tr><tr><td class="NLM_term">MBP</td><td class="NLM_def"><p class="first last">maltose binding protein</p></td></tr><tr><td class="NLM_term">PNPS</td><td class="NLM_def"><p class="first last"><i>p</i>-nitrophenyl sulfate</p></td></tr><tr><td class="NLM_term">PAPS</td><td class="NLM_def"><p class="first last">3<sup>′</sup>-phosphoadenosine 5<sup>′</sup>-phosphosulfate</p></td></tr><tr><td class="NLM_term">MWCO</td><td class="NLM_def"><p class="first last">molecular weight cutoff</p></td></tr><tr><td class="NLM_term">AST-IV</td><td class="NLM_def"><p class="first last">arylsulfotransferase-IV</p></td></tr><tr><td class="NLM_term">SAX</td><td class="NLM_def"><p class="first last">strong anion exchange</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high performance liquid chromatography</p></td></tr><tr><td class="NLM_term">PI</td><td class="NLM_def"><p class="first last">porcine intestinal</p></td></tr><tr><td class="NLM_term">BI</td><td class="NLM_def"><p class="first last">bovine intestinal</p></td></tr><tr><td class="NLM_term">1D</td><td class="NLM_def"><p class="first last">one-dimensional</p></td></tr><tr><td class="NLM_term">DEPT</td><td class="NLM_def"><p class="first last">distortionless enhancement by polarization transfer</p></td></tr><tr><td class="NLM_term">RPIP</td><td class="NLM_def"><p class="first last">reverse phase ion pairing</p></td></tr><tr><td class="NLM_term">MS</td><td class="NLM_def"><p class="first last">mass spectral</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">surface plasmon resonance</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">pharmacodynamics</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">MRM</td><td class="NLM_def"><p class="first last">multiple reaction monitoring</p></td></tr><tr><td class="NLM_term">MES</td><td class="NLM_def"><p class="first last">2-(<i>N</i>-morpholino)ethanesulfonic acid</p></td></tr><tr><td class="NLM_term">GPC</td><td class="NLM_def"><p class="first last">gel permeation chromatography</p></td></tr><tr><td class="NLM_term">M<sub>W</sub></td><td class="NLM_def"><p class="first last">weight-average molecular weight</p></td></tr><tr><td class="NLM_term">EDTA</td><td class="NLM_def"><p class="first last">ethylenediaminetetraacetic acid</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45241" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45241" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 39 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Onishi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Ange, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dordick, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Heparin and anticoagulation, glycosaminoglycans and related disorders</span> <span class="citation_source-journal">Front. Biosci., Landmark Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1372</span><span class="NLM_x">–</span> <span class="NLM_lpage">1392</span><span class="refDoi"> DOI: 10.2741/4462</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.2741%2F4462" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=27100512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A280%3ADC%252BC28bisVWntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=1372-1392&author=A.+Onishiauthor=K.+St.+Angeauthor=J.+S.+Dordickauthor=R.+J.+Linhardt&title=Heparin+and+anticoagulation%2C+glycosaminoglycans+and+related+disorders&doi=10.2741%2F4462"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Heparin and anticoagulation</span></div><div class="casAuthors">Onishi Akihiro; St Ange Kalib; Dordick Jonathan S; Linhardt Robert J</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in bioscience (Landmark edition)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1372-92</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Heparin, a sulfated polysaccharide, has been used as a clinical anticoagulant for over 90 years.  Newer anticoagulants, introduced for certain specialized applications, have not significantly displaced heparin and newer heparin-based anticoagulants in most medical procedures.  This chapter, while reviewing anticoagulation and these newer anticoagulants, focuses on heparin-based anticoagulants, including unfractionated heparin, low molecular weight heparins and ultra-low molecular weight heparins.  Heparin's structures and its biological and therapeutic roles are discussed.  Particular emphasis is placed on heparin's therapeutic application and its adverse effects.  The future prospects are excellent for new heparins and new heparin-based therapeutics with improved properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTxto5WiqPPps-crCu0nI_sfW6udTcc2ebWRXY6QGKMdLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28bisVWntw%253D%253D&md5=e8b8df6bd3d5d5486d7686ffdc0feaeb</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2741%2F4462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F4462%26sid%3Dliteratum%253Aachs%26aulast%3DOnishi%26aufirst%3DA.%26aulast%3DSt.%2BAnge%26aufirst%3DK.%26aulast%3DDordick%26aufirst%3DJ.%2BS.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DHeparin%2520and%2520anticoagulation%252C%2520glycosaminoglycans%2520and%2520related%2520disorders%26jtitle%3DFront.%2520Biosci.%252C%2520Landmark%2520Ed.%26date%3D2016%26volume%3D21%26spage%3D1372%26epage%3D1392%26doi%3D10.2741%2F4462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Mulloy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogwood, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lever, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, C. P.</span><span> </span><span class="NLM_article-title">Pharmacology of heparin and related drugs</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">76</span><span class="NLM_x">–</span> <span class="NLM_lpage">141</span><span class="refDoi"> DOI: 10.1124/pr.115.011247</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1124%2Fpr.115.011247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=26672027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A280%3ADC%252BC28rit1ygsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2016&pages=76-141&author=B.+Mulloyauthor=J.+Hogwoodauthor=E.+Grayauthor=R.+Leverauthor=C.+P.+Page&title=Pharmacology+of+heparin+and+related+drugs&doi=10.1124%2Fpr.115.011247"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology of Heparin and Related Drugs</span></div><div class="casAuthors">Mulloy Barbara; Hogwood John; Gray Elaine; Lever Rebecca; Page Clive P</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">76-141</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Heparin has been recognized as a valuable anticoagulant and antithrombotic for several decades and is still widely used in clinical practice for a variety of indications.  The anticoagulant activity of heparin is mainly attributable to the action of a specific pentasaccharide sequence that acts in concert with antithrombin, a plasma coagulation factor inhibitor.  This observation has led to the development of synthetic heparin mimetics for clinical use.  However, it is increasingly recognized that heparin has many other pharmacological properties, including but not limited to antiviral, anti-inflammatory, and antimetastatic actions.  Many of these activities are independent of its anticoagulant activity, although the mechanisms of these other activities are currently less well defined.  Nonetheless, heparin is being exploited for clinical uses beyond anticoagulation and developed for a wide range of clinical disorders.  This article provides a "state of the art" review of our current understanding of the pharmacology of heparin and related drugs and an overview of the status of development of such drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR6h7u2NTAthnp3bfzSLaX5fW6udTcc2eb9zekhw1ud9bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rit1ygsw%253D%253D&md5=3f4ff312be9b121ee845ccf1ff10fbee</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1124%2Fpr.115.011247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.115.011247%26sid%3Dliteratum%253Aachs%26aulast%3DMulloy%26aufirst%3DB.%26aulast%3DHogwood%26aufirst%3DJ.%26aulast%3DGray%26aufirst%3DE.%26aulast%3DLever%26aufirst%3DR.%26aulast%3DPage%26aufirst%3DC.%2BP.%26atitle%3DPharmacology%2520of%2520heparin%2520and%2520related%2520drugs%26jtitle%3DPharmacol.%2520Rev.%26date%3D2016%26volume%3D68%26spage%3D76%26epage%3D141%26doi%3D10.1124%2Fpr.115.011247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhaskar, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akihiro, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dordick, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Response surface optimization of the heparosan <i>N</i>-deacetylation in producing bioengineered heparin</span> <span class="citation_source-journal">J. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">156</span><span class="NLM_x">, </span> <span class="NLM_fpage">188</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span><span class="refDoi"> DOI: 10.1016/j.jbiotec.2011.08.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1016%2Fj.jbiotec.2011.08.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=21925548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlalurjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2011&pages=188-196&author=Z.+Wangauthor=J.+Liauthor=S.+Cheongauthor=U.+Bhaskarauthor=O.+Akihiroauthor=F.+Zhangauthor=J.+S.+Dordickauthor=R.+J.+Linhardt&title=Response+surface+optimization+of+the+heparosan+N-deacetylation+in+producing+bioengineered+heparin&doi=10.1016%2Fj.jbiotec.2011.08.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Response surface optimization of the heparosan N-deacetylation in producing bioengineered heparin</span></div><div class="casAuthors">Wang, Zhenyu; Li, Jennifer; Cheong, Samantha; Bhaskar, Ujjwal; Akihiro, Onishi; Zhang, Fuming; Dordick, Jonathan S.; Linhardt, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">188-196</span>CODEN:
                <span class="NLM_cas:coden">JBITD4</span>;
        ISSN:<span class="NLM_cas:issn">0168-1656</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The chem. step in the chemoenzymic synthesis of bioengineered heparin has been examd. and optimized statistically using a response surface methodol.  A four factor, two level full factorial design expt. and a three factor Box-Behnken design were carried out.  The goal was to establish a method to prep. N-sulfo, N-acetyl heparosan of the desired N-acetyl content, no. av. mol. wt., and in max. yield by controlling the reactant concns., reaction time and reaction temp.  The response surface models obtained were used to predict the reaction conditions required to optimally prep. N-sulfo, N-acetyl heparosan from Escherichia coli generated heparosan starting material of different mol. wts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3yYyMCPPukbVg90H21EOLACvtfcHk0ljdLvmAYYa0FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlalurjJ&md5=09644ad975da2bf61e3bf7d6b56d2fc1</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.jbiotec.2011.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jbiotec.2011.08.013%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DCheong%26aufirst%3DS.%26aulast%3DBhaskar%26aufirst%3DU.%26aulast%3DAkihiro%26aufirst%3DO.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DDordick%26aufirst%3DJ.%2BS.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DResponse%2520surface%2520optimization%2520of%2520the%2520heparosan%2520N-deacetylation%2520in%2520producing%2520bioengineered%2520heparin%26jtitle%3DJ.%2520Biotechnol.%26date%3D2011%26volume%3D156%26spage%3D188%26epage%3D196%26doi%3D10.1016%2Fj.jbiotec.2011.08.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Carlsson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kjellén, L.</span><span> </span><span class="NLM_article-title">Heparin biosynthesis</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">207</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span><span class="refDoi"> DOI: 10.1007/978-3-642-23056-1_2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1007%2F978-3-642-23056-1_2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=22566219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkvVCnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=207&publication_year=2012&pages=23-41&author=P.+Carlssonauthor=L.+Kjell%C3%A9n&title=Heparin+biosynthesis&doi=10.1007%2F978-3-642-23056-1_2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Heparin Biosynthesis</span></div><div class="casAuthors">Carlsson, Pernilla; Kjellen, Lena</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">207</span>
        (<span class="NLM_cas:issue">Heparin</span>),
    <span class="NLM_cas:pages">23-41</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">This review details the biosynthesis of heparin and heparan sulfate.  Heparin and heparan sulfate share the same polysaccharide backbone structure but differ in sulfation degree and expression pattern.  Whereas heparan sulfate is found in virtually all cells of the human body, heparin expression is restricted to mast cells, where it has a function in storage of granular components such as histamine and mast cell specific proteases.  Although differing in charge and sulfation pattern, current knowledge indicates that the same pathway is used for synthesis of heparin and heparan sulfate, with a large no. of different enzymes taking part in the process.  At present, little is known about how the individual enzymes are coordinated and how biosynthesis is regulated.  These questions are addressed in this chapter together with a review of the basic enzymic steps involved in initiation, elongation, and modification of the polysaccharides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCywP-6a0xPbVg90H21EOLACvtfcHk0ljdLvmAYYa0FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkvVCnuw%253D%253D&md5=ef10b01eb2301503f48198aac6199815</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-23056-1_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-642-23056-1_2%26sid%3Dliteratum%253Aachs%26aulast%3DCarlsson%26aufirst%3DP.%26aulast%3DKjell%25C3%25A9n%26aufirst%3DL.%26atitle%3DHeparin%2520biosynthesis%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2012%26volume%3D207%26spage%3D23%26epage%3D41%26doi%3D10.1007%2F978-3-642-23056-1_2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Casu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindahl, U.</span><span> </span><span class="NLM_article-title">Structure and biological interactions of heparin and heparan sulfate</span> <span class="citation_source-journal">Adv. Carbohydr. Chem. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span><span class="refDoi"> DOI: 10.1016/S0065-2318(01)57017-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1016%2FS0065-2318%2801%2957017-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2001&pages=159-206&author=B.+Casuauthor=U.+Lindahl&title=Structure+and+biological+interactions+of+heparin+and+heparan+sulfate&doi=10.1016%2FS0065-2318%2801%2957017-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0065-2318%2801%2957017-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0065-2318%252801%252957017-1%26sid%3Dliteratum%253Aachs%26aulast%3DCasu%26aufirst%3DB.%26aulast%3DLindahl%26aufirst%3DU.%26atitle%3DStructure%2520and%2520biological%2520interactions%2520of%2520heparin%2520and%2520heparan%2520sulfate%26jtitle%3DAdv.%2520Carbohydr.%2520Chem.%2520Biochem.%26date%3D2001%26volume%3D57%26spage%3D159%26epage%3D206%26doi%3D10.1016%2FS0065-2318%2801%2957017-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Heparin: Structure and activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2551</span><span class="NLM_x">–</span> <span class="NLM_lpage">2554</span><span class="refDoi"> DOI: 10.1021/jm030176m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030176m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjvVahurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2551-2554&author=R.+J.+Linhardt&title=Heparin%3A+Structure+and+activity&doi=10.1021%2Fjm030176m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">2003 Claude S. Hudson Award Address in Carbohydrate Chemistry. Heparin: Structure and Activity</span></div><div class="casAuthors">Linhardt, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2551-2564</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWePYNjeX7jrVg90H21EOLACvtfcHk0ljWueCM34fIeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjvVahurc%253D&md5=0df0318e0547d6dcd8120c4516b3b320</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm030176m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030176m%26sid%3Dliteratum%253Aachs%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DHeparin%253A%2520Structure%2520and%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D2551%26epage%3D2554%26doi%3D10.1021%2Fjm030176m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agyekum, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Ange, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amster, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Structural analysis of heparin-derived 3-O-sulfated tetrasaccharides: Antithrombin binding site variants</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">973</span><span class="NLM_x">–</span> <span class="NLM_lpage">981</span><span class="refDoi"> DOI: 10.1016/j.xphs.2016.11.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1016%2Fj.xphs.2016.11.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=28007564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC2sXos1KitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2017&pages=973-981&author=Y.+Chenauthor=L.+Linauthor=I.+Agyekumauthor=X.+Zhangauthor=K.+St.+Angeauthor=Y.+Yuauthor=F.+Zhangauthor=J.+Liuauthor=I.+J.+Amsterauthor=R.+J.+Linhardt&title=Structural+analysis+of+heparin-derived+3-O-sulfated+tetrasaccharides%3A+Antithrombin+binding+site+variants&doi=10.1016%2Fj.xphs.2016.11.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Analysis of Heparin-Derived 3-O-Sulfated Tetrasaccharides: Antithrombin Binding Site Variants</span></div><div class="casAuthors">Chen, Yin; Lin, Lei; Agyekum, Isaac; Zhang, Xing; St. Ange, Kalib; Yu, Yanlei; Zhang, Fuming; Liu, Jian; Amster, I. Jonathan; Linhardt, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">973-981</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Heparin is a polysaccharide that is widely used as an anticoagulant drug.  The mechanism for heparin's anticoagulant activity is primarily through its interaction with a serine protease inhibitor, antithrombin III (AT), that enhances its ability to inactivate blood coagulation serine proteases, including thrombin (factor IIa) and factor Xa.  The AT-binding site in the heparin is one of the most well-studied carbohydrate-protein binding sites and its structure is the basis for the synthesis of the heparin pentasaccharide drug, fondaparinux.  Despite the authors' understanding of the structural requirements for the heparin pentasaccharide AT-binding site, there is a lack of data on the natural variability of these binding sites in heparins extd. from animal tissues.  The present work provides a detailed study on the structural variants of the tetrasaccharide fragments of this binding site afforded following treatment of a heparin with heparin lyase II.  The 5 most commonly obsd. tetrasaccharide fragments of the AT-binding site are fully characterized, and a method for their quantification in heparin and low-mol.-wt. heparin products is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoboAnvJZE187Vg90H21EOLACvtfcHk0ljWueCM34fIeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXos1KitQ%253D%253D&md5=1c43579482248fd186fb462b9293f03b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.xphs.2016.11.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.xphs.2016.11.023%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DAgyekum%26aufirst%3DI.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DSt.%2BAnge%26aufirst%3DK.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DAmster%26aufirst%3DI.%2BJ.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DStructural%2520analysis%2520of%2520heparin-derived%25203-O-sulfated%2520tetrasaccharides%253A%2520Antithrombin%2520binding%2520site%2520variants%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2017%26volume%3D106%26spage%3D973%26epage%3D981%26doi%3D10.1016%2Fj.xphs.2016.11.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Yu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirakane, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Structural and activity variability of fractions with different charge density and chain length from pharmaceutical heparins</span> <span class="citation_source-journal">Glycoconjugate J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">545</span><span class="NLM_x">–</span> <span class="NLM_lpage">552</span><span class="refDoi"> DOI: 10.1007/s10719-017-9774-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1007%2Fs10719-017-9774-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=28555433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC2sXos1Wns7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2017&pages=545-552&author=Y.+Yuauthor=M.+Hirakaneauthor=D.+Moriauthor=L.+Linauthor=F.+Zhangauthor=H.+Zhangauthor=R.+J.+Linhardt&title=Structural+and+activity+variability+of+fractions+with+different+charge+density+and+chain+length+from+pharmaceutical+heparins&doi=10.1007%2Fs10719-017-9774-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and activity variability of fractions with different charge density and chain length from pharmaceutical heparins</span></div><div class="casAuthors">Yu, Yanlei; Hirakane, Makoto; Mori, Daisuke; Lin, Lei; Zhang, Fuming; Zhang, Hong; Linhardt, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Glycoconjugate Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">545-552</span>CODEN:
                <span class="NLM_cas:coden">GLJOEW</span>;
        ISSN:<span class="NLM_cas:issn">0282-0080</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Heparin is a structurally complex polysaccharide used as a clin. anticoagulant.  It is comprised of a heterogeneous mixt. of polysaccharide chains having a variety of sequences and lengths.  The prodn. methods and regulatory controls of pharmaceutical heparins have changed over the years.  This study assesses the structural and activity uniformity of the polysaccharide chains comprising two contemporary heparin products.  The heparin fractions with different sizes and charges were sepd. with size exclusion and ion exchange chromatog.  The fractions were analyzed for their mol. wt. properties, di- and tetrasaccharide compns., and anti-factor IIa and anti-factor-Xa activities.  The distribution of these properties through chains of different lengths and ones with different charge d. were compared.  The results demonstrate that with the increase in heparin purity, activity and mol. wt. required by the current pharmacopeia, the uniformity of pharmaceutical heparin products have increased.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4NUR2fLSnSbVg90H21EOLACvtfcHk0ljWueCM34fIeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXos1Wns7c%253D&md5=cd794ab7c17107764513878c602adb2a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2Fs10719-017-9774-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10719-017-9774-7%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DY.%26aulast%3DHirakane%26aufirst%3DM.%26aulast%3DMori%26aufirst%3DD.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DStructural%2520and%2520activity%2520variability%2520of%2520fractions%2520with%2520different%2520charge%2520density%2520and%2520chain%2520length%2520from%2520pharmaceutical%2520heparins%26jtitle%3DGlycoconjugate%2520J.%26date%3D2017%26volume%3D34%26spage%3D545%26epage%3D552%26doi%3D10.1007%2Fs10719-017-9774-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Linhardt, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loganathan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, J. H.</span><span> </span><span class="NLM_article-title">Search for the heparin antithrombin III-binding site precursor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">2380</span><span class="NLM_x">–</span> <span class="NLM_lpage">2387</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=2380-2387&author=R.+J.+Linhardtauthor=H.+M.+Wangauthor=D.+Loganathanauthor=J.+H.+Bae&title=Search+for+the+heparin+antithrombin+III-binding+site+precursor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26aulast%3DWang%26aufirst%3DH.%2BM.%26aulast%3DLoganathan%26aufirst%3DD.%26aulast%3DBae%26aufirst%3DJ.%2BH.%26atitle%3DSearch%2520for%2520the%2520heparin%2520antithrombin%2520III-binding%2520site%2520precursor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D2380%26epage%3D2387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Bhaskar, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sterner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onishi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dordick, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Engineering of routes to heparin and related polysaccharides</span> <span class="citation_source-journal">Appl. Microbiol. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span><span class="refDoi"> DOI: 10.1007/s00253-011-3641-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1007%2Fs00253-011-3641-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=22048616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A280%3ADC%252BC387hsl2lsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2012&pages=1-16&author=U.+Bhaskarauthor=E.+Sternerauthor=A.+M.+Hickeyauthor=A.+Onishiauthor=F.+Zhangauthor=J.+S.+Dordickauthor=R.+J.+Linhardt&title=Engineering+of+routes+to+heparin+and+related+polysaccharides&doi=10.1007%2Fs00253-011-3641-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Engineering of routes to heparin and related polysaccharides</span></div><div class="casAuthors">Bhaskar Ujjwal; Sterner Eric; Hickey Anne Marie; Onishi Akihiro; Zhang Fuming; Dordick Jonathan S; Linhardt Robert J</div><div class="citationInfo"><span class="NLM_cas:title">Applied microbiology and biotechnology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-16</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Anticoagulant heparin has been shown to possess important biological functions that vary according to its fine structure.  Variability within heparin's structure occurs owing to its biosynthesis and animal tissue-based recovery and adds another dimension to its complex polymeric structure.  The structural variations in chain length and sulfation patterns mediate its interaction with many heparin-binding proteins, thereby eliciting complex biological responses.  The advent of novel chemical and enzymatic approaches for polysaccharide synthesis coupled with high throughput combinatorial approaches for drug discovery have facilitated an increased effort to understand heparin's structure-activity relationships.  An improved understanding would offer potential for new therapeutic development through the engineering of polysaccharides.  Such a bioengineering approach requires the amalgamation of several different disciplines, including carbohydrate synthesis, applied enzymology, metabolic engineering, and process biochemistry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQLyT6Rs_ItBZcXNb62YGmbfW6udTcc2ebp0bCtvXjADLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC387hsl2lsA%253D%253D&md5=8efbda2da1e3c07c35bff885530f4c08</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs00253-011-3641-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00253-011-3641-4%26sid%3Dliteratum%253Aachs%26aulast%3DBhaskar%26aufirst%3DU.%26aulast%3DSterner%26aufirst%3DE.%26aulast%3DHickey%26aufirst%3DA.%2BM.%26aulast%3DOnishi%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DDordick%26aufirst%3DJ.%2BS.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DEngineering%2520of%2520routes%2520to%2520heparin%2520and%2520related%2520polysaccharides%26jtitle%3DAppl.%2520Microbiol.%2520Biotechnol.%26date%3D2012%26volume%3D93%26spage%3D1%26epage%3D16%26doi%3D10.1007%2Fs00253-011-3641-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">St Ange, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onishi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dordick, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fareed, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoppensteadt, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeske, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Analysis of heparins derived from bovine tissues and comparison to porcine intestinal heparins</span> <span class="citation_source-journal">Clin. Appl. Thromb./Hemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">520</span><span class="NLM_x">–</span> <span class="NLM_lpage">527</span><span class="refDoi"> DOI: 10.1177/1076029616643822</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1177%2F1076029616643822" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=27084870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtl2qsbnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=520-527&author=K.+St+Angeauthor=A.+Onishiauthor=L.+Fuauthor=X.+Sunauthor=L.+Linauthor=D.+Moriauthor=F.+Zhangauthor=J.+S.+Dordickauthor=J.+Fareedauthor=D.+Hoppensteadtauthor=W.+Jeskeauthor=R.+J.+Linhardt&title=Analysis+of+heparins+derived+from+bovine+tissues+and+comparison+to+porcine+intestinal+heparins&doi=10.1177%2F1076029616643822"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of heparins derived from bovine tissues and comparison to porcine intestinal heparins</span></div><div class="casAuthors">St. Ange, Kalib; Onishi, Akihiro; Fu, Li; Sun, Xiaojun; Lin, Lei; Mori, Daisuke; Zhang, Fuming; Dordick, Jonathan S.; Fareed, Jawed; Hoppensteadt, Debra; Jeske, Walter; Linhardt, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Applied Thrombosis/Hemostasis</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">520-527</span>CODEN:
                <span class="NLM_cas:coden">CATHF9</span>;
        ISSN:<span class="NLM_cas:issn">1076-0296</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Heparin is a widely used clin. anticoagulant.  It is also a linear glycosaminoglycan with an av. mass between 10 and 20 kDa and is primarily made up of trisulfated disaccharides comprised of 1,4-linked iduronic acid and glucosamine residues contg. some glucuronic acid residues.  Heparin is biosynthesized in the Golgi of mast cells commonly found in the liver, intestines, and lungs.  Pharmaceutical heparin currently used in the United States is primarily extd. from porcine intestines.  Other sources of heparin including bovine intestine and bovine lung are being examd. as potential substitutes for porcine intestinal heparin.  These addnl. sources are intended to serve to diversify the heparin supply, making this lifesaving drug more secure.  The current study examines bovine heparins prepd. from both intestines and lung and compares these to porcine intestinal heparin.  The structural properties of these heparins are examd. using NMR, gel permeation chromatog., and disaccharide anal. of heparinase-catalyzed depolymd. heparin.  The in vitro functional activities of these heparins have also been detd.  The goal of this study is to establish the structural and functional similarities and potential differences between bovine and porcine heparins.  Porcine and bovine heparins have structural and compositional similarities and differences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohKshEhaI73LVg90H21EOLACvtfcHk0ljhGPJKoR820g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtl2qsbnI&md5=640058911b8b72696c611d3b94fbb83f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1177%2F1076029616643822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1076029616643822%26sid%3Dliteratum%253Aachs%26aulast%3DSt%2BAnge%26aufirst%3DK.%26aulast%3DOnishi%26aufirst%3DA.%26aulast%3DFu%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DMori%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DDordick%26aufirst%3DJ.%2BS.%26aulast%3DFareed%26aufirst%3DJ.%26aulast%3DHoppensteadt%26aufirst%3DD.%26aulast%3DJeske%26aufirst%3DW.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DAnalysis%2520of%2520heparins%2520derived%2520from%2520bovine%2520tissues%2520and%2520comparison%2520to%2520porcine%2520intestinal%2520heparins%26jtitle%3DClin.%2520Appl.%2520Thromb.%252FHemostasis%26date%3D2016%26volume%3D22%26spage%3D520%26epage%3D527%26doi%3D10.1177%2F1076029616643822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Naggi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedrinola, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urso, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alekseeva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassinelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iacomini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baigorria, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torri, G.</span><span> </span><span class="NLM_article-title">Structural peculiarity and antithrombin binding region profile of mucosal bovine and porcine heparins</span> <span class="citation_source-journal">J. Pharm. Biomed. Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">52</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span><span class="refDoi"> DOI: 10.1016/j.jpba.2015.10.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1016%2Fj.jpba.2015.10.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=26512999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslensLfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2016&pages=52-63&author=A.+Naggiauthor=C.+Gardiniauthor=G.+Pedrinolaauthor=L.+Mauriauthor=E.+Ursoauthor=A.+Alekseevaauthor=B.+Casuauthor=G.+Cassinelliauthor=M.+Guerriniauthor=M.+Iacominiauthor=V.+Baigorriaauthor=G.+Torri&title=Structural+peculiarity+and+antithrombin+binding+region+profile+of+mucosal+bovine+and+porcine+heparins&doi=10.1016%2Fj.jpba.2015.10.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Structural peculiarity and antithrombin binding region profile of mucosal bovine and porcine heparins</span></div><div class="casAuthors">Naggi, Annamaria; Gardini, Cristina; Pedrinola, Giacomo; Mauri, Lucio; Urso, Elena; Alekseeva, Anna; Casu, Benito; Cassinelli, Giuseppe; Guerrini, Marco; Iacomini, Marcello; Baigorria, Valentina; Torri, Giangiacomo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">52-63</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The major compositional differences between bovine mucosal heparin (BMH) and the currently employed porcine mucosal heparin (PMH) have been reported to essentially consist of reduced 6-O-sulfation of the glucosamine residues in BMH and somewhat lower 2-O-sulfation of the iduronate residues in PMH.  The present work is based on direct comparison of several BMH and PMH com. prepns.  A combined study by 2D (heteronuclear single quantum coherence, HSQC) NMR and ion-pair reversed-phase high performance liq. chromatog. (IPRP-HPLC) coupled with electrospray ionization mass spectrometry (ESI-MS) on the heparins, extended to the anal. of their heparinases digests and fractions sepd. by affinity chromatog. on antithrombin (AT), confirmed the previously reported lower degree of 6-O-sulfation and showed lower 3-O-sulfated glucosamine content in BMH.  More detailed studies allowed the identification of structural variants of AT-binding region (ATBR) structural variants, showing higher content of the N-sulfated components in BMH than in PMH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoemOl5x64iW7Vg90H21EOLACvtfcHk0lhBY0fED6L00Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslensLfK&md5=fe88c260413cf8993a5c396e1002e30d</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2015.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2015.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DNaggi%26aufirst%3DA.%26aulast%3DGardini%26aufirst%3DC.%26aulast%3DPedrinola%26aufirst%3DG.%26aulast%3DMauri%26aufirst%3DL.%26aulast%3DUrso%26aufirst%3DE.%26aulast%3DAlekseeva%26aufirst%3DA.%26aulast%3DCasu%26aufirst%3DB.%26aulast%3DCassinelli%26aufirst%3DG.%26aulast%3DGuerrini%26aufirst%3DM.%26aulast%3DIacomini%26aufirst%3DM.%26aulast%3DBaigorria%26aufirst%3DV.%26aulast%3DTorri%26aufirst%3DG.%26atitle%3DStructural%2520peculiarity%2520and%2520antithrombin%2520binding%2520region%2520profile%2520of%2520mucosal%2520bovine%2520and%2520porcine%2520heparins%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2016%26volume%3D118%26spage%3D52%26epage%3D63%26doi%3D10.1016%2Fj.jpba.2015.10.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Jasper, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poe, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Stable-isotopic analysis of porcine, bovine, and ovine heparins</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">463</span><span class="refDoi"> DOI: 10.1002/jps.24134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1002%2Fjps.24134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=25186630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVyhtLbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2015&pages=457-463&author=J.+P.+Jasperauthor=F.+Zhangauthor=R.+B.+Poeauthor=R.+J.+Linhardt&title=Stable-isotopic+analysis+of+porcine%2C+bovine%2C+and+ovine+heparins&doi=10.1002%2Fjps.24134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Stable isotopic analysis of porcine, bovine, and ovine heparins</span></div><div class="casAuthors">Jasper, John P.; Zhang, Fuming; Poe, Russell B.; Linhardt, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">457-463</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The assessment of provenance of heparin is becoming a major concern for the pharmaceutical industry and its regulatory bodies.  Batch-specific [carbon (δ13C), nitrogen (δ15N), oxygen (δ18O), sulfur (δ34S), and hydrogen (δD)] stable isotopic compns. of five different animal-derived heparins were performed.  Measurements readily allowed their differentiation into groups and/or subgroups based on their isotopic provenance.  Principle component anal. showed that a bivariate plot of δ13C and δ18O is the best single, bivariate plot that results in the max. discrimination ability when only two stable isotopes are used to describe the variation in the data set.  Stable isotopic analyses revealed that (1) stable isotope measurements on these highly sulfated polysaccharide (mol. wt. ∼15 kDa) natural products ("biologics") were feasible; (2) in bivariate plots, the δ13C vs. δ18O plot reveals a well-defined relationship for source differentiation of hogs raised in the United States from hogs raised in Europe and China; (3) the δD vs. δ18O plot revealed the most well-defined relationship for source differentiation based on the hydrol. environmental isotopes of water (D/H and 18O/16O); and (4) the δ15N vs. δ18O and δ34S vs. δ18O relationships are both very similar, possibly reflecting the food sources used by the different heparin producers. © 2014 Wiley Periodicals, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC1lUcTCfSa7Vg90H21EOLACvtfcHk0lhBY0fED6L00Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVyhtLbN&md5=08b9d500c9afc07f8f6eb4ebe1dabe07</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Fjps.24134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.24134%26sid%3Dliteratum%253Aachs%26aulast%3DJasper%26aufirst%3DJ.%2BP.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DPoe%26aufirst%3DR.%2BB.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DStable-isotopic%2520analysis%2520of%2520porcine%252C%2520bovine%252C%2520and%2520ovine%2520heparins%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2015%26volume%3D104%26spage%3D457%26epage%3D463%26doi%3D10.1002%2Fjps.24134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Santos, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tovar, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capillé, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pereira, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomin, V. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourão, P. A.</span><span> </span><span class="NLM_article-title">Structural and functional analyses of bovine and porcine intestinal heparins confirm they are different drugs</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1801</span><span class="NLM_x">–</span> <span class="NLM_lpage">1807</span><span class="refDoi"> DOI: 10.1016/j.drudis.2014.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1016%2Fj.drudis.2014.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=25019497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1ent7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=1801-1807&author=G.+R.+Santosauthor=A.+M.+Tovarauthor=N.+V.+Capill%C3%A9author=M.+S.+Pereiraauthor=V.+H.+Pominauthor=P.+A.+Mour%C3%A3o&title=Structural+and+functional+analyses+of+bovine+and+porcine+intestinal+heparins+confirm+they+are+different+drugs&doi=10.1016%2Fj.drudis.2014.07.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and functional analyses of bovine and porcine intestinal heparins confirm they are different drugs</span></div><div class="casAuthors">Santos, Gustavo R. C.; Tovar, Ana M. F.; Capille, Nina V. M.; Pereira, Mariana S.; Pomin, Vitor H.; Mourao, Paulo A. S.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1801-1807</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Anticoagulant heparins are mostly obtained from porcine intestine.  Occasionally they are also obtained from bovine intestine.  Structural and functional analyses of pharmaceutical-grade heparins from these two sources using multiple methods such as NMR spectroscopy, in vitro and in vivo assays of the anticoagulant, antithrombotic and bleeding effects, complemented by fractionation on anion exchange chromatog., confirm they are different drugs.  Although bovine heparin is more heterogeneous and less sulfated, heparins from both sources are overall made of a similar mixt. of fractions, however with different proportions.  Therefore, high-anticoagulant composites from bovine origin, similar to porcine counterparts, can be properly obtained.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoayoGIO_yHabVg90H21EOLACvtfcHk0lhBY0fED6L00Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1ent7%252FK&md5=cffe775c12a8947fe4a338c5f6ff6a88</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2014.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2014.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DSantos%26aufirst%3DG.%2BR.%26aulast%3DTovar%26aufirst%3DA.%2BM.%26aulast%3DCapill%25C3%25A9%26aufirst%3DN.%2BV.%26aulast%3DPereira%26aufirst%3DM.%2BS.%26aulast%3DPomin%26aufirst%3DV.%2BH.%26aulast%3DMour%25C3%25A3o%26aufirst%3DP.%2BA.%26atitle%3DStructural%2520and%2520functional%2520analyses%2520of%2520bovine%2520and%2520porcine%2520intestinal%2520heparins%2520confirm%2520they%2520are%2520different%2520drugs%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2014%26volume%3D19%26spage%3D1801%26epage%3D1807%26doi%3D10.1016%2Fj.drudis.2014.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Fu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onishi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Structural characterization of pharmaceutical heparins prepared from different animal tissues</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">1447</span><span class="NLM_x">–</span> <span class="NLM_lpage">1457</span><span class="refDoi"> DOI: 10.1002/jps.23501</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1002%2Fjps.23501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=23526651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksVOgsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2013&pages=1447-1457&author=L.+Fuauthor=G.+Liauthor=B.+Yangauthor=A.+Onishiauthor=L.+Liauthor=P.+Sunauthor=F.+Zhangauthor=R.+J.+Linhardt&title=Structural+characterization+of+pharmaceutical+heparins+prepared+from+different+animal+tissues&doi=10.1002%2Fjps.23501"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Structural characterization of pharmaceutical heparins prepared from different animal tissues</span></div><div class="casAuthors">Fu, Li; Li, Guoyun; Yang, Bo; Onishi, Akihiro; Li, Lingyun; Sun, Peilong; Zhang, Fuming; Linhardt, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1447-1457</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Although most pharmaceutical heparin used today is obtained from porcine intestine, heparin has historically been prepd. from bovine lung and ovine intestine.  There is some regulatory concern about establishing the species origin of heparin.  This concern began with the outbreak of mad cow disease in the 1990s and was exacerbated during the heparin shortage in the 2000s and the heparin contamination crisis of 2007-2008.  Three heparins from porcine, ovine, and bovine were characterized through state-of-the-art carbohydrate anal. methods with a view profiling their physicochem. properties.  Differences in mol. wt., monosaccharide and disaccharide compn., oligosaccharide sequence, and antithrombin III-binding affinity were obsd.  These data provide some insight into the variability of heparins obtained from these three species and suggest some anal. approaches that may be useful in confirming the species origin of a heparin active pharmaceutical ingredient. © 2013 Wiley Periodicals, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8bUKmkC1Eb7Vg90H21EOLACvtfcHk0lie9_lvd5PU_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksVOgsbw%253D&md5=06bf2dd70af3e0333711d42f42e00640</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fjps.23501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.23501%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DB.%26aulast%3DOnishi%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DStructural%2520characterization%2520of%2520pharmaceutical%2520heparins%2520prepared%2520from%2520different%2520animal%2520tissues%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2013%26volume%3D102%26spage%3D1447%26epage%3D1457%26doi%3D10.1002%2Fjps.23501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Tovar, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capillé, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vairo, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonseca, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourão, P. A.</span><span> </span><span class="NLM_article-title">Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects</span> <span class="citation_source-journal">Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">903</span><span class="NLM_x">–</span> <span class="NLM_lpage">915</span><span class="refDoi"> DOI: 10.1160/TH-11-07-0518</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1160%2FTH-11-07-0518" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=22437650" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC38XosFaqtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2012&pages=903-915&author=A.+M.+Tovarauthor=N.+V.+Capill%C3%A9author=G.+R.+Santosauthor=B.+C.+Vairoauthor=S.+N.+Oliveiraauthor=R.+J.+Fonsecaauthor=P.+A.+Mour%C3%A3o&title=Heparin+from+bovine+intestinal+mucosa%3A+glycans+with+multiple+sulfation+patterns+and+anticoagulant+effects&doi=10.1160%2FTH-11-07-0518"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects</span></div><div class="casAuthors">Tovar, Ana M. F.; Capille, Nina V. M.; Santos, Gustavo R. C.; Vairo, Bruno C.; Oliveira, Stephan-Nicollas M. C. G.; Fonseca, Roberto J. C.; Mourao, Paulo A. S.</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">903-915</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">Schattauer GmbH</span>)
        </div><div class="casAbstract">Pharmaceutical grade heparins from porcine intestine and bovine lung consist mainly of repeating tri-sulfated units, of the disaccharide →4-α-IdoA2S-1→4-α-GlcNS6S-1→.  Heparin prepns. from bovine intestine, in contrast, are more heterogeneous.  NMR (NMR) and disaccharide anal. after heparinase digestions show that heparin from bovine intestine contains α-glucosamine with significant substitutive variations: 64% are 6-O-sulfated and N-sulfated, as in porcine intestinal heparin while 36% are 6-desulfated.  Desulfated α-iduronic acid units are contained in slightly lower proportions in bovine than in porcine heparin.  NMR data also indicate N-, 3- and 6-trisulfated α-glucosamine (lower proportions) and α-GlcNS-1→4-α-GlcA and α-IdoA2S-1→4-α-GlcNAc (higher amts.) in bovine than in porcine heparin.  Porcine and bovine heparins can be fractionated by anion exchange chromatog. into three fractions contg. different substitutions on the α-glucosamine units.  Each individual fraction shows close disaccharide compn. and anticoagulant activity, regardless of their origin (bovine or porcine intestine).  However, these two heparins differ markedly in the proportions of the three fractions.  Interestingly, fractions with the typical heparin disaccharides of porcine intestine are present in bovine intestinal heparin.  These fractions contain high in vitro anticoagulant activity, reduced antithrombotic effect and high bleeding tendency.  These observations indicate that the prediction of haemostatic effects of heparin prepns. cannot rely exclusively on structural anal. and anticoagulant assays in vitro.  Minor structural components may account for variations on in vivo effects.  In conclusion, we suggest that pharmaceutical grade bovine intestinal heparin, even after purifn. procedures, is not an equiv. drug to porcine intestinal heparin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocjEblc9IS6bVg90H21EOLACvtfcHk0lie9_lvd5PU_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosFaqtLY%253D&md5=478940a58099c5405961b3cdc8479ac9</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1160%2FTH-11-07-0518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1160%252FTH-11-07-0518%26sid%3Dliteratum%253Aachs%26aulast%3DTovar%26aufirst%3DA.%2BM.%26aulast%3DCapill%25C3%25A9%26aufirst%3DN.%2BV.%26aulast%3DSantos%26aufirst%3DG.%2BR.%26aulast%3DVairo%26aufirst%3DB.%2BC.%26aulast%3DOliveira%26aufirst%3DS.%2BN.%26aulast%3DFonseca%26aufirst%3DR.%2BJ.%26aulast%3DMour%25C3%25A3o%26aufirst%3DP.%2BA.%26atitle%3DHeparin%2520from%2520bovine%2520intestinal%2520mucosa%253A%2520glycans%2520with%2520multiple%2520sulfation%2520patterns%2520and%2520anticoagulant%2520effects%26jtitle%3DThromb.%2520Haemostasis%26date%3D2012%26volume%3D107%26spage%3D903%26epage%3D915%26doi%3D10.1160%2FTH-11-07-0518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Mauri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boccardi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karfunkle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macchi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keire, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, M. J.</span><span> </span><span class="NLM_article-title">Qualification of HSQC methods for quantitative composition of heparin and low molecular weight heparins</span> <span class="citation_source-journal">J. Pharm. Biomed. Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">92</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span><span class="refDoi"> DOI: 10.1016/j.jpba.2016.12.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1016%2Fj.jpba.2016.12.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=28068519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmsVyrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2017&pages=92-105&author=L.+Mauriauthor=G.+Boccardiauthor=G.+Torriauthor=M.+Karfunkleauthor=E.+Macchiauthor=L.+Muziauthor=D.+Keireauthor=M.+J.+Guerrini&title=Qualification+of+HSQC+methods+for+quantitative+composition+of+heparin+and+low+molecular+weight+heparins&doi=10.1016%2Fj.jpba.2016.12.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Qualification of HSQC methods for quantitative composition of heparin and low molecular weight heparins</span></div><div class="casAuthors">Mauri, Lucio; Boccardi, Giovanni; Torri, Giangiacomo; Karfunkle, Michael; Macchi, Eleonora; Muzi, Laura; Keire, David; Guerrini, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">92-105</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">An NMR HSQC method has recently been proposed for the quant. detn. of the mono- and disaccharide subunits of heparin and low mol. wt. heparins (LMWH).  The focus of the current study was the validation of this procedure to make the 2D-NMR method suitable for pharmaceutical quality control applications.  Pre-validation work investigated the effects of several exptl. parameters to assess robustness and to optimize crit. factors.  Important exptl. parameters were pulse sequence selection, equilibration interval between pulse trains and temp.  These observations were needed so that the NMR method was sufficiently understood to enable continuous improvement.  A std. validation study on heparin then examd. linearity, repeatability, intermediate precision and limits of detection and quantitation; selected validation parameters were also detd. for LMWH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5eysMbpVls7Vg90H21EOLACvtfcHk0lie9_lvd5PU_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmsVyrtQ%253D%253D&md5=fec77c6fd579a70913d6b054a66f3d62</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2016.12.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2016.12.031%26sid%3Dliteratum%253Aachs%26aulast%3DMauri%26aufirst%3DL.%26aulast%3DBoccardi%26aufirst%3DG.%26aulast%3DTorri%26aufirst%3DG.%26aulast%3DKarfunkle%26aufirst%3DM.%26aulast%3DMacchi%26aufirst%3DE.%26aulast%3DMuzi%26aufirst%3DL.%26aulast%3DKeire%26aufirst%3DD.%26aulast%3DGuerrini%26aufirst%3DM.%2BJ.%26atitle%3DQualification%2520of%2520HSQC%2520methods%2520for%2520quantitative%2520composition%2520of%2520heparin%2520and%2520low%2520molecular%2520weight%2520heparins%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2017%26volume%3D136%26spage%3D92%26epage%3D105%26doi%3D10.1016%2Fj.jpba.2016.12.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Keire, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulloy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Hakim, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cairatti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogwood, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourão, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DaLuz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szajek, A.</span><span> </span><span class="NLM_article-title">Diversifying the global heparin supply chain: reintroduction of bovine heparin in the United States?</span> <span class="citation_source-journal">Pharm. Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2015&pages=28-35&author=D.+Keireauthor=B.+Mulloyauthor=C.+Chaseauthor=A.+Al-Hakimauthor=D.+Cairattiauthor=E.+Grayauthor=J.+Hogwoodauthor=T.+Morrisauthor=P.+Mour%C3%A3oauthor=C.+DaLuzauthor=M.+Soaresauthor=A.+Szajek&title=Diversifying+the+global+heparin+supply+chain%3A+reintroduction+of+bovine+heparin+in+the+United+States%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKeire%26aufirst%3DD.%26aulast%3DMulloy%26aufirst%3DB.%26aulast%3DChase%26aufirst%3DC.%26aulast%3DAl-Hakim%26aufirst%3DA.%26aulast%3DCairatti%26aufirst%3DD.%26aulast%3DGray%26aufirst%3DE.%26aulast%3DHogwood%26aufirst%3DJ.%26aulast%3DMorris%26aufirst%3DT.%26aulast%3DMour%25C3%25A3o%26aufirst%3DP.%26aulast%3DDaLuz%26aufirst%3DC.%26aulast%3DSoares%26aufirst%3DM.%26aulast%3DSzajek%26aufirst%3DA.%26atitle%3DDiversifying%2520the%2520global%2520heparin%2520supply%2520chain%253A%2520reintroduction%2520of%2520bovine%2520heparin%2520in%2520the%2520United%2520States%253F%26jtitle%3DPharm.%2520Technol.%26date%3D2015%26volume%3D39%26spage%3D28%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Szajek, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chess, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gratzl, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keire, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulloy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shriver, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torralba, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viskov, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodcock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Hakim, A.</span><span> </span><span class="NLM_article-title">The US regulatory and pharmacopeia response to the global heparin contamination crisis</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">625</span><span class="NLM_x">–</span> <span class="NLM_lpage">630</span><span class="refDoi"> DOI: 10.1038/nbt.3606</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1038%2Fnbt.3606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=27281424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC28XpsFCltrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2016&pages=625-630&author=A.+Y.+Szajekauthor=E.+Chessauthor=K.+Johansenauthor=G.+Gratzlauthor=E.+Grayauthor=D.+Keireauthor=R.+J.+Linhardtauthor=J.+Liuauthor=T.+Morrisauthor=B.+Mulloyauthor=M.+Nasrauthor=Z.+Shriverauthor=P.+Torralbaauthor=C.+Viskovauthor=R.+Williamsauthor=J.+Woodcockauthor=W.+Workmanauthor=A.+Al-Hakim&title=The+US+regulatory+and+pharmacopeia+response+to+the+global+heparin+contamination+crisis&doi=10.1038%2Fnbt.3606"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The US regulatory and pharmacopeia response to the global heparin contamination crisis</span></div><div class="casAuthors">Szajek, Anita Y.; Chess, Edward; Johansen, Kristian; Gratzl, Gyongyi; Gray, Elaine; Keire, David; Linhardt, Robert J.; Liu, Jian; Morris, Tina; Mulloy, Barbara; Nasr, Moheb; Shriver, Zachary; Torralba, Pearle; Viskov, Christian; Williams, Roger; Woodcock, Janet; Workman, Wesley; Al-Hakim, Ali</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">625-630</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The contamination of the widely used lifesaving anticoagulant drug heparin in 2007 has drawn renewed attention to the challenges that are assocd. with the characterization, quality control and standardization of complex biol. medicines from natural sources.  Heparin is a linear, highly sulfated polysaccharide consisting of alternating glucosamine and uronic acid monosaccharide residues.  Heparin has been used successfully as an injectable antithrombotic medicine since the 1930s, and its isolation from animal sources (primarily porcine intestine) as well as its manufg. processes have not changed substantially since its introduction.  The 2007 heparin contamination crisis resulted in several deaths in the United States and hundreds of adverse reactions worldwide, revealing the vulnerability of a complex global supply chain to sophisticated adulteration.  This Perspective discusses how the US Food and Drug Administration (FDA), the United States Pharmacopeial Convention (USP) and international stakeholders collaborated to redefine quality expectations for heparin, thus making an important natural product better controlled and less susceptible to economically motivated adulteration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY0ESVJNOCH7Vg90H21EOLACvtfcHk0lh2HqTCKYe9fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpsFCltrk%253D&md5=b73afb1d503ad195c93e9492b73dd1c1</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnbt.3606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.3606%26sid%3Dliteratum%253Aachs%26aulast%3DSzajek%26aufirst%3DA.%2BY.%26aulast%3DChess%26aufirst%3DE.%26aulast%3DJohansen%26aufirst%3DK.%26aulast%3DGratzl%26aufirst%3DG.%26aulast%3DGray%26aufirst%3DE.%26aulast%3DKeire%26aufirst%3DD.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DMorris%26aufirst%3DT.%26aulast%3DMulloy%26aufirst%3DB.%26aulast%3DNasr%26aufirst%3DM.%26aulast%3DShriver%26aufirst%3DZ.%26aulast%3DTorralba%26aufirst%3DP.%26aulast%3DViskov%26aufirst%3DC.%26aulast%3DWilliams%26aufirst%3DR.%26aulast%3DWoodcock%26aufirst%3DJ.%26aulast%3DWorkman%26aufirst%3DW.%26aulast%3DAl-Hakim%26aufirst%3DA.%26atitle%3DThe%2520US%2520regulatory%2520and%2520pharmacopeia%2520response%2520to%2520the%2520global%2520heparin%2520contamination%2520crisis%26jtitle%3DNat.%2520Biotechnol.%26date%3D2016%26volume%3D34%26spage%3D625%26epage%3D630%26doi%3D10.1038%2Fnbt.3606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Lessons learned from the contamination of heparin</span> <span class="citation_source-journal">Nat. Prod. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">313</span><span class="NLM_x">–</span> <span class="NLM_lpage">321</span><span class="refDoi"> DOI: 10.1039/b819896a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1039%2Fb819896a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=19240943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisVGjsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2009&pages=313-321&author=H.+Liuauthor=Z.+Zhangauthor=R.+J.+Linhardt&title=Lessons+learned+from+the+contamination+of+heparin&doi=10.1039%2Fb819896a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons learned from the contamination of heparin</span></div><div class="casAuthors">Liu, Haiying; Zhang, Zhenqing; Linhardt, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Reports</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">313-321</span>CODEN:
                <span class="NLM_cas:coden">NPRRDF</span>;
        ISSN:<span class="NLM_cas:issn">0265-0568</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Heparin is unique as one of the oldest drugs currently still in widespread clin. use as an anticoagulant, a natural product, one of the first biopolymeric drugs, and one of the few carbohydrate drugs.  Recently, certain batches of heparin were assocd. with anaphylactoid-type reactions, some leading to hypotension and death.  These reactions were traced to contamination with a semi-synthetic oversulfated chondroitin sulfate (OSCS).  This Highlight reviews the heparin contamination crisis, its resoln., and the lessons learned.  Pharmaceutical scientists now must consider dozens of natural and synthetic heparinoids as potential heparin contaminants.  Effective assays, which can detect both known and unknown contaminants, are required to monitor the quality of heparin.  Safer and better-regulated processes are needed for heparin prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyeErJWeTMMLVg90H21EOLACvtfcHk0lh2HqTCKYe9fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisVGjsL8%253D&md5=bb640e69bd3e6940f6fc81758ab00e2f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1039%2Fb819896a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb819896a%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DLessons%2520learned%2520from%2520the%2520contamination%2520of%2520heparin%26jtitle%3DNat.%2520Prod.%2520Rep.%26date%3D2009%26volume%3D26%26spage%3D313%26epage%3D321%26doi%3D10.1039%2Fb819896a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Guerrini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beccati, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shriver, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naggi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viswanathan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capila, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lansing, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guglieri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Hakim, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunay, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhse, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodcock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkataraman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasisekharan, R.</span><span> </span><span class="NLM_article-title">Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">669</span><span class="NLM_x">–</span> <span class="NLM_lpage">675</span><span class="refDoi"> DOI: 10.1038/nbt1407</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1038%2Fnbt1407" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=18437154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmvVCisrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=669-675&author=M.+Guerriniauthor=D.+Beccatiauthor=Z.+Shriverauthor=A.+Naggiauthor=K.+Viswanathanauthor=A.+Bisioauthor=I.+Capilaauthor=J.+C.+Lansingauthor=S.+Guglieriauthor=B.+Fraserauthor=A.+Al-Hakimauthor=N.+S.+Gunayauthor=Z.+Zhangauthor=L.+Robinsonauthor=L.+Buhseauthor=M.+Nasrauthor=J.+Woodcockauthor=R.+Langerauthor=G.+Venkataramanauthor=R.+J.+Linhardtauthor=B.+Casuauthor=G.+Torriauthor=R.+Sasisekharan&title=Oversulfated+chondroitin+sulfate+is+a+contaminant+in+heparin+associated+with+adverse+clinical+events&doi=10.1038%2Fnbt1407"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events</span></div><div class="casAuthors">Guerrini, Marco; Beccati, Daniela; Shriver, Zachary; Naggi, Annamaria; Viswanathan, Karthik; Bisio, Antonella; Capila, Ishan; Lansing, Jonathan C.; Guglieri, Sara; Fraser, Blair; Al-Hakim, Ali; Gunay, Nur Sibel; Zhang, Zhenqing; Robinson, Luke; Buhse, Lucinda; Nasr, Moheb; Woodcock, Janet; Langer, Robert; Venkataraman, Ganesh; Linhardt, Robert J.; Casu, Benito; Torri, Giangiacomo; Sasisekharan, Ram</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">669-675</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Recently, certain lots of heparin have been assocd. with an acute, rapid onset of serious side effects indicative of an allergic-type reaction.  To identify potential causes for this sudden rise in side effects, we examd. lots of heparin that correlated with adverse events using orthogonal high-resoln. anal. techniques.  Through detailed structural anal., the contaminant was found to contain a disaccharide repeat unit of glucuronic acid linked β1 3 to a β-N-acetylgalactosamine.  The disaccharide unit has an unusual sulfation pattern and is sulfated at the 2-O and 3-O positions of the glucuronic acid as well as at the 4-O and 6-O positions of the galactosamine.  Given the nature of this contaminant, traditional screening tests cannot differentiate between affected and unaffected lots.  Our anal. suggests effective screening methods that can be used to det. whether or not heparin lots contain the contaminant reported here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX-IanwUPD4bVg90H21EOLACvtfcHk0lh2HqTCKYe9fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmvVCisrY%253D&md5=42fa6cf94a3534ed36992977bb4985d9</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnbt1407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1407%26sid%3Dliteratum%253Aachs%26aulast%3DGuerrini%26aufirst%3DM.%26aulast%3DBeccati%26aufirst%3DD.%26aulast%3DShriver%26aufirst%3DZ.%26aulast%3DNaggi%26aufirst%3DA.%26aulast%3DViswanathan%26aufirst%3DK.%26aulast%3DBisio%26aufirst%3DA.%26aulast%3DCapila%26aufirst%3DI.%26aulast%3DLansing%26aufirst%3DJ.%2BC.%26aulast%3DGuglieri%26aufirst%3DS.%26aulast%3DFraser%26aufirst%3DB.%26aulast%3DAl-Hakim%26aufirst%3DA.%26aulast%3DGunay%26aufirst%3DN.%2BS.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DRobinson%26aufirst%3DL.%26aulast%3DBuhse%26aufirst%3DL.%26aulast%3DNasr%26aufirst%3DM.%26aulast%3DWoodcock%26aufirst%3DJ.%26aulast%3DLanger%26aufirst%3DR.%26aulast%3DVenkataraman%26aufirst%3DG.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26aulast%3DCasu%26aufirst%3DB.%26aulast%3DTorri%26aufirst%3DG.%26aulast%3DSasisekharan%26aufirst%3DR.%26atitle%3DOversulfated%2520chondroitin%2520sulfate%2520is%2520a%2520contaminant%2520in%2520heparin%2520associated%2520with%2520adverse%2520clinical%2520events%26jtitle%3DNat.%2520Biotechnol.%26date%3D2008%26volume%3D26%26spage%3D669%26epage%3D675%26doi%3D10.1038%2Fnbt1407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Maruyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imanari, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Conformational changes and anticoagulant activity of chondroitin sulfate following its O-sulfonation</span> <span class="citation_source-journal">Carbohydr. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">306</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span><span class="refDoi"> DOI: 10.1016/S0008-6215(97)10060-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1016%2FS0008-6215%2897%2910060-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=1998&pages=35-43&author=T.+Maruyamaauthor=T.+Toidaauthor=T.+Imanariauthor=G.+Yuauthor=R.+J.+Linhardt&title=Conformational+changes+and+anticoagulant+activity+of+chondroitin+sulfate+following+its+O-sulfonation&doi=10.1016%2FS0008-6215%2897%2910060-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0008-6215%2897%2910060-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0008-6215%252897%252910060-X%26sid%3Dliteratum%253Aachs%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DToida%26aufirst%3DT.%26aulast%3DImanari%26aufirst%3DT.%26aulast%3DYu%26aufirst%3DG.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DConformational%2520changes%2520and%2520anticoagulant%2520activity%2520of%2520chondroitin%2520sulfate%2520following%2520its%2520O-sulfonation%26jtitle%3DCarbohydr.%2520Res.%26date%3D1998%26volume%3D306%26spage%3D35%26epage%3D43%26doi%3D10.1016%2FS0008-6215%2897%2910060-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Harrich, V. D.; Mayer, P.; Turczynski, J.</span><span> </span><span class="NLM_article-title">Medikamentenskandal: Erneut probleme mit heparin (Medication scandal: Problems with heparin again)</span>. <a href="http://www.tagesschau.de/wirtschaft/pharmacrime/pharmacrime-heparin-103.html" class="extLink">http://www.tagesschau.de/wirtschaft/pharmacrime/pharmacrime-heparin-103.html</a> (accessed May 17, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Harrich%2C+V.+D.%3B+Mayer%2C+P.%3B+Turczynski%2C+J.+Medikamentenskandal%3A+Erneut+probleme+mit+heparin+%28Medication+scandal%3A+Problems+with+heparin+again%29.+http%3A%2F%2Fwww.tagesschau.de%2Fwirtschaft%2Fpharmacrime%2Fpharmacrime-heparin-103.html+%28accessed+May+17%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3DHarrich%26aufirst%3DV.%2BD.%26atitle%3DMedikamentenskandal%253A%2520Erneut%2520probleme%2520mit%2520heparin%2520%2528Medication%2520scandal%253A%2520Problems%2520with%2520heparin%2520again%2529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Fu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suflita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Bioengineered heparins and heparan sulfates</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">249</span><span class="refDoi"> DOI: 10.1016/j.addr.2015.11.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1016%2Fj.addr.2015.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=26555370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVSks7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2016&pages=237-249&author=L.+Fuauthor=M.+Suflitaauthor=R.+J.+Linhardt&title=Bioengineered+heparins+and+heparan+sulfates&doi=10.1016%2Fj.addr.2015.11.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Bioengineered heparins and heparan sulfates</span></div><div class="casAuthors">Fu, Li; Suflita, Matthew; Linhardt, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">237-249</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Heparin and heparan sulfates are closely related linear anionic polysaccharides, called glycosaminoglycans, which exhibit a no. of important biol. and pharmacol. activities.  These polysaccharides, having complex structures and polydispersity, are biosynthesized in the Golgi of animal cells.  While heparan sulfate is a widely distributed membrane and extracellular glycosaminoglycan, heparin is found primarily intracellularly in the granules of mast cells.  While heparin has historically received most of the scientific attention for its anticoagulant activity, interest has steadily grown in the multi-faceted role heparan sulfate plays in normal and pathophysiol.  The chem. synthesis of these glycosaminoglycans is largely precluded by their structural complexity.  Today, we depend on livestock animal tissues for the isolation and the annual com. prodn. of hundred ton quantities of heparin used in the manuf. of anticoagulant drugs and medical device coatings.  The variability of animal-sourced heparin and heparan sulfates, their inherent impurities, the limited availability of source tissues, the poor control of these source materials and their manufg. processes, suggest a need for new approaches for their prodn.  Over the past decade there have been major efforts in the biotechnol. prodn. of these glycosaminoglycans, driven by both therapeutic applications and as probes to study their natural functions.  This review focuses on the complex biol. of these glycosaminoglycans in human health and disease, and the use of recombinant technol. in the chemoenzymic synthesis and metabolic engineering of heparin and heparan sulfates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoicKOhyeX6ZLVg90H21EOLACvtfcHk0ljcBQnLujwZ7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVSks7jI&md5=0ce99640a8b2ec3920cdca63aec3ebcd</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2015.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2015.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DL.%26aulast%3DSuflita%26aufirst%3DM.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DBioengineered%2520heparins%2520and%2520heparan%2520sulfates%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2016%26volume%3D97%26spage%3D237%26epage%3D249%26doi%3D10.1016%2Fj.addr.2015.11.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Chemoenzymatic synthesis of heparan sulfate and heparin</span> <span class="citation_source-journal">Nat. Prod. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1676</span><span class="NLM_x">–</span> <span class="NLM_lpage">1685</span><span class="refDoi"> DOI: 10.1039/C4NP00076E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1039%2FC4NP00076E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=25197032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFWjtLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2014&pages=1676-1685&author=J.+Liuauthor=R.+J.+Linhardt&title=Chemoenzymatic+synthesis+of+heparan+sulfate+and+heparin&doi=10.1039%2FC4NP00076E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoenzymatic synthesis of heparan sulfate and heparin</span></div><div class="casAuthors">Liu, Jian; Linhardt, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1676-1685</span>CODEN:
                <span class="NLM_cas:coden">NPRRDF</span>;
        ISSN:<span class="NLM_cas:issn">0265-0568</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">This review covers recent development of chemoenzymic synthesis methodol. and its progress towards the synthesis of HS oligosaccharide targets having diverse sulfation patterns.  Heparan sulfate is a polysaccharide that plays essential physiol. functions in the animal kingdom.  Heparin, a highly sulfated form of heparan sulfate, is a widely prescribed anticoagulant drug worldwide.  The heparan sulfate and heparin isolated from natural sources are highly heterogeneous mixts. differing in their polysaccharide chain lengths and sulfation patterns.  The access to structurally defined heparan sulfate and heparin is crit. to probe the contribution of specific sulfated saccharide structures to the biol. functions as well as for the development of the next generation of heparin-based anticoagulant drugs.  The synthesis of heparan sulfate and heparin, using a purely chem. approach, has proven extremely difficult, esp. for targets larger than octasaccharides having a high degree of site-specific sulfation.  A new chemoenzymic method has emerged as an effective alternative approach.  This method uses recombinant heparan sulfate biosynthetic enzymes combined with unnatural uridine diphosphate-monosaccharide donors.  Recent examples demonstrate the successful synthesis of ultra-low mol. wt. heparin, low-mol. wt. heparin and bioengineered heparin with unprecedented efficiency.  The new method provides an opportunity to develop improved heparin-based therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbCgIXG0lkfrVg90H21EOLACvtfcHk0ljcBQnLujwZ7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFWjtLfL&md5=7d1200967bbc7d0abaed4c89baa311ed</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1039%2FC4NP00076E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4NP00076E%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DChemoenzymatic%2520synthesis%2520of%2520heparan%2520sulfate%2520and%2520heparin%26jtitle%3DNat.%2520Prod.%2520Rep.%26date%3D2014%26volume%3D31%26spage%3D1676%26epage%3D1685%26doi%3D10.1039%2FC4NP00076E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Junqueira, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viana, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peixoto, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barros, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carvalho, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perini, E.</span><span> </span><span class="NLM_article-title">Heparin pharmacovigilance in Brazil</span> <span class="citation_source-journal">Rev. Assoc. Med. Bras. (1992)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">322</span><span class="NLM_x">–</span> <span class="NLM_lpage">326</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1016%2FS0104-4230%2811%2970067-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=21691698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A280%3ADC%252BC3MjksFaisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2011&pages=322-326&author=D.+R.+Junqueiraauthor=T.+G.+Vianaauthor=E.+R.+Peixotoauthor=F.+C.+Barrosauthor=M.+Carvalhoauthor=E.+Perini&title=Heparin+pharmacovigilance+in+Brazil"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Heparin pharmacovigilance in Brazil</span></div><div class="casAuthors">Junqueira Daniela Rezende Garcia; Viana Thercia Guedes; Peixoto Eliane R de M; Barros Fabiana C R de; Carvalho Maria das Gracas; Perini Edson</div><div class="citationInfo"><span class="NLM_cas:title">Revista da Associacao Medica Brasileira (1992)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">322-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To investigate the biological origin of injectable unfractioned heparin available in Brazilian market by discussing the impact of the profile of commercial products and the changes in heparin monograph on the drug safety.  METHODS:  The Anvisa data base for the Registered Products of Pharmaceutical Companies and the Dictionary of Pharmaceutical Specialties (DEF 2008/2009) were searched.  A survey with industries having an active permission for marketing the drug in Brazil was conducted.  RESULTS:  Five companies were granted a permission to market unfractioned heparin in Brazil.  Three of them are porcine in origin and two of them are bovine in origin, with only one explicitly showing this information in the package insert.  The effectiveness and safety of heparin studied in non-Brazilian populations may not represent the Brazilian reality, since most countries no longer produce bovine heparin.  The currently marketed heparin has approximately 10% less anticoagulant activity than that previously produced and this change may have clinical implications.  CONCLUSIONS:  Evidence about the lack of dose interchangeability between bovine and porcine heparins and the unique safety profile of these drugs indicates the need to follow the treatment and the patients' response.  Events threatening the patient's safety must be reported to the pharmacovigilance system in each particular country.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ6zi8ee1B0tLBItaL1WaVAfW6udTcc2eaRMytRzj5PSbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MjksFaisA%253D%253D&md5=84ca2acb85a5c2d4526c087f5fbec74f</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS0104-4230%2811%2970067-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0104-4230%252811%252970067-7%26sid%3Dliteratum%253Aachs%26aulast%3DJunqueira%26aufirst%3DD.%2BR.%26aulast%3DViana%26aufirst%3DT.%2BG.%26aulast%3DPeixoto%26aufirst%3DE.%2BR.%26aulast%3DBarros%26aufirst%3DF.%2BC.%26aulast%3DCarvalho%26aufirst%3DM.%26aulast%3DPerini%26aufirst%3DE.%26atitle%3DHeparin%2520pharmacovigilance%2520in%2520Brazil%26jtitle%3DRev.%2520Assoc.%2520Med.%2520Bras.%2520%25281992%2529%26date%3D2011%26volume%3D57%26spage%3D322%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Warda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Turkey intestine as a commercial source of heparin? Comparative structural studies of intestinal avian and mammalian glycosaminoglycans</span> <span class="citation_source-journal">Comp. Biochem. Physiol., Part B: Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span><span class="refDoi"> DOI: 10.1016/S1096-4959(02)00250-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1016%2FS1096-4959%2802%2900250-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=12524047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1Wr" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2003&pages=189-197&author=M.+Wardaauthor=W.+Maoauthor=T.+Toidaauthor=R.+J.+Linhardt&title=Turkey+intestine+as+a+commercial+source+of+heparin%3F+Comparative+structural+studies+of+intestinal+avian+and+mammalian+glycosaminoglycans&doi=10.1016%2FS1096-4959%2802%2900250-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Turkey intestine as a commercial source of heparin? Comparative structural studies of intestinal avian and mammalian glycosaminoglycans</span></div><div class="casAuthors">Warda, Mohamad; Mao, Wenjun; Toida, Toshihiko; Linhardt, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Comparative Biochemistry and Physiology, Part B: Biochemistry & Molecular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">134B</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">189-197</span>CODEN:
                <span class="NLM_cas:coden">CBPBB8</span>;
        ISSN:<span class="NLM_cas:issn">1096-4959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Heparin is a glycosaminoglycan (GAG) that is extd. primarily from porcine intestinal tissues and is widely used as a clin. anticoagulant.  It is biosynthesized as a proteoglycan and stored exclusively in mast cells and is partially degraded to peptidoglycan and GAG upon immunol. activated mast cell degranulation.  In contrast, the structurally related heparan sulfate, is the polysaccharide portion of a ubiquitous proteoglycan, localized on cell surface and in the extracellular matrix of all animal tissues.  Heparin and heparan sulfate are made in the Golgi through a similar biosynthetic pathway.  The current study was undertaken in a search for alternative, non-mammalian, sources of anticoagulant heparin.  The heparin/heparan sulfate family of GAGs, prepd. and purified from turkey intestine, were assayed for anticoagulant activity and structurally characterized.  The resulting GAGs displayed a very low anticoagulant activity when compared to those obtained from porcine intestine using an identical procedure.  Structural characterization studies clearly demonstrate that heparan sulfate is the major GAG in the turkey intestine.  This observation is rationalized based on differences in the mammalian and avian coagulation and immune systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxLTQcG7peqrVg90H21EOLACvtfcHk0litYuGmLAFCCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1Wr&md5=97011b80e9d003d310078f2f728b7161</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS1096-4959%2802%2900250-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1096-4959%252802%252900250-6%26sid%3Dliteratum%253Aachs%26aulast%3DWarda%26aufirst%3DM.%26aulast%3DMao%26aufirst%3DW.%26aulast%3DToida%26aufirst%3DT.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DTurkey%2520intestine%2520as%2520a%2520commercial%2520source%2520of%2520heparin%253F%2520Comparative%2520structural%2520studies%2520of%2520intestinal%2520avian%2520and%2520mammalian%2520glycosaminoglycans%26jtitle%3DComp.%2520Biochem.%2520Physiol.%252C%2520Part%2520B%253A%2520Biochem.%2520Mol.%2520Biol.%26date%3D2003%26volume%3D134%26spage%3D189%26epage%3D197%26doi%3D10.1016%2FS1096-4959%2802%2900250-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Guan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chi, L.</span><span> </span><span class="NLM_article-title">Comparison of low molecular weight heparins prepared using bovine lung heparin and porcine intestine heparin as starting materials</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">1843</span><span class="NLM_x">–</span> <span class="NLM_lpage">1850</span><span class="refDoi"> DOI: 10.1016/j.xphs.2016.03.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1016%2Fj.xphs.2016.03.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=27238483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtF2mtrvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2016&pages=1843-1850&author=Y.+Guanauthor=X.+Xuauthor=X.+Liuauthor=A.+Shengauthor=L.+Jinauthor=R.+J.+Linhardtauthor=L.+Chi&title=Comparison+of+low+molecular+weight+heparins+prepared+using+bovine+lung+heparin+and+porcine+intestine+heparin+as+starting+materials&doi=10.1016%2Fj.xphs.2016.03.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of Low-Molecular-Weight Heparins Prepared From Bovine Lung Heparin and Porcine Intestine Heparin</span></div><div class="casAuthors">Guan, Yudong; Xu, Xiaohui; Liu, Xinyue; Sheng, Anran; Jin, Lan; Linhardt, Robert J.; Chi, Lianli</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1843-1850</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Currently porcine intestine is the only approved source for producing pharmaceutical heparin in most countries.  Enoxaparin, prepd. by benzylation and alk. depolymn. from porcine intestine heparin, is prevalent in the anticoagulant drug market.  It is predicted that porcine intestine heparin-derived enoxaparin (PIE) will encounter shortage, and expanding its prodn. from heparins obtained from other animal tissues may, therefore, be inevitable.  Bovine lung heparin is a potential alternative source for producing enoxaparin.  Crit. processing parameters for producing bovine lung heparin-derived enoxaparin (BLE) are discussed.  Three batches of BLEs were prepd. and their detailed structures were compared with PIEs using modern anal. techniques, including disaccharide compn., intact chain mapping by liq. chromatog.-mass spectrometry and 2-dimensional NMR spectroscopy.  The results suggested that the differences between PIEs and BLEs mainly result from N-acetylation differences derived from the parent heparins.  In addn., bioactivities of BLEs were about 70% of PIEs based on anti-factor IIa and Xa chromogenic assays.  We conclude that BLE has the potential to be developed as an analog of PIE, although some challenges still remain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2sEKMSXf9VbVg90H21EOLACvtfcHk0litYuGmLAFCCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtF2mtrvI&md5=6d3fa91429735c023aba9551121a21a5</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.xphs.2016.03.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.xphs.2016.03.037%26sid%3Dliteratum%253Aachs%26aulast%3DGuan%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DSheng%26aufirst%3DA.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26aulast%3DChi%26aufirst%3DL.%26atitle%3DComparison%2520of%2520low%2520molecular%2520weight%2520heparins%2520prepared%2520using%2520bovine%2520lung%2520heparin%2520and%2520porcine%2520intestine%2520heparin%2520as%2520starting%2520materials%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2016%26volume%3D105%26spage%3D1843%26epage%3D1850%26doi%3D10.1016%2Fj.xphs.2016.03.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Ange, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fareed, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoppensteadt, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeske, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Comparison of low molecular weight heparins prepared from bovine heparins with enoxaparin</span> <span class="citation_source-journal">Clin. Appl. Thromb./Hemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">542</span><span class="refDoi"> DOI: 10.1177/1076029616686422</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1177%2F1076029616686422" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=28056526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVCisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=542&author=X.+Liuauthor=K.+St.+Angeauthor=J.+Fareedauthor=D.+Hoppensteadtauthor=W.+Jeskeauthor=A.+Koutaauthor=L.+Chiauthor=C.+Jinauthor=Y.+Jinauthor=Y.+Yaoauthor=R.+J.+Linhardt&title=Comparison+of+low+molecular+weight+heparins+prepared+from+bovine+heparins+with+enoxaparin&doi=10.1177%2F1076029616686422"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of Low-Molecular-Weight Heparins Prepared From Bovine Heparins With Enoxaparin</span></div><div class="casAuthors">Liu, Xinyue; St. Ange, Kalib; Fareed, Jawed; Hoppensteadt, Debra; Jeske, Walter; Kouta, Ahmed; Chi, Lianli; Jin, Caijuan; Jin, Yongsheng; Yao, Yiming; Linhardt, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Applied Thrombosis/Hemostasis</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">542-553</span>CODEN:
                <span class="NLM_cas:coden">CATHF9</span>;
        ISSN:<span class="NLM_cas:issn">1076-0296</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Heparin and its low-mol.-wt. heparin (LMWH) derivs. are widely used clin. anticoagulants.  These drugs are crit. for the practice of medicine in applications including kidney dialysis, cardiopulmonary bypass, and in the management of venous thromboembolism.  Currently, these drugs are derived from livestock, primarily porcine intestine.  The worldwide dependence on a single animal species has made the supply chain for this crit. drug quite fragile, leading to the search for other sources of these drugs, including bovine tissues such as bovine intestine or lung.  A no. of labs. are currently examg. the similarities and differences between heparins prepd. from porcine and bovine tissues.  The current study is designed to compare LMWH prepd. from bovine heparins through chem. β-elimination, a process currently used to prep. the LMWH, enoxaparin, from porcine heparin.  Using top-down, bottom-up, compositional anal. and bioassays, LMWHs, derived from bovine lung and intestine, are shown to closely resemble enoxaparin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7-IFPIM9yzrVg90H21EOLACvtfcHk0litYuGmLAFCCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVCisbc%253D&md5=18879b0dd0915d1bb7ce9cad980438e2</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1177%2F1076029616686422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1076029616686422%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DSt.%2BAnge%26aufirst%3DK.%26aulast%3DFareed%26aufirst%3DJ.%26aulast%3DHoppensteadt%26aufirst%3DD.%26aulast%3DJeske%26aufirst%3DW.%26aulast%3DKouta%26aufirst%3DA.%26aulast%3DChi%26aufirst%3DL.%26aulast%3DJin%26aufirst%3DC.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DComparison%2520of%2520low%2520molecular%2520weight%2520heparins%2520prepared%2520from%2520bovine%2520heparins%2520with%2520enoxaparin%26jtitle%3DClin.%2520Appl.%2520Thromb.%252FHemostasis%26date%3D2017%26volume%3D23%26spage%3D542%26doi%3D10.1177%2F1076029616686422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Mikhailov, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayo, K. H.</span><span> </span><span class="NLM_article-title">Heparin dodecasaccharide binding to platelet factor-4 and growth-related protein-a: Transition through a partially folded state and implications for heparin induced thrombocytopenia</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">25317</span><span class="NLM_x">–</span> <span class="NLM_lpage">25329</span><span class="refDoi"> DOI: 10.1074/jbc.274.36.25317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1074%2Fjbc.274.36.25317" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=25317-25329&author=D.+Mikhailovauthor=H.+C.+Youngauthor=R.+J.+Linhardtauthor=K.+H.+Mayo&title=Heparin+dodecasaccharide+binding+to+platelet+factor-4+and+growth-related+protein-a%3A+Transition+through+a+partially+folded+state+and+implications+for+heparin+induced+thrombocytopenia&doi=10.1074%2Fjbc.274.36.25317"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.36.25317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.36.25317%26sid%3Dliteratum%253Aachs%26aulast%3DMikhailov%26aufirst%3DD.%26aulast%3DYoung%26aufirst%3DH.%2BC.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26aulast%3DMayo%26aufirst%3DK.%2BH.%26atitle%3DHeparin%2520dodecasaccharide%2520binding%2520to%2520platelet%2520factor-4%2520and%2520growth-related%2520protein-a%253A%2520Transition%2520through%2520a%2520partially%2520folded%2520state%2520and%2520implications%2520for%2520heparin%2520induced%2520thrombocytopenia%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D25317%26epage%3D25329%26doi%3D10.1074%2Fjbc.274.36.25317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Arepally, G. M.</span><span> </span><span class="NLM_article-title">Heparin-induced thrombocytopenia</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">2864</span><span class="NLM_x">–</span> <span class="NLM_lpage">2872</span><span class="refDoi"> DOI: 10.1182/blood-2016-11-709873</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1182%2Fblood-2016-11-709873" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=28416511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1emtbjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2017&pages=2864-2872&author=G.+M.+Arepally&title=Heparin-induced+thrombocytopenia&doi=10.1182%2Fblood-2016-11-709873"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Heparin-induced thrombocytopenia</span></div><div class="casAuthors">Arepally, Gowthami M.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2864-2872</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">1528-0020</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Heparin-induced thrombocytopenia (HIT) is an immune complication of heparin therapy caused by antibodies to complexes of platelet factor 4 (PF4) and heparin.  Pathogenic antibodies to PF4/heparin bind and activate cellular FcgRIIA on platelets and monocytes to propagate ahypercoagulable state culminating in life-threatening thrombosis.  It is now recognized that anti-PF4/heparin antibodies develop commonly after heparin exposure, but only a subset of sensitized patients progress to lifethreatening complications of thrombocytopenia and thrombosis.  Recent scientific developments have clarified mechanisms underlying PF4/heparin immunogenicity, disease susceptibility, and clinicalmanifestations of disease.  Insights from clin. and lab. findings have also been recently harnessed for disease prevention.  This review will summarize our current understanding of HIT by reviewing pathogenesis, essential clin. and lab. features, and management.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj-0WEzMTzYrVg90H21EOLACvtfcHk0lgRk8h4nS21Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1emtbjM&md5=d2e15cbe1028978e4c37e47324e1fa43</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1182%2Fblood-2016-11-709873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2016-11-709873%26sid%3Dliteratum%253Aachs%26aulast%3DArepally%26aufirst%3DG.%2BM.%26atitle%3DHeparin-induced%2520thrombocytopenia%26jtitle%3DBlood%26date%3D2017%26volume%3D129%26spage%3D2864%26epage%3D2872%26doi%3D10.1182%2Fblood-2016-11-709873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Bhaskar, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onishi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suflita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dordick, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Combinatorial one-pot chemoenzymatic synthesis of heparin</span> <span class="citation_source-journal">Carbohydr. Polym.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">407</span><span class="refDoi"> DOI: 10.1016/j.carbpol.2014.10.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1016%2Fj.carbpol.2014.10.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=25817684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFWitrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2015&pages=399-407&author=U.+Bhaskarauthor=G.+Liauthor=L.+Fuauthor=A.+Onishiauthor=M.+Suflitaauthor=J.+S.+Dordickauthor=R.+J.+Linhardt&title=Combinatorial+one-pot+chemoenzymatic+synthesis+of+heparin&doi=10.1016%2Fj.carbpol.2014.10.054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Combinatorial one-pot chemoenzymatic synthesis of heparin</span></div><div class="casAuthors">Bhaskar, Ujjwal; Li, Guoyun; Fu, Li; Onishi, Akihiro; Suflita, Mathew; Dordick, Jonathan S.; Linhardt, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Carbohydrate Polymers</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">399-407</span>CODEN:
                <span class="NLM_cas:coden">CAPOD8</span>;
        ISSN:<span class="NLM_cas:issn">0144-8617</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Contamination in heparin batches during early 2008 has resulted in a significant effort to develop a safer bioengineered heparin using bacterial capsular polysaccharide heparosan and recombinant enzymes derived from the heparin/heparan sulfate biosynthetic pathway.  This requires controlled chem. N-deacetylation/N-sulfonation of heparosan followed by epimerization of most of its glucuronic acid residues to iduronic acid and O-sulfation of the C2 position of iduronic acid and the C3 and C6 positions of the glucosamine residues.  A combinatorial study of multi-enzyme, one-pot, in vitro biocatalytic synthesis, carried out in tandem with sensitive anal. techniques, reveals controlled structural changes leading to heparin products similar to animal-derived heparin active pharmaceutical ingredients.  Liq. chromatog.-mass spectrometry and NMR spectroscopy anal. confirms an abundance of heparin's characteristic trisulfated disaccharide, as well as 3-O-sulfo contg. residues crit. for heparin binding to antithrombin III and its anticoagulant activity.  The bioengineered heparins prepd. using this simplified one-pot chemoenzymic synthesis also show in vitro anticoagulant activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriyerybtU4MLVg90H21EOLACvtfcHk0lgRk8h4nS21Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFWitrrK&md5=58861efade1229ced35c1d92d357acae</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.carbpol.2014.10.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.carbpol.2014.10.054%26sid%3Dliteratum%253Aachs%26aulast%3DBhaskar%26aufirst%3DU.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DFu%26aufirst%3DL.%26aulast%3DOnishi%26aufirst%3DA.%26aulast%3DSuflita%26aufirst%3DM.%26aulast%3DDordick%26aufirst%3DJ.%2BS.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DCombinatorial%2520one-pot%2520chemoenzymatic%2520synthesis%2520of%2520heparin%26jtitle%3DCarbohydr.%2520Polym.%26date%3D2015%26volume%3D122%26spage%3D399%26epage%3D407%26doi%3D10.1016%2Fj.carbpol.2014.10.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Yang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weyers, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sterner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Disaccharide analysis of glycosaminoglycan mixtures by ultra-performance liquid chromatography-mass spectrometry</span> <span class="citation_source-journal">J. Chromatogr. A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">1225</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span><span class="refDoi"> DOI: 10.1016/j.chroma.2011.12.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1016%2Fj.chroma.2011.12.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=22236563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFSitLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1225&publication_year=2012&pages=91-98&author=B.+Yangauthor=Y.+Changauthor=A.+M.+Weyersauthor=E.+Sternerauthor=R.+J.+Linhardt&title=Disaccharide+analysis+of+glycosaminoglycan+mixtures+by+ultra-performance+liquid+chromatography-mass+spectrometry&doi=10.1016%2Fj.chroma.2011.12.063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Disaccharide analysis of glycosaminoglycan mixtures by ultra-high-performance liquid chromatography-mass spectrometry</span></div><div class="casAuthors">Yang, Bo; Chang, Yuqing; Weyers, Amanda M.; Sterner, Eric; Linhardt, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatography A</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1225</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">91-98</span>CODEN:
                <span class="NLM_cas:coden">JCRAEY</span>;
        ISSN:<span class="NLM_cas:issn">0021-9673</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Glycosaminoglycans are a family of polysaccharides widely distributed in all eukaryotic cells.  These polyanionic, linear chain polysaccharides are composed of repeating disaccharide units that are often differentially substituted with sulfo groups.  The diversity of glycosaminoglycan structures in cells, tissues and among different organisms reflect their functional an evolutionary importance.  Glycosaminoglycan compn. and structure also changes in development, aging and in disease progression, making their accurate and reliable anal. a crit., albeit, challenging endeavor.  Quant. disaccharide compositional anal. is one of the primary ways to characterize glycosaminoglycan compn. and structure and has a direct relation with glycosaminoglycan biol. functions.  In this study, glycosaminoglycan disaccharides, prepd. from heparan sulfate/heparin, chondroitin sulfate/dermatan sulfate and neutral hyaluronic acid using multiple polysaccharide lyases, were fluorescently labeled with 2-aminoacridone, fractionated into 17 well-resolved components by reverse-phase ultra-performance liq. chromatog., and analyzed by electrospray ionization mass spectrometry.  This anal. was successfully applied to cell, tissue, and biol. fluid samples for the picomole level detection of glycosaminoglycan compn. and structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ0TFyREyzj7Vg90H21EOLACvtfcHk0lgRk8h4nS21Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFSitLs%253D&md5=60751b81903f6bcfb9a06cc495c44c6a</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.chroma.2011.12.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chroma.2011.12.063%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DB.%26aulast%3DChang%26aufirst%3DY.%26aulast%3DWeyers%26aufirst%3DA.%2BM.%26aulast%3DSterner%26aufirst%3DE.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DDisaccharide%2520analysis%2520of%2520glycosaminoglycan%2520mixtures%2520by%2520ultra-performance%2520liquid%2520chromatography-mass%2520spectrometry%26jtitle%3DJ.%2520Chromatogr.%2520A%26date%3D2012%26volume%3D1225%26spage%3D91%26epage%3D98%26doi%3D10.1016%2Fj.chroma.2011.12.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Xiao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tappen, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ly, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canova, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Heparin mapping using heparin lyases and the generation of a novel low molecular weight heparin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">610</span><span class="refDoi"> DOI: 10.1021/jm101381k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101381k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFOqt77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=603-610&author=Z.+Xiaoauthor=B.+R.+Tappenauthor=M.+Lyauthor=W.+Zhaoauthor=L.+P.+Canovaauthor=H.+Guanauthor=R.+J.+Linhardt&title=Heparin+mapping+using+heparin+lyases+and+the+generation+of+a+novel+low+molecular+weight+heparin&doi=10.1021%2Fjm101381k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Heparin mapping using heparin lyases and the generation of a novel low molecular weight heparin</span></div><div class="casAuthors">Xiao, Zhongping; Tappen, Britney R.; Ly, Mellisa; Zhao, Wenjing; Canova, Lauren P.; Guan, Huashi; Linhardt, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">603-610</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Seven pharmaceutical heparins were investigated by oligosaccharide mapping by digestion with heparin lyase 1, 2, or 3, followed by high performance liq. chromatog. anal.  The structure of one of the prepd. mapping stds., ΔUA-Gal-Gal-Xyl-O-CH2CONHCH2COOH (where ΔUA is 4-deoxy-α-L-threo-hex-4-eno-pyranosyluronic acid, Gal is β-D-galactopyranose, and Xyl is β-D-xylopyranose) released from the linkage region using either heparin lyase 2 or heparin lyase 3 digestion, is reported for the first time.  A size-dependent susceptibility of site cleaved by heparin lyase 3 was also obsd.  Heparin lyase 3 acts on the undersulfated domains of the heparin chain and does not cleave the linkages within heparin's antithrombin III binding site.  Thus, a novel low mol. wt. heparin (LMWH) is afforded on heparin lyase 3 digestion of heparin due to this unique substrate specificity, which has anticoagulant activity comparable to that of currently available LMWH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq-WextauHcrVg90H21EOLACvtfcHk0liBtxfvBwEHsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFOqt77O&md5=618a944505e39aff3c44099bed0ae599</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm101381k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101381k%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DZ.%26aulast%3DTappen%26aufirst%3DB.%2BR.%26aulast%3DLy%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DCanova%26aufirst%3DL.%2BP.%26aulast%3DGuan%26aufirst%3DH.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DHeparin%2520mapping%2520using%2520heparin%2520lyases%2520and%2520the%2520generation%2520of%2520a%2520novel%2520low%2520molecular%2520weight%2520heparin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D603%26epage%3D610%26doi%3D10.1021%2Fjm101381k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Jones, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limtiaco, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langeslay, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larive, C. K.</span><span> </span><span class="NLM_article-title">Heparin characterization: challenges and solutions</span> <span class="citation_source-journal">Annu. Rev. Anal. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">65</span><span class="refDoi"> DOI: 10.1146/annurev-anchem-061010-113911</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1146%2Fannurev-anchem-061010-113911" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=21469955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVynsbfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=439-65&author=C.+J.+Jonesauthor=S.+Beniauthor=J.+F.+Limtiacoauthor=D.+J.+Langeslayauthor=C.+K.+Larive&title=Heparin+characterization%3A+challenges+and+solutions&doi=10.1146%2Fannurev-anchem-061010-113911"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Heparin characterization: challenges and solutions</span></div><div class="casAuthors">Jones, Christopher J.; Beni, Szabolcs; Limtiaco, John F. K.; Langeslay, Derek J.; Larive, Cynthia K.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Analytical Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">439-465</span>CODEN:
                <span class="NLM_cas:coden">ARACFU</span>;
        ISSN:<span class="NLM_cas:issn">1936-1327</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Although heparin is an important and widely prescribed pharmaceutical anticoagulant, its high degree of sequence microheterogeneity and size polydispersity make mol.-level characterization challenging.  Unlike nucleic acids and proteins that are biosynthesized through template-driven assembly processes, heparin and the related glycosaminoglycan heparan sulfate are actively remodeled during biosynthesis through a series of enzymic reactions that lead to variable levels of O- and N-sulfonation and uronic acid epimers.  As summarized in this review, heparin sequence information is detd. through a bottom-up approach that relies on depolymn. reactions, size- and charge-based sepns., and sensitive mass spectrometric and NMR expts. to det. the structural identity of component oligosaccharides.  The structure-elucidation process, along with its challenges and opportunities for future anal. improvements, is reviewed and illustrated for a heparin-derived hexasaccharide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptSehKDoGOJbVg90H21EOLACvtfcHk0liBtxfvBwEHsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVynsbfI&md5=cae7fcdbee40cc22c09b7b7d3affd642</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1146%2Fannurev-anchem-061010-113911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-anchem-061010-113911%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DC.%2BJ.%26aulast%3DBeni%26aufirst%3DS.%26aulast%3DLimtiaco%26aufirst%3DJ.%2BF.%26aulast%3DLangeslay%26aufirst%3DD.%2BJ.%26aulast%3DLarive%26aufirst%3DC.%2BK.%26atitle%3DHeparin%2520characterization%253A%2520challenges%2520and%2520solutions%26jtitle%3DAnnu.%2520Rev.%2520Anal.%2520Chem.%26date%3D2011%26volume%3D4%26spage%3D439%26epage%3D65%26doi%3D10.1146%2Fannurev-anchem-061010-113911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Mauri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boccardi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karfunkle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macchi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keire, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, M.</span><span> </span><span class="NLM_article-title">Qualification of HSQC methods for quantitative composition of heparin and low molecular weight heparins</span> <span class="citation_source-journal">J. Pharm. Biomed. Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">92</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span><span class="refDoi"> DOI: 10.1016/j.jpba.2016.12.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1016%2Fj.jpba.2016.12.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=28068519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmsVyrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2017&pages=92-105&author=L.+Mauriauthor=G.+Boccardiauthor=G.+Torriauthor=M.+Karfunkleauthor=E.+Macchiauthor=L.+Muziauthor=D.+Keireauthor=M.+Guerrini&title=Qualification+of+HSQC+methods+for+quantitative+composition+of+heparin+and+low+molecular+weight+heparins&doi=10.1016%2Fj.jpba.2016.12.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Qualification of HSQC methods for quantitative composition of heparin and low molecular weight heparins</span></div><div class="casAuthors">Mauri, Lucio; Boccardi, Giovanni; Torri, Giangiacomo; Karfunkle, Michael; Macchi, Eleonora; Muzi, Laura; Keire, David; Guerrini, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">92-105</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">An NMR HSQC method has recently been proposed for the quant. detn. of the mono- and disaccharide subunits of heparin and low mol. wt. heparins (LMWH).  The focus of the current study was the validation of this procedure to make the 2D-NMR method suitable for pharmaceutical quality control applications.  Pre-validation work investigated the effects of several exptl. parameters to assess robustness and to optimize crit. factors.  Important exptl. parameters were pulse sequence selection, equilibration interval between pulse trains and temp.  These observations were needed so that the NMR method was sufficiently understood to enable continuous improvement.  A std. validation study on heparin then examd. linearity, repeatability, intermediate precision and limits of detection and quantitation; selected validation parameters were also detd. for LMWH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5eysMbpVls7Vg90H21EOLACvtfcHk0liBtxfvBwEHsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmsVyrtQ%253D%253D&md5=fec77c6fd579a70913d6b054a66f3d62</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2016.12.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2016.12.031%26sid%3Dliteratum%253Aachs%26aulast%3DMauri%26aufirst%3DL.%26aulast%3DBoccardi%26aufirst%3DG.%26aulast%3DTorri%26aufirst%3DG.%26aulast%3DKarfunkle%26aufirst%3DM.%26aulast%3DMacchi%26aufirst%3DE.%26aulast%3DMuzi%26aufirst%3DL.%26aulast%3DKeire%26aufirst%3DD.%26aulast%3DGuerrini%26aufirst%3DM.%26atitle%3DQualification%2520of%2520HSQC%2520methods%2520for%2520quantitative%2520composition%2520of%2520heparin%2520and%2520low%2520molecular%2520weight%2520heparins%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2017%26volume%3D136%26spage%3D92%26epage%3D105%26doi%3D10.1016%2Fj.jpba.2016.12.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malhotra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Novel Method for Measurement of Heparin Anticoagulant Activity Using SPR</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">526</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span><span class="refDoi"> DOI: 10.1016/j.ab.2017.03.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1016%2Fj.ab.2017.03.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=28322799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC2sXksFSisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=526&publication_year=2017&pages=39-42&author=J.+Zhaoauthor=X.+Liuauthor=A.+Malhotraauthor=Q.+Liauthor=F.+Zhangauthor=R.+J.+Linhardt&title=Novel+Method+for+Measurement+of+Heparin+Anticoagulant+Activity+Using+SPR&doi=10.1016%2Fj.ab.2017.03.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Novel method for measurement of heparin anticoagulant activity using SPR</span></div><div class="casAuthors">Zhao, Jing; Liu, Xinyue; Malhotra, Anju; Li, Quanhong; Zhang, Fuming; Linhardt, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">526</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">39-42</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A novel method has been developed for the easy measurement of heparin's anticoagulant activity using surface plasmon resonance.  The anticoagulant activity of target heparin was evaluated by measuring the competitive antithrombin III binding of analyte heparin in the soln. phase and USP heparin immobilized on chip surface.  Heparins, obtained from different animal sources, and low mol. wt. heparins were analyzed.  The results were reproducible and correlated well with the results of chromogenic assays (correlation coeff. r = 0.98 for anti-Xa and r = 0.94 for anti-IIa).  This protocol provides many advantages, significantly minimizing time, cost and the complications of chromogenic assay methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaJe7ckmOfkLVg90H21EOLACvtfcHk0lji8YgNeJopsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXksFSisb0%253D&md5=4e6037dfd7d6e5bc54ec0cfb1fcf81be</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2017.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2017.03.013%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DMalhotra%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DNovel%2520Method%2520for%2520Measurement%2520of%2520Heparin%2520Anticoagulant%2520Activity%2520Using%2520SPR%26jtitle%3DAnal.%2520Biochem.%26date%3D2017%26volume%3D526%26spage%3D39%26epage%3D42%26doi%3D10.1016%2Fj.ab.2017.03.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span> </span><span class="NLM_article-title">Heparin Sodium</span>. USP37 Official Monograph; <span class="NLM_publisher-name">United States Pharmacopeia</span>: <span class="NLM_publisher-loc">Rockville, MD</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Heparin+Sodium.+USP37+Official+Monograph%3B+United+States+Pharmacopeia%3A+Rockville%2C+MD%2C+2013."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26atitle%3DHeparin%2520Sodium%26pub%3DUnited%2520States%2520Pharmacopeia%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Mousa, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aljada, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takieddin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castelli, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and pharmacodynamics of oral heparin solid dosage form in healthy human subjects</span> <span class="citation_source-journal">J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1508</span><span class="NLM_x">–</span> <span class="NLM_lpage">1520</span><span class="refDoi"> DOI: 10.1177/0091270007307242</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1177%2F0091270007307242" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=18048572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVyjtr%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=1508-1520&author=S.+A.+Mousaauthor=F.+Zhangauthor=A.+Aljadaauthor=S.+Chaturvediauthor=M.+Takieddinauthor=H.+Zhangauthor=L.+Chiauthor=M.+C.+Castelliauthor=K.+Friedmanauthor=M.+M.+Goldbergauthor=R.+J.+Linhardt&title=Pharmacokinetics+and+pharmacodynamics+of+oral+heparin+solid+dosage+form+in+healthy+human+subjects&doi=10.1177%2F0091270007307242"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and pharmacodynamics of oral heparin solid dosage form in healthy human subjects</span></div><div class="casAuthors">Mousa, Shaker A.; Zhang, Fuming; Aljada, Ahmad; Chaturvedi, Seema; Takieddin, Majde; Zhang, Haifeng; Chi, Lianli; Castelli, M. Cristina; Friedman, Kristen; Goldberg, Michael M.; Linhardt, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1508-1520</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">The present investigation detd. the mol. structure and the pharmacokinetic and pharmacodynamic profiles of oral unfractionated heparin contg. oral absorption enhancer sodium N-[8-(2-hydroxybenzoyl) amino]caprylate, salcaprozate sodium (SNAC) and assessed the safety and tolerability of the orally dosed heparin solid dosage form vs. other routes.  Sixteen healthy men were included in this single-dose, 3-way crossover, randomized, open-label study.  Disaccharide compositional anal. was performed using capillary high-performance liq. chromatog. with electrospray ionization mass spectrometry detection.  The pharmacodynamics of heparin were obtained from anal. of plasma anti-factor Xa, anti-factor IIa, activated partial thromboplastin time, and total tissue factor pathway inhibitor data.  The mol. wt. properties and the disaccharide compn. of orally administered unfractionated heparin/SNAC and parenterally administered unfractionated heparin are identical and consistent with the starting pharmaceutical std. heparin.  Furthermore, the anti-factor Xa/anti-factor IIa ratio achieved is of approx. 1:1.  This is the first true pharmacokinetic study to measure the chem. compns. of heparin administered by different routes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwS6_f159JTrVg90H21EOLACvtfcHk0lji8YgNeJopsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVyjtr%252FP&md5=aa4b3ee7291fba7a9b120e74bea53a17</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1177%2F0091270007307242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270007307242%26sid%3Dliteratum%253Aachs%26aulast%3DMousa%26aufirst%3DS.%2BA.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DAljada%26aufirst%3DA.%26aulast%3DChaturvedi%26aufirst%3DS.%26aulast%3DTakieddin%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DChi%26aufirst%3DL.%26aulast%3DCastelli%26aufirst%3DM.%2BC.%26aulast%3DFriedman%26aufirst%3DK.%26aulast%3DGoldberg%26aufirst%3DM.%2BM.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DPharmacokinetics%2520and%2520pharmacodynamics%2520of%2520oral%2520heparin%2520solid%2520dosage%2520form%2520in%2520healthy%2520human%2520subjects%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2007%26volume%3D47%26spage%3D1508%26epage%3D1520%26doi%3D10.1177%2F0091270007307242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 12 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Sultan N. Baytas, Sony S. Varghese, Weihua Jin, Yanlei Yu, Peng He, Marc Douaisi, Fuming Zhang, Paul Brodfuehrer, Ke Xia, Jonathan S. Dordick, <span class="NLM_string-name hlFld-ContribAuthor">Robert J. Linhardt</span>. </span><span class="cited-content_cbyCitation_article-title">Preparation of Low Molecular Weight Heparin from a Remodeled Bovine Intestinal Heparin. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (4)
                                     , 2242-2253. <a href="https://doi.org/10.1021/acs.jmedchem.0c02019" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02019%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPreparation%252Bof%252BLow%252BMolecular%252BWeight%252BHeparin%252Bfrom%252Ba%252BRemodeled%252BBovine%252BIntestinal%252BHeparin%26aulast%3DBaytas%26aufirst%3DSultan%2BN.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D21112020%26date%3D15022021%26volume%3D64%26issue%3D4%26spage%3D2242%26epage%3D2253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weihua  Jin</span>, <span class="hlFld-ContribAuthor ">Fuming  Zhang</span>, <span class="hlFld-ContribAuthor ">Robert J.  Linhardt</span>. </span><span class="cited-content_cbyCitation_article-title">Bioengineered production of glycosaminoglycans and their analogues. </span><span class="cited-content_cbyCitation_journal-name">Systems Microbiology and Biomanufacturing</span><span> <strong>2021,</strong> <em>1 </em>
                                    (2)
                                     , 123-130. <a href="https://doi.org/10.1007/s43393-020-00011-x" title="DOI URL">https://doi.org/10.1007/s43393-020-00011-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s43393-020-00011-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs43393-020-00011-x%26sid%3Dliteratum%253Aachs%26jtitle%3DSystems%2520Microbiology%2520and%2520Biomanufacturing%26atitle%3DBioengineered%252Bproduction%252Bof%252Bglycosaminoglycans%252Band%252Btheir%252Banalogues%26aulast%3DJin%26aufirst%3DWeihua%26date%3D2021%26date%3D2020%26volume%3D1%26issue%3D2%26spage%3D123%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Payel  Datta</span>, <span class="hlFld-ContribAuthor ">LuFeng  Yan</span>, <span class="hlFld-ContribAuthor ">Adeola  Awofiranye</span>, <span class="hlFld-ContribAuthor ">Jonathan S.  Dordick</span>, <span class="hlFld-ContribAuthor ">Robert J.  Linhardt</span>. </span><span class="cited-content_cbyCitation_article-title">Heparosan Chain Characterization: Sequential Depolymerization of
              E. Coli
              K5 Heparosan by a Bacterial Eliminase Heparin Lyase III and a Bacterial Hydrolase Heparanase Bp to Prepare Defined Oligomers. </span><span class="cited-content_cbyCitation_journal-name">Biotechnology Journal</span><span> <strong>2021,</strong> <em>16 </em>
                                    (3)
                                     , 2000336. <a href="https://doi.org/10.1002/biot.202000336" title="DOI URL">https://doi.org/10.1002/biot.202000336</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/biot.202000336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fbiot.202000336%26sid%3Dliteratum%253Aachs%26jtitle%3DBiotechnology%2520Journal%26atitle%3DHeparosan%252BChain%252BCharacterization%25253A%252BSequential%252BDepolymerization%252Bof%252BE.%252BColi%252BK5%252BHeparosan%252Bby%252Ba%252BBacterial%252BEliminase%252BHeparin%252BLyase%252BIII%252Band%252Ba%252BBacterial%252BHydrolase%252BHeparanase%252BBp%252Bto%252BPrepare%252BDefined%252BOligomers%26aulast%3DDatta%26aufirst%3DPayel%26date%3D2021%26date%3D2020%26volume%3D16%26issue%3D3%26spage%3D2000336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Payel  Datta</span>, <span class="hlFld-ContribAuthor ">Li  Fu</span>, <span class="hlFld-ContribAuthor ">Paul  Brodfuerer</span>, <span class="hlFld-ContribAuthor ">Jonathan S.  Dordick</span>, <span class="hlFld-ContribAuthor ">Robert J.  Linhardt</span>. </span><span class="cited-content_cbyCitation_article-title">High density fermentation of probiotic E. coli Nissle 1917 towards heparosan production, characterization, and modification. </span><span class="cited-content_cbyCitation_journal-name">Applied Microbiology and Biotechnology</span><span> <strong>2021,</strong> <em>105 </em>
                                    (3)
                                     , 1051-1062. <a href="https://doi.org/10.1007/s00253-020-11079-9" title="DOI URL">https://doi.org/10.1007/s00253-020-11079-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00253-020-11079-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00253-020-11079-9%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Microbiology%2520and%2520Biotechnology%26atitle%3DHigh%252Bdensity%252Bfermentation%252Bof%252Bprobiotic%252BE.%252Bcoli%252BNissle%252B1917%252Btowards%252Bheparosan%252Bproduction%25252C%252Bcharacterization%25252C%252Band%252Bmodification%26aulast%3DDatta%26aufirst%3DPayel%26date%3D2021%26date%3D2021%26volume%3D105%26issue%3D3%26spage%3D1051%26epage%3D1062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Omozusi  Andrews</span>, <span class="hlFld-ContribAuthor ">Cyrus  Bett</span>, <span class="hlFld-ContribAuthor ">Qin  Shu</span>, <span class="hlFld-ContribAuthor ">Nadine  Kaelber</span>, <span class="hlFld-ContribAuthor ">David M.  Asher</span>, <span class="hlFld-ContribAuthor ">David  Keire</span>, <span class="hlFld-ContribAuthor ">Luisa  Gregori</span>. </span><span class="cited-content_cbyCitation_article-title">Processing bovine intestinal mucosa to active heparin removes spiked BSE agent. </span><span class="cited-content_cbyCitation_journal-name">Biologicals</span><span> <strong>2020,</strong> <em>67 </em>, 56-61. <a href="https://doi.org/10.1016/j.biologicals.2020.06.004" title="DOI URL">https://doi.org/10.1016/j.biologicals.2020.06.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biologicals.2020.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biologicals.2020.06.004%26sid%3Dliteratum%253Aachs%26jtitle%3DBiologicals%26atitle%3DProcessing%252Bbovine%252Bintestinal%252Bmucosa%252Bto%252Bactive%252Bheparin%252Bremoves%252Bspiked%252BBSE%252Bagent%26aulast%3DAndrews%26aufirst%3DOmozusi%26date%3D2020%26volume%3D67%26spage%3D56%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Payel  Datta</span>, <span class="hlFld-ContribAuthor ">Li  Fu</span>, <span class="hlFld-ContribAuthor ">Wenqin  He</span>, <span class="hlFld-ContribAuthor ">M. A. G.  Koffas</span>, <span class="hlFld-ContribAuthor ">J. S.  Dordick</span>, <span class="hlFld-ContribAuthor ">R. J.  Linhardt</span>. </span><span class="cited-content_cbyCitation_article-title">Expression of enzymes for 3′-phosphoadenosine-5′-phosphosulfate (PAPS) biosynthesis and their preparation for PAPS synthesis and regeneration. </span><span class="cited-content_cbyCitation_journal-name">Applied Microbiology and Biotechnology</span><span> <strong>2020,</strong> <em>104 </em>
                                    (16)
                                     , 7067-7078. <a href="https://doi.org/10.1007/s00253-020-10709-6" title="DOI URL">https://doi.org/10.1007/s00253-020-10709-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00253-020-10709-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00253-020-10709-6%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Microbiology%2520and%2520Biotechnology%26atitle%3DExpression%252Bof%252Benzymes%252Bfor%252B3%2525E2%252580%2525B2-phosphoadenosine-5%2525E2%252580%2525B2-phosphosulfate%252B%252528PAPS%252529%252Bbiosynthesis%252Band%252Btheir%252Bpreparation%252Bfor%252BPAPS%252Bsynthesis%252Band%252Bregeneration%26aulast%3DDatta%26aufirst%3DPayel%26date%3D2020%26date%3D2020%26volume%3D104%26issue%3D16%26spage%3D7067%26epage%3D7078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ting  Wang</span>, <span class="hlFld-ContribAuthor ">Li  Liu</span>, <span class="hlFld-ContribAuthor ">Josef  Voglmeir</span>. </span><span class="cited-content_cbyCitation_article-title">Chemoenzymatic synthesis of ultralow and low-molecular weight heparins. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics</span><span> <strong>2020,</strong> <em>1868 </em>
                                    (2)
                                     , 140301. <a href="https://doi.org/10.1016/j.bbapap.2019.140301" title="DOI URL">https://doi.org/10.1016/j.bbapap.2019.140301</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbapap.2019.140301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbapap.2019.140301%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Proteins%2520and%2520Proteomics%26atitle%3DChemoenzymatic%252Bsynthesis%252Bof%252Bultralow%252Band%252Blow-molecular%252Bweight%252Bheparins%26aulast%3DWang%26aufirst%3DTing%26date%3D2020%26volume%3D1868%26issue%3D2%26spage%3D140301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eric  Boittier</span>, <span class="hlFld-ContribAuthor ">Neha  Gandhi</span>, <span class="hlFld-ContribAuthor ">Vito  Ferro</span>, <span class="hlFld-ContribAuthor ">Deirdre  Coombe</span>. </span><span class="cited-content_cbyCitation_article-title">Cross-Species Analysis of Glycosaminoglycan Binding Proteins Reveals Some Animal Models Are “More Equal” than Others. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (5)
                                     , 924. <a href="https://doi.org/10.3390/molecules24050924" title="DOI URL">https://doi.org/10.3390/molecules24050924</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24050924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24050924%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DCross-Species%252BAnalysis%252Bof%252BGlycosaminoglycan%252BBinding%252BProteins%252BReveals%252BSome%252BAnimal%252BModels%252BAre%252B%2525E2%252580%25259CMore%252BEqual%2525E2%252580%25259D%252Bthan%252BOthers%26aulast%3DBoittier%26aufirst%3DEric%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D5%26spage%3D924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eduardo  Vilanova</span>, <span class="hlFld-ContribAuthor ">Bruno C.  Vairo</span>, <span class="hlFld-ContribAuthor ">Stephan-Nicollas M. C. G.  Oliveira</span>, <span class="hlFld-ContribAuthor ">Bianca F.  Glauser</span>, <span class="hlFld-ContribAuthor ">Nina V.  Capillé</span>, <span class="hlFld-ContribAuthor ">Gustavo R. C.  Santos</span>, <span class="hlFld-ContribAuthor ">Ana M. F.  Tovar</span>, <span class="hlFld-ContribAuthor ">Mariana S.  Pereira</span>, <span class="hlFld-ContribAuthor ">Paulo A. S.  Mourão</span>. </span><span class="cited-content_cbyCitation_article-title">Heparins Sourced From Bovine and Porcine Mucosa Gain Exclusive Monographs in the Brazilian Pharmacopeia. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Medicine</span><span> <strong>2019,</strong> <em>6 </em><a href="https://doi.org/10.3389/fmed.2019.00016" title="DOI URL">https://doi.org/10.3389/fmed.2019.00016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmed.2019.00016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmed.2019.00016%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Medicine%26atitle%3DHeparins%252BSourced%252BFrom%252BBovine%252Band%252BPorcine%252BMucosa%252BGain%252BExclusive%252BMonographs%252Bin%252Bthe%252BBrazilian%252BPharmacopeia%26aulast%3DVilanova%26aufirst%3DEduardo%26date%3D2019%26date%3D2019%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yilan  Ouyang</span>, <span class="hlFld-ContribAuthor ">Xiaorui  Han</span>, <span class="hlFld-ContribAuthor ">Yanlei  Yu</span>, <span class="hlFld-ContribAuthor ">Jianle  Chen</span>, <span class="hlFld-ContribAuthor ">Li  Fu</span>, <span class="hlFld-ContribAuthor ">Fuming  Zhang</span>, <span class="hlFld-ContribAuthor ">Robert J.  Linhardt</span>, <span class="hlFld-ContribAuthor ">Jawed  Fareed</span>, <span class="hlFld-ContribAuthor ">Debra  Hoppensteadt</span>, <span class="hlFld-ContribAuthor ">Walter  Jeske</span>, <span class="hlFld-ContribAuthor ">Ahmed  Kouta</span>, <span class="hlFld-ContribAuthor ">Zhenqing  Zhang</span>, <span class="hlFld-ContribAuthor ">Ke  Xia</span>. </span><span class="cited-content_cbyCitation_article-title">Chemometric analysis of porcine, bovine and ovine heparins. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmaceutical and Biomedical Analysis</span><span> <strong>2019,</strong> <em>164 </em>, 345-352. <a href="https://doi.org/10.1016/j.jpba.2018.10.052" title="DOI URL">https://doi.org/10.1016/j.jpba.2018.10.052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jpba.2018.10.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jpba.2018.10.052%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmaceutical%2520and%2520Biomedical%2520Analysis%26atitle%3DChemometric%252Banalysis%252Bof%252Bporcine%25252C%252Bbovine%252Band%252Bovine%252Bheparins%26aulast%3DOuyang%26aufirst%3DYilan%26date%3D2019%26volume%3D164%26spage%3D345%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Walter  Jeske</span>, <span class="hlFld-ContribAuthor ">Ahmed  Kouta</span>, <span class="hlFld-ContribAuthor ">Ambar  Farooqui</span>, <span class="hlFld-ContribAuthor ">Fakiha  Siddiqui</span>, <span class="hlFld-ContribAuthor ">Varun  Rangnekar</span>, <span class="hlFld-ContribAuthor ">Manoj  Niverthi</span>, <span class="hlFld-ContribAuthor ">Rajan  Laddu</span>, <span class="hlFld-ContribAuthor ">Debra  Hoppensteadt</span>, <span class="hlFld-ContribAuthor ">Omer  Iqbal</span>, <span class="hlFld-ContribAuthor ">Jeanine  Walenga</span>, <span class="hlFld-ContribAuthor ">Jawed  Fareed</span>. </span><span class="cited-content_cbyCitation_article-title">Bovine Mucosal Heparins Are Comparable to Porcine Mucosal Heparin at USP Potency Adjusted Levels. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Medicine</span><span> <strong>2019,</strong> <em>5 </em><a href="https://doi.org/10.3389/fmed.2018.00360" title="DOI URL">https://doi.org/10.3389/fmed.2018.00360</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmed.2018.00360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmed.2018.00360%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Medicine%26atitle%3DBovine%252BMucosal%252BHeparins%252BAre%252BComparable%252Bto%252BPorcine%252BMucosal%252BHeparin%252Bat%252BUSP%252BPotency%252BAdjusted%252BLevels%26aulast%3DJeske%26aufirst%3DWalter%26date%3D2019%26date%3D2019%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weihua  Jin</span>, <span class="hlFld-ContribAuthor ">Shuai  Li</span>, <span class="hlFld-ContribAuthor ">Jiale  Chen</span>, <span class="hlFld-ContribAuthor ">Bing  Liu</span>, <span class="hlFld-ContribAuthor ">Jie  Li</span>, <span class="hlFld-ContribAuthor ">Xueliang  Li</span>, <span class="hlFld-ContribAuthor ">Fuming  Zhang</span>, <span class="hlFld-ContribAuthor ">Robert J.  Linhardt</span>, <span class="hlFld-ContribAuthor ">Weihong  Zhong</span>. </span><span class="cited-content_cbyCitation_article-title">Increased soluble heterologous expression of a rat brain 3- O -sulfotransferase 1 – A key enzyme for heparin biosynthesis. </span><span class="cited-content_cbyCitation_journal-name">Protein Expression and Purification</span><span> <strong>2018,</strong> <em>151 </em>, 23-29. <a href="https://doi.org/10.1016/j.pep.2018.06.007" title="DOI URL">https://doi.org/10.1016/j.pep.2018.06.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pep.2018.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pep.2018.06.007%26sid%3Dliteratum%253Aachs%26jtitle%3DProtein%2520Expression%2520and%2520Purification%26atitle%3DIncreased%252Bsoluble%252Bheterologous%252Bexpression%252Bof%252Ba%252Brat%252Bbrain%252B3-%252BO%252B-sulfotransferase%252B1%252B%2525E2%252580%252593%252BA%252Bkey%252Benzyme%252Bfor%252Bheparin%252Bbiosynthesis%26aulast%3DJin%26aufirst%3DWeihua%26date%3D2018%26volume%3D151%26spage%3D23%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01269/20171020/images/medium/jm-2017-01269a_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01269/20171020/images/large/jm-2017-01269a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01269&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01269/20171020/images/medium/jm-2017-01269a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01269/20171020/images/large/jm-2017-01269a_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of heparins and their remodeled structures. a + d ∼ 20, b = 1, c ∼ 8 for MW weight average 20 000. X or X′ = SO<sub>3</sub><sup>–</sup>, H; Y or Y′ = SO<sub>3</sub><sup>–</sup>, COCH<sub>3</sub>, H; Z = SO<sub>3</sub><sup>–</sup>, H. (A) Schematic structure of an average chain present in PI heparin. (C) Schematic structure of an average chain present in BI heparin. (B) Schematic structure of an average chain present in BI 3S6S heparin. (D) Schematic structure of an average chain present in BI 3S heparin. See <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.7b01269/suppl_file/jm7b01269_si_001.pdf" class="ext-link">Supporting Information Table S1 and Figure S1</a> for detailed MW data.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01269/20171020/images/large/jm-2017-01269a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01269&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01269/20171020/images/medium/jm-2017-01269a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01269/20171020/images/large/jm-2017-01269a_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. NMR analysis of BI heparin and modified BI heparins: (A) 1D <sup>1</sup>H NMR spectra of bovine heparins BI, BI 3S, BI 3S6S; (B) 1D DEPT-135 <sup>13</sup>C NMR spectra of bovine heparins BI, BI 3S, BI 3S6S.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01269/20171020/images/large/jm-2017-01269a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01269&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01269/20171020/images/medium/jm-2017-01269a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01269/20171020/images/large/jm-2017-01269a_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Extracted ion chromatogram of tetrasaccharide mapping on BI heparins and PI heparin. T1 (<i>m</i>/<i>z</i> 477) is ΔUA-GlcNAc6S-GlcA-GlcNS3S. T2 (<i>m</i>/<i>z</i> 517) is ΔUA-GlcNAc6S-GlcA-GlcNS3S6S. T3 (<i>m</i>/<i>z</i> 536) is ΔUA-GlcNS6S-GlcA-GlcNS3S6S. T4 (<i>m</i>/<i>z</i> 557) is ΔUA-GlcNAc2S6S-GlcA-GlcNS3S6S. T5 (<i>m</i>/<i>z</i> 536) and T6 (<i>m</i>/<i>z</i> 536) have unknown structures.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01269/20171020/images/large/jm-2017-01269a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01269&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01269/20171020/images/medium/jm-2017-01269a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01269/20171020/images/large/jm-2017-01269a_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Surface plasmon resonance IC<sub>50</sub> measurement of bovine heparins using surface competition SPR: (A) IC<sub>50</sub> for AT binding of heparins; (B) IC<sub>50</sub> for PF4 binding of heparins.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01269/20171020/images/large/jm-2017-01269a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01269&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01269/20171020/images/medium/jm-2017-01269a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01269/20171020/images/large/jm-2017-01269a_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Pharmacodynamics/pharmacokinetics (PK/PD) of heparins in the rabbit: (A) BI 3S heparin (in triplicate, ±SD); (B) PI heparin (<i>n</i> = 7 USP PI heparins, each in triplicate, ±SD).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b01269/20171020/images/large/jm-2017-01269a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01269&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i18">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27377" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27377" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 39 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Onishi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Ange, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dordick, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Heparin and anticoagulation, glycosaminoglycans and related disorders</span> <span class="citation_source-journal">Front. Biosci., Landmark Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1372</span><span class="NLM_x">–</span> <span class="NLM_lpage">1392</span><span class="refDoi"> DOI: 10.2741/4462</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.2741%2F4462" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=27100512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A280%3ADC%252BC28bisVWntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=1372-1392&author=A.+Onishiauthor=K.+St.+Angeauthor=J.+S.+Dordickauthor=R.+J.+Linhardt&title=Heparin+and+anticoagulation%2C+glycosaminoglycans+and+related+disorders&doi=10.2741%2F4462"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Heparin and anticoagulation</span></div><div class="casAuthors">Onishi Akihiro; St Ange Kalib; Dordick Jonathan S; Linhardt Robert J</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in bioscience (Landmark edition)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1372-92</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Heparin, a sulfated polysaccharide, has been used as a clinical anticoagulant for over 90 years.  Newer anticoagulants, introduced for certain specialized applications, have not significantly displaced heparin and newer heparin-based anticoagulants in most medical procedures.  This chapter, while reviewing anticoagulation and these newer anticoagulants, focuses on heparin-based anticoagulants, including unfractionated heparin, low molecular weight heparins and ultra-low molecular weight heparins.  Heparin's structures and its biological and therapeutic roles are discussed.  Particular emphasis is placed on heparin's therapeutic application and its adverse effects.  The future prospects are excellent for new heparins and new heparin-based therapeutics with improved properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTxto5WiqPPps-crCu0nI_sfW6udTcc2eZhDD6NB8OFJbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28bisVWntw%253D%253D&md5=e8b8df6bd3d5d5486d7686ffdc0feaeb</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2741%2F4462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F4462%26sid%3Dliteratum%253Aachs%26aulast%3DOnishi%26aufirst%3DA.%26aulast%3DSt.%2BAnge%26aufirst%3DK.%26aulast%3DDordick%26aufirst%3DJ.%2BS.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DHeparin%2520and%2520anticoagulation%252C%2520glycosaminoglycans%2520and%2520related%2520disorders%26jtitle%3DFront.%2520Biosci.%252C%2520Landmark%2520Ed.%26date%3D2016%26volume%3D21%26spage%3D1372%26epage%3D1392%26doi%3D10.2741%2F4462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Mulloy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogwood, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lever, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, C. P.</span><span> </span><span class="NLM_article-title">Pharmacology of heparin and related drugs</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">76</span><span class="NLM_x">–</span> <span class="NLM_lpage">141</span><span class="refDoi"> DOI: 10.1124/pr.115.011247</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1124%2Fpr.115.011247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=26672027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A280%3ADC%252BC28rit1ygsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2016&pages=76-141&author=B.+Mulloyauthor=J.+Hogwoodauthor=E.+Grayauthor=R.+Leverauthor=C.+P.+Page&title=Pharmacology+of+heparin+and+related+drugs&doi=10.1124%2Fpr.115.011247"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology of Heparin and Related Drugs</span></div><div class="casAuthors">Mulloy Barbara; Hogwood John; Gray Elaine; Lever Rebecca; Page Clive P</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">76-141</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Heparin has been recognized as a valuable anticoagulant and antithrombotic for several decades and is still widely used in clinical practice for a variety of indications.  The anticoagulant activity of heparin is mainly attributable to the action of a specific pentasaccharide sequence that acts in concert with antithrombin, a plasma coagulation factor inhibitor.  This observation has led to the development of synthetic heparin mimetics for clinical use.  However, it is increasingly recognized that heparin has many other pharmacological properties, including but not limited to antiviral, anti-inflammatory, and antimetastatic actions.  Many of these activities are independent of its anticoagulant activity, although the mechanisms of these other activities are currently less well defined.  Nonetheless, heparin is being exploited for clinical uses beyond anticoagulation and developed for a wide range of clinical disorders.  This article provides a "state of the art" review of our current understanding of the pharmacology of heparin and related drugs and an overview of the status of development of such drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR6h7u2NTAthnp3bfzSLaX5fW6udTcc2eYeaC5X5QXFeLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rit1ygsw%253D%253D&md5=3f4ff312be9b121ee845ccf1ff10fbee</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1124%2Fpr.115.011247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.115.011247%26sid%3Dliteratum%253Aachs%26aulast%3DMulloy%26aufirst%3DB.%26aulast%3DHogwood%26aufirst%3DJ.%26aulast%3DGray%26aufirst%3DE.%26aulast%3DLever%26aufirst%3DR.%26aulast%3DPage%26aufirst%3DC.%2BP.%26atitle%3DPharmacology%2520of%2520heparin%2520and%2520related%2520drugs%26jtitle%3DPharmacol.%2520Rev.%26date%3D2016%26volume%3D68%26spage%3D76%26epage%3D141%26doi%3D10.1124%2Fpr.115.011247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhaskar, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akihiro, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dordick, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Response surface optimization of the heparosan <i>N</i>-deacetylation in producing bioengineered heparin</span> <span class="citation_source-journal">J. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">156</span><span class="NLM_x">, </span> <span class="NLM_fpage">188</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span><span class="refDoi"> DOI: 10.1016/j.jbiotec.2011.08.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1016%2Fj.jbiotec.2011.08.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=21925548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlalurjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2011&pages=188-196&author=Z.+Wangauthor=J.+Liauthor=S.+Cheongauthor=U.+Bhaskarauthor=O.+Akihiroauthor=F.+Zhangauthor=J.+S.+Dordickauthor=R.+J.+Linhardt&title=Response+surface+optimization+of+the+heparosan+N-deacetylation+in+producing+bioengineered+heparin&doi=10.1016%2Fj.jbiotec.2011.08.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Response surface optimization of the heparosan N-deacetylation in producing bioengineered heparin</span></div><div class="casAuthors">Wang, Zhenyu; Li, Jennifer; Cheong, Samantha; Bhaskar, Ujjwal; Akihiro, Onishi; Zhang, Fuming; Dordick, Jonathan S.; Linhardt, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">188-196</span>CODEN:
                <span class="NLM_cas:coden">JBITD4</span>;
        ISSN:<span class="NLM_cas:issn">0168-1656</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The chem. step in the chemoenzymic synthesis of bioengineered heparin has been examd. and optimized statistically using a response surface methodol.  A four factor, two level full factorial design expt. and a three factor Box-Behnken design were carried out.  The goal was to establish a method to prep. N-sulfo, N-acetyl heparosan of the desired N-acetyl content, no. av. mol. wt., and in max. yield by controlling the reactant concns., reaction time and reaction temp.  The response surface models obtained were used to predict the reaction conditions required to optimally prep. N-sulfo, N-acetyl heparosan from Escherichia coli generated heparosan starting material of different mol. wts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3yYyMCPPukbVg90H21EOLACvtfcHk0lg4tP17v3UC-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlalurjJ&md5=09644ad975da2bf61e3bf7d6b56d2fc1</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.jbiotec.2011.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jbiotec.2011.08.013%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DCheong%26aufirst%3DS.%26aulast%3DBhaskar%26aufirst%3DU.%26aulast%3DAkihiro%26aufirst%3DO.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DDordick%26aufirst%3DJ.%2BS.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DResponse%2520surface%2520optimization%2520of%2520the%2520heparosan%2520N-deacetylation%2520in%2520producing%2520bioengineered%2520heparin%26jtitle%3DJ.%2520Biotechnol.%26date%3D2011%26volume%3D156%26spage%3D188%26epage%3D196%26doi%3D10.1016%2Fj.jbiotec.2011.08.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Carlsson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kjellén, L.</span><span> </span><span class="NLM_article-title">Heparin biosynthesis</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">207</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span><span class="refDoi"> DOI: 10.1007/978-3-642-23056-1_2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1007%2F978-3-642-23056-1_2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=22566219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkvVCnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=207&publication_year=2012&pages=23-41&author=P.+Carlssonauthor=L.+Kjell%C3%A9n&title=Heparin+biosynthesis&doi=10.1007%2F978-3-642-23056-1_2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Heparin Biosynthesis</span></div><div class="casAuthors">Carlsson, Pernilla; Kjellen, Lena</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">207</span>
        (<span class="NLM_cas:issue">Heparin</span>),
    <span class="NLM_cas:pages">23-41</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">This review details the biosynthesis of heparin and heparan sulfate.  Heparin and heparan sulfate share the same polysaccharide backbone structure but differ in sulfation degree and expression pattern.  Whereas heparan sulfate is found in virtually all cells of the human body, heparin expression is restricted to mast cells, where it has a function in storage of granular components such as histamine and mast cell specific proteases.  Although differing in charge and sulfation pattern, current knowledge indicates that the same pathway is used for synthesis of heparin and heparan sulfate, with a large no. of different enzymes taking part in the process.  At present, little is known about how the individual enzymes are coordinated and how biosynthesis is regulated.  These questions are addressed in this chapter together with a review of the basic enzymic steps involved in initiation, elongation, and modification of the polysaccharides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCywP-6a0xPbVg90H21EOLACvtfcHk0lg4tP17v3UC-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkvVCnuw%253D%253D&md5=ef10b01eb2301503f48198aac6199815</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-23056-1_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-642-23056-1_2%26sid%3Dliteratum%253Aachs%26aulast%3DCarlsson%26aufirst%3DP.%26aulast%3DKjell%25C3%25A9n%26aufirst%3DL.%26atitle%3DHeparin%2520biosynthesis%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2012%26volume%3D207%26spage%3D23%26epage%3D41%26doi%3D10.1007%2F978-3-642-23056-1_2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Casu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindahl, U.</span><span> </span><span class="NLM_article-title">Structure and biological interactions of heparin and heparan sulfate</span> <span class="citation_source-journal">Adv. Carbohydr. Chem. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span><span class="refDoi"> DOI: 10.1016/S0065-2318(01)57017-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1016%2FS0065-2318%2801%2957017-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2001&pages=159-206&author=B.+Casuauthor=U.+Lindahl&title=Structure+and+biological+interactions+of+heparin+and+heparan+sulfate&doi=10.1016%2FS0065-2318%2801%2957017-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0065-2318%2801%2957017-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0065-2318%252801%252957017-1%26sid%3Dliteratum%253Aachs%26aulast%3DCasu%26aufirst%3DB.%26aulast%3DLindahl%26aufirst%3DU.%26atitle%3DStructure%2520and%2520biological%2520interactions%2520of%2520heparin%2520and%2520heparan%2520sulfate%26jtitle%3DAdv.%2520Carbohydr.%2520Chem.%2520Biochem.%26date%3D2001%26volume%3D57%26spage%3D159%26epage%3D206%26doi%3D10.1016%2FS0065-2318%2801%2957017-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Heparin: Structure and activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2551</span><span class="NLM_x">–</span> <span class="NLM_lpage">2554</span><span class="refDoi"> DOI: 10.1021/jm030176m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030176m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjvVahurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2551-2554&author=R.+J.+Linhardt&title=Heparin%3A+Structure+and+activity&doi=10.1021%2Fjm030176m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">2003 Claude S. Hudson Award Address in Carbohydrate Chemistry. Heparin: Structure and Activity</span></div><div class="casAuthors">Linhardt, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2551-2564</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWePYNjeX7jrVg90H21EOLACvtfcHk0lj2Z0beTV3-bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjvVahurc%253D&md5=0df0318e0547d6dcd8120c4516b3b320</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm030176m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030176m%26sid%3Dliteratum%253Aachs%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DHeparin%253A%2520Structure%2520and%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D2551%26epage%3D2554%26doi%3D10.1021%2Fjm030176m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agyekum, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Ange, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amster, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Structural analysis of heparin-derived 3-O-sulfated tetrasaccharides: Antithrombin binding site variants</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">973</span><span class="NLM_x">–</span> <span class="NLM_lpage">981</span><span class="refDoi"> DOI: 10.1016/j.xphs.2016.11.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1016%2Fj.xphs.2016.11.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=28007564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC2sXos1KitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2017&pages=973-981&author=Y.+Chenauthor=L.+Linauthor=I.+Agyekumauthor=X.+Zhangauthor=K.+St.+Angeauthor=Y.+Yuauthor=F.+Zhangauthor=J.+Liuauthor=I.+J.+Amsterauthor=R.+J.+Linhardt&title=Structural+analysis+of+heparin-derived+3-O-sulfated+tetrasaccharides%3A+Antithrombin+binding+site+variants&doi=10.1016%2Fj.xphs.2016.11.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Analysis of Heparin-Derived 3-O-Sulfated Tetrasaccharides: Antithrombin Binding Site Variants</span></div><div class="casAuthors">Chen, Yin; Lin, Lei; Agyekum, Isaac; Zhang, Xing; St. Ange, Kalib; Yu, Yanlei; Zhang, Fuming; Liu, Jian; Amster, I. Jonathan; Linhardt, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">973-981</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Heparin is a polysaccharide that is widely used as an anticoagulant drug.  The mechanism for heparin's anticoagulant activity is primarily through its interaction with a serine protease inhibitor, antithrombin III (AT), that enhances its ability to inactivate blood coagulation serine proteases, including thrombin (factor IIa) and factor Xa.  The AT-binding site in the heparin is one of the most well-studied carbohydrate-protein binding sites and its structure is the basis for the synthesis of the heparin pentasaccharide drug, fondaparinux.  Despite the authors' understanding of the structural requirements for the heparin pentasaccharide AT-binding site, there is a lack of data on the natural variability of these binding sites in heparins extd. from animal tissues.  The present work provides a detailed study on the structural variants of the tetrasaccharide fragments of this binding site afforded following treatment of a heparin with heparin lyase II.  The 5 most commonly obsd. tetrasaccharide fragments of the AT-binding site are fully characterized, and a method for their quantification in heparin and low-mol.-wt. heparin products is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoboAnvJZE187Vg90H21EOLACvtfcHk0lj2Z0beTV3-bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXos1KitQ%253D%253D&md5=1c43579482248fd186fb462b9293f03b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.xphs.2016.11.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.xphs.2016.11.023%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DAgyekum%26aufirst%3DI.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DSt.%2BAnge%26aufirst%3DK.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DAmster%26aufirst%3DI.%2BJ.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DStructural%2520analysis%2520of%2520heparin-derived%25203-O-sulfated%2520tetrasaccharides%253A%2520Antithrombin%2520binding%2520site%2520variants%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2017%26volume%3D106%26spage%3D973%26epage%3D981%26doi%3D10.1016%2Fj.xphs.2016.11.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Yu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirakane, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Structural and activity variability of fractions with different charge density and chain length from pharmaceutical heparins</span> <span class="citation_source-journal">Glycoconjugate J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">545</span><span class="NLM_x">–</span> <span class="NLM_lpage">552</span><span class="refDoi"> DOI: 10.1007/s10719-017-9774-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1007%2Fs10719-017-9774-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=28555433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC2sXos1Wns7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2017&pages=545-552&author=Y.+Yuauthor=M.+Hirakaneauthor=D.+Moriauthor=L.+Linauthor=F.+Zhangauthor=H.+Zhangauthor=R.+J.+Linhardt&title=Structural+and+activity+variability+of+fractions+with+different+charge+density+and+chain+length+from+pharmaceutical+heparins&doi=10.1007%2Fs10719-017-9774-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and activity variability of fractions with different charge density and chain length from pharmaceutical heparins</span></div><div class="casAuthors">Yu, Yanlei; Hirakane, Makoto; Mori, Daisuke; Lin, Lei; Zhang, Fuming; Zhang, Hong; Linhardt, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Glycoconjugate Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">545-552</span>CODEN:
                <span class="NLM_cas:coden">GLJOEW</span>;
        ISSN:<span class="NLM_cas:issn">0282-0080</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Heparin is a structurally complex polysaccharide used as a clin. anticoagulant.  It is comprised of a heterogeneous mixt. of polysaccharide chains having a variety of sequences and lengths.  The prodn. methods and regulatory controls of pharmaceutical heparins have changed over the years.  This study assesses the structural and activity uniformity of the polysaccharide chains comprising two contemporary heparin products.  The heparin fractions with different sizes and charges were sepd. with size exclusion and ion exchange chromatog.  The fractions were analyzed for their mol. wt. properties, di- and tetrasaccharide compns., and anti-factor IIa and anti-factor-Xa activities.  The distribution of these properties through chains of different lengths and ones with different charge d. were compared.  The results demonstrate that with the increase in heparin purity, activity and mol. wt. required by the current pharmacopeia, the uniformity of pharmaceutical heparin products have increased.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4NUR2fLSnSbVg90H21EOLACvtfcHk0liPj6C9s7bdKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXos1Wns7c%253D&md5=cd794ab7c17107764513878c602adb2a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2Fs10719-017-9774-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10719-017-9774-7%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DY.%26aulast%3DHirakane%26aufirst%3DM.%26aulast%3DMori%26aufirst%3DD.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DStructural%2520and%2520activity%2520variability%2520of%2520fractions%2520with%2520different%2520charge%2520density%2520and%2520chain%2520length%2520from%2520pharmaceutical%2520heparins%26jtitle%3DGlycoconjugate%2520J.%26date%3D2017%26volume%3D34%26spage%3D545%26epage%3D552%26doi%3D10.1007%2Fs10719-017-9774-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Linhardt, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loganathan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, J. H.</span><span> </span><span class="NLM_article-title">Search for the heparin antithrombin III-binding site precursor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">2380</span><span class="NLM_x">–</span> <span class="NLM_lpage">2387</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=2380-2387&author=R.+J.+Linhardtauthor=H.+M.+Wangauthor=D.+Loganathanauthor=J.+H.+Bae&title=Search+for+the+heparin+antithrombin+III-binding+site+precursor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26aulast%3DWang%26aufirst%3DH.%2BM.%26aulast%3DLoganathan%26aufirst%3DD.%26aulast%3DBae%26aufirst%3DJ.%2BH.%26atitle%3DSearch%2520for%2520the%2520heparin%2520antithrombin%2520III-binding%2520site%2520precursor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D2380%26epage%3D2387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Bhaskar, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sterner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onishi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dordick, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Engineering of routes to heparin and related polysaccharides</span> <span class="citation_source-journal">Appl. Microbiol. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span><span class="refDoi"> DOI: 10.1007/s00253-011-3641-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1007%2Fs00253-011-3641-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=22048616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A280%3ADC%252BC387hsl2lsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2012&pages=1-16&author=U.+Bhaskarauthor=E.+Sternerauthor=A.+M.+Hickeyauthor=A.+Onishiauthor=F.+Zhangauthor=J.+S.+Dordickauthor=R.+J.+Linhardt&title=Engineering+of+routes+to+heparin+and+related+polysaccharides&doi=10.1007%2Fs00253-011-3641-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Engineering of routes to heparin and related polysaccharides</span></div><div class="casAuthors">Bhaskar Ujjwal; Sterner Eric; Hickey Anne Marie; Onishi Akihiro; Zhang Fuming; Dordick Jonathan S; Linhardt Robert J</div><div class="citationInfo"><span class="NLM_cas:title">Applied microbiology and biotechnology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-16</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Anticoagulant heparin has been shown to possess important biological functions that vary according to its fine structure.  Variability within heparin's structure occurs owing to its biosynthesis and animal tissue-based recovery and adds another dimension to its complex polymeric structure.  The structural variations in chain length and sulfation patterns mediate its interaction with many heparin-binding proteins, thereby eliciting complex biological responses.  The advent of novel chemical and enzymatic approaches for polysaccharide synthesis coupled with high throughput combinatorial approaches for drug discovery have facilitated an increased effort to understand heparin's structure-activity relationships.  An improved understanding would offer potential for new therapeutic development through the engineering of polysaccharides.  Such a bioengineering approach requires the amalgamation of several different disciplines, including carbohydrate synthesis, applied enzymology, metabolic engineering, and process biochemistry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQLyT6Rs_ItBZcXNb62YGmbfW6udTcc2ebFyafpVB3gSbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC387hsl2lsA%253D%253D&md5=8efbda2da1e3c07c35bff885530f4c08</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs00253-011-3641-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00253-011-3641-4%26sid%3Dliteratum%253Aachs%26aulast%3DBhaskar%26aufirst%3DU.%26aulast%3DSterner%26aufirst%3DE.%26aulast%3DHickey%26aufirst%3DA.%2BM.%26aulast%3DOnishi%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DDordick%26aufirst%3DJ.%2BS.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DEngineering%2520of%2520routes%2520to%2520heparin%2520and%2520related%2520polysaccharides%26jtitle%3DAppl.%2520Microbiol.%2520Biotechnol.%26date%3D2012%26volume%3D93%26spage%3D1%26epage%3D16%26doi%3D10.1007%2Fs00253-011-3641-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">St Ange, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onishi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dordick, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fareed, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoppensteadt, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeske, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Analysis of heparins derived from bovine tissues and comparison to porcine intestinal heparins</span> <span class="citation_source-journal">Clin. Appl. Thromb./Hemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">520</span><span class="NLM_x">–</span> <span class="NLM_lpage">527</span><span class="refDoi"> DOI: 10.1177/1076029616643822</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1177%2F1076029616643822" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=27084870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtl2qsbnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=520-527&author=K.+St+Angeauthor=A.+Onishiauthor=L.+Fuauthor=X.+Sunauthor=L.+Linauthor=D.+Moriauthor=F.+Zhangauthor=J.+S.+Dordickauthor=J.+Fareedauthor=D.+Hoppensteadtauthor=W.+Jeskeauthor=R.+J.+Linhardt&title=Analysis+of+heparins+derived+from+bovine+tissues+and+comparison+to+porcine+intestinal+heparins&doi=10.1177%2F1076029616643822"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of heparins derived from bovine tissues and comparison to porcine intestinal heparins</span></div><div class="casAuthors">St. Ange, Kalib; Onishi, Akihiro; Fu, Li; Sun, Xiaojun; Lin, Lei; Mori, Daisuke; Zhang, Fuming; Dordick, Jonathan S.; Fareed, Jawed; Hoppensteadt, Debra; Jeske, Walter; Linhardt, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Applied Thrombosis/Hemostasis</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">520-527</span>CODEN:
                <span class="NLM_cas:coden">CATHF9</span>;
        ISSN:<span class="NLM_cas:issn">1076-0296</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Heparin is a widely used clin. anticoagulant.  It is also a linear glycosaminoglycan with an av. mass between 10 and 20 kDa and is primarily made up of trisulfated disaccharides comprised of 1,4-linked iduronic acid and glucosamine residues contg. some glucuronic acid residues.  Heparin is biosynthesized in the Golgi of mast cells commonly found in the liver, intestines, and lungs.  Pharmaceutical heparin currently used in the United States is primarily extd. from porcine intestines.  Other sources of heparin including bovine intestine and bovine lung are being examd. as potential substitutes for porcine intestinal heparin.  These addnl. sources are intended to serve to diversify the heparin supply, making this lifesaving drug more secure.  The current study examines bovine heparins prepd. from both intestines and lung and compares these to porcine intestinal heparin.  The structural properties of these heparins are examd. using NMR, gel permeation chromatog., and disaccharide anal. of heparinase-catalyzed depolymd. heparin.  The in vitro functional activities of these heparins have also been detd.  The goal of this study is to establish the structural and functional similarities and potential differences between bovine and porcine heparins.  Porcine and bovine heparins have structural and compositional similarities and differences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohKshEhaI73LVg90H21EOLACvtfcHk0liPj6C9s7bdKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtl2qsbnI&md5=640058911b8b72696c611d3b94fbb83f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1177%2F1076029616643822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1076029616643822%26sid%3Dliteratum%253Aachs%26aulast%3DSt%2BAnge%26aufirst%3DK.%26aulast%3DOnishi%26aufirst%3DA.%26aulast%3DFu%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DMori%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DDordick%26aufirst%3DJ.%2BS.%26aulast%3DFareed%26aufirst%3DJ.%26aulast%3DHoppensteadt%26aufirst%3DD.%26aulast%3DJeske%26aufirst%3DW.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DAnalysis%2520of%2520heparins%2520derived%2520from%2520bovine%2520tissues%2520and%2520comparison%2520to%2520porcine%2520intestinal%2520heparins%26jtitle%3DClin.%2520Appl.%2520Thromb.%252FHemostasis%26date%3D2016%26volume%3D22%26spage%3D520%26epage%3D527%26doi%3D10.1177%2F1076029616643822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Naggi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedrinola, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urso, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alekseeva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassinelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iacomini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baigorria, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torri, G.</span><span> </span><span class="NLM_article-title">Structural peculiarity and antithrombin binding region profile of mucosal bovine and porcine heparins</span> <span class="citation_source-journal">J. Pharm. Biomed. Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">52</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span><span class="refDoi"> DOI: 10.1016/j.jpba.2015.10.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1016%2Fj.jpba.2015.10.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=26512999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslensLfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2016&pages=52-63&author=A.+Naggiauthor=C.+Gardiniauthor=G.+Pedrinolaauthor=L.+Mauriauthor=E.+Ursoauthor=A.+Alekseevaauthor=B.+Casuauthor=G.+Cassinelliauthor=M.+Guerriniauthor=M.+Iacominiauthor=V.+Baigorriaauthor=G.+Torri&title=Structural+peculiarity+and+antithrombin+binding+region+profile+of+mucosal+bovine+and+porcine+heparins&doi=10.1016%2Fj.jpba.2015.10.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Structural peculiarity and antithrombin binding region profile of mucosal bovine and porcine heparins</span></div><div class="casAuthors">Naggi, Annamaria; Gardini, Cristina; Pedrinola, Giacomo; Mauri, Lucio; Urso, Elena; Alekseeva, Anna; Casu, Benito; Cassinelli, Giuseppe; Guerrini, Marco; Iacomini, Marcello; Baigorria, Valentina; Torri, Giangiacomo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">52-63</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The major compositional differences between bovine mucosal heparin (BMH) and the currently employed porcine mucosal heparin (PMH) have been reported to essentially consist of reduced 6-O-sulfation of the glucosamine residues in BMH and somewhat lower 2-O-sulfation of the iduronate residues in PMH.  The present work is based on direct comparison of several BMH and PMH com. prepns.  A combined study by 2D (heteronuclear single quantum coherence, HSQC) NMR and ion-pair reversed-phase high performance liq. chromatog. (IPRP-HPLC) coupled with electrospray ionization mass spectrometry (ESI-MS) on the heparins, extended to the anal. of their heparinases digests and fractions sepd. by affinity chromatog. on antithrombin (AT), confirmed the previously reported lower degree of 6-O-sulfation and showed lower 3-O-sulfated glucosamine content in BMH.  More detailed studies allowed the identification of structural variants of AT-binding region (ATBR) structural variants, showing higher content of the N-sulfated components in BMH than in PMH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoemOl5x64iW7Vg90H21EOLACvtfcHk0lgYQDaJJNdBBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslensLfK&md5=fe88c260413cf8993a5c396e1002e30d</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2015.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2015.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DNaggi%26aufirst%3DA.%26aulast%3DGardini%26aufirst%3DC.%26aulast%3DPedrinola%26aufirst%3DG.%26aulast%3DMauri%26aufirst%3DL.%26aulast%3DUrso%26aufirst%3DE.%26aulast%3DAlekseeva%26aufirst%3DA.%26aulast%3DCasu%26aufirst%3DB.%26aulast%3DCassinelli%26aufirst%3DG.%26aulast%3DGuerrini%26aufirst%3DM.%26aulast%3DIacomini%26aufirst%3DM.%26aulast%3DBaigorria%26aufirst%3DV.%26aulast%3DTorri%26aufirst%3DG.%26atitle%3DStructural%2520peculiarity%2520and%2520antithrombin%2520binding%2520region%2520profile%2520of%2520mucosal%2520bovine%2520and%2520porcine%2520heparins%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2016%26volume%3D118%26spage%3D52%26epage%3D63%26doi%3D10.1016%2Fj.jpba.2015.10.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Jasper, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poe, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Stable-isotopic analysis of porcine, bovine, and ovine heparins</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">463</span><span class="refDoi"> DOI: 10.1002/jps.24134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1002%2Fjps.24134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=25186630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVyhtLbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2015&pages=457-463&author=J.+P.+Jasperauthor=F.+Zhangauthor=R.+B.+Poeauthor=R.+J.+Linhardt&title=Stable-isotopic+analysis+of+porcine%2C+bovine%2C+and+ovine+heparins&doi=10.1002%2Fjps.24134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Stable isotopic analysis of porcine, bovine, and ovine heparins</span></div><div class="casAuthors">Jasper, John P.; Zhang, Fuming; Poe, Russell B.; Linhardt, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">457-463</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The assessment of provenance of heparin is becoming a major concern for the pharmaceutical industry and its regulatory bodies.  Batch-specific [carbon (δ13C), nitrogen (δ15N), oxygen (δ18O), sulfur (δ34S), and hydrogen (δD)] stable isotopic compns. of five different animal-derived heparins were performed.  Measurements readily allowed their differentiation into groups and/or subgroups based on their isotopic provenance.  Principle component anal. showed that a bivariate plot of δ13C and δ18O is the best single, bivariate plot that results in the max. discrimination ability when only two stable isotopes are used to describe the variation in the data set.  Stable isotopic analyses revealed that (1) stable isotope measurements on these highly sulfated polysaccharide (mol. wt. ∼15 kDa) natural products ("biologics") were feasible; (2) in bivariate plots, the δ13C vs. δ18O plot reveals a well-defined relationship for source differentiation of hogs raised in the United States from hogs raised in Europe and China; (3) the δD vs. δ18O plot revealed the most well-defined relationship for source differentiation based on the hydrol. environmental isotopes of water (D/H and 18O/16O); and (4) the δ15N vs. δ18O and δ34S vs. δ18O relationships are both very similar, possibly reflecting the food sources used by the different heparin producers. © 2014 Wiley Periodicals, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC1lUcTCfSa7Vg90H21EOLACvtfcHk0lgYQDaJJNdBBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVyhtLbN&md5=08b9d500c9afc07f8f6eb4ebe1dabe07</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Fjps.24134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.24134%26sid%3Dliteratum%253Aachs%26aulast%3DJasper%26aufirst%3DJ.%2BP.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DPoe%26aufirst%3DR.%2BB.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DStable-isotopic%2520analysis%2520of%2520porcine%252C%2520bovine%252C%2520and%2520ovine%2520heparins%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2015%26volume%3D104%26spage%3D457%26epage%3D463%26doi%3D10.1002%2Fjps.24134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Santos, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tovar, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capillé, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pereira, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomin, V. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourão, P. A.</span><span> </span><span class="NLM_article-title">Structural and functional analyses of bovine and porcine intestinal heparins confirm they are different drugs</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1801</span><span class="NLM_x">–</span> <span class="NLM_lpage">1807</span><span class="refDoi"> DOI: 10.1016/j.drudis.2014.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1016%2Fj.drudis.2014.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=25019497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1ent7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=1801-1807&author=G.+R.+Santosauthor=A.+M.+Tovarauthor=N.+V.+Capill%C3%A9author=M.+S.+Pereiraauthor=V.+H.+Pominauthor=P.+A.+Mour%C3%A3o&title=Structural+and+functional+analyses+of+bovine+and+porcine+intestinal+heparins+confirm+they+are+different+drugs&doi=10.1016%2Fj.drudis.2014.07.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and functional analyses of bovine and porcine intestinal heparins confirm they are different drugs</span></div><div class="casAuthors">Santos, Gustavo R. C.; Tovar, Ana M. F.; Capille, Nina V. M.; Pereira, Mariana S.; Pomin, Vitor H.; Mourao, Paulo A. S.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1801-1807</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Anticoagulant heparins are mostly obtained from porcine intestine.  Occasionally they are also obtained from bovine intestine.  Structural and functional analyses of pharmaceutical-grade heparins from these two sources using multiple methods such as NMR spectroscopy, in vitro and in vivo assays of the anticoagulant, antithrombotic and bleeding effects, complemented by fractionation on anion exchange chromatog., confirm they are different drugs.  Although bovine heparin is more heterogeneous and less sulfated, heparins from both sources are overall made of a similar mixt. of fractions, however with different proportions.  Therefore, high-anticoagulant composites from bovine origin, similar to porcine counterparts, can be properly obtained.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoayoGIO_yHabVg90H21EOLACvtfcHk0lgYQDaJJNdBBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1ent7%252FK&md5=cffe775c12a8947fe4a338c5f6ff6a88</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2014.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2014.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DSantos%26aufirst%3DG.%2BR.%26aulast%3DTovar%26aufirst%3DA.%2BM.%26aulast%3DCapill%25C3%25A9%26aufirst%3DN.%2BV.%26aulast%3DPereira%26aufirst%3DM.%2BS.%26aulast%3DPomin%26aufirst%3DV.%2BH.%26aulast%3DMour%25C3%25A3o%26aufirst%3DP.%2BA.%26atitle%3DStructural%2520and%2520functional%2520analyses%2520of%2520bovine%2520and%2520porcine%2520intestinal%2520heparins%2520confirm%2520they%2520are%2520different%2520drugs%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2014%26volume%3D19%26spage%3D1801%26epage%3D1807%26doi%3D10.1016%2Fj.drudis.2014.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Fu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onishi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Structural characterization of pharmaceutical heparins prepared from different animal tissues</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">1447</span><span class="NLM_x">–</span> <span class="NLM_lpage">1457</span><span class="refDoi"> DOI: 10.1002/jps.23501</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1002%2Fjps.23501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=23526651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksVOgsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2013&pages=1447-1457&author=L.+Fuauthor=G.+Liauthor=B.+Yangauthor=A.+Onishiauthor=L.+Liauthor=P.+Sunauthor=F.+Zhangauthor=R.+J.+Linhardt&title=Structural+characterization+of+pharmaceutical+heparins+prepared+from+different+animal+tissues&doi=10.1002%2Fjps.23501"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Structural characterization of pharmaceutical heparins prepared from different animal tissues</span></div><div class="casAuthors">Fu, Li; Li, Guoyun; Yang, Bo; Onishi, Akihiro; Li, Lingyun; Sun, Peilong; Zhang, Fuming; Linhardt, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1447-1457</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Although most pharmaceutical heparin used today is obtained from porcine intestine, heparin has historically been prepd. from bovine lung and ovine intestine.  There is some regulatory concern about establishing the species origin of heparin.  This concern began with the outbreak of mad cow disease in the 1990s and was exacerbated during the heparin shortage in the 2000s and the heparin contamination crisis of 2007-2008.  Three heparins from porcine, ovine, and bovine were characterized through state-of-the-art carbohydrate anal. methods with a view profiling their physicochem. properties.  Differences in mol. wt., monosaccharide and disaccharide compn., oligosaccharide sequence, and antithrombin III-binding affinity were obsd.  These data provide some insight into the variability of heparins obtained from these three species and suggest some anal. approaches that may be useful in confirming the species origin of a heparin active pharmaceutical ingredient. © 2013 Wiley Periodicals, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8bUKmkC1Eb7Vg90H21EOLACvtfcHk0liAnocaEBNisg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksVOgsbw%253D&md5=06bf2dd70af3e0333711d42f42e00640</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fjps.23501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.23501%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DB.%26aulast%3DOnishi%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DStructural%2520characterization%2520of%2520pharmaceutical%2520heparins%2520prepared%2520from%2520different%2520animal%2520tissues%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2013%26volume%3D102%26spage%3D1447%26epage%3D1457%26doi%3D10.1002%2Fjps.23501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Tovar, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capillé, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vairo, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonseca, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourão, P. A.</span><span> </span><span class="NLM_article-title">Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects</span> <span class="citation_source-journal">Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">903</span><span class="NLM_x">–</span> <span class="NLM_lpage">915</span><span class="refDoi"> DOI: 10.1160/TH-11-07-0518</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1160%2FTH-11-07-0518" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=22437650" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC38XosFaqtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2012&pages=903-915&author=A.+M.+Tovarauthor=N.+V.+Capill%C3%A9author=G.+R.+Santosauthor=B.+C.+Vairoauthor=S.+N.+Oliveiraauthor=R.+J.+Fonsecaauthor=P.+A.+Mour%C3%A3o&title=Heparin+from+bovine+intestinal+mucosa%3A+glycans+with+multiple+sulfation+patterns+and+anticoagulant+effects&doi=10.1160%2FTH-11-07-0518"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects</span></div><div class="casAuthors">Tovar, Ana M. F.; Capille, Nina V. M.; Santos, Gustavo R. C.; Vairo, Bruno C.; Oliveira, Stephan-Nicollas M. C. G.; Fonseca, Roberto J. C.; Mourao, Paulo A. S.</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">903-915</span>CODEN:
                <span class="NLM_cas:coden">THHADQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6245</span>.
    
            (<span class="NLM_cas:orgname">Schattauer GmbH</span>)
        </div><div class="casAbstract">Pharmaceutical grade heparins from porcine intestine and bovine lung consist mainly of repeating tri-sulfated units, of the disaccharide →4-α-IdoA2S-1→4-α-GlcNS6S-1→.  Heparin prepns. from bovine intestine, in contrast, are more heterogeneous.  NMR (NMR) and disaccharide anal. after heparinase digestions show that heparin from bovine intestine contains α-glucosamine with significant substitutive variations: 64% are 6-O-sulfated and N-sulfated, as in porcine intestinal heparin while 36% are 6-desulfated.  Desulfated α-iduronic acid units are contained in slightly lower proportions in bovine than in porcine heparin.  NMR data also indicate N-, 3- and 6-trisulfated α-glucosamine (lower proportions) and α-GlcNS-1→4-α-GlcA and α-IdoA2S-1→4-α-GlcNAc (higher amts.) in bovine than in porcine heparin.  Porcine and bovine heparins can be fractionated by anion exchange chromatog. into three fractions contg. different substitutions on the α-glucosamine units.  Each individual fraction shows close disaccharide compn. and anticoagulant activity, regardless of their origin (bovine or porcine intestine).  However, these two heparins differ markedly in the proportions of the three fractions.  Interestingly, fractions with the typical heparin disaccharides of porcine intestine are present in bovine intestinal heparin.  These fractions contain high in vitro anticoagulant activity, reduced antithrombotic effect and high bleeding tendency.  These observations indicate that the prediction of haemostatic effects of heparin prepns. cannot rely exclusively on structural anal. and anticoagulant assays in vitro.  Minor structural components may account for variations on in vivo effects.  In conclusion, we suggest that pharmaceutical grade bovine intestinal heparin, even after purifn. procedures, is not an equiv. drug to porcine intestinal heparin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocjEblc9IS6bVg90H21EOLACvtfcHk0liAnocaEBNisg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosFaqtLY%253D&md5=478940a58099c5405961b3cdc8479ac9</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1160%2FTH-11-07-0518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1160%252FTH-11-07-0518%26sid%3Dliteratum%253Aachs%26aulast%3DTovar%26aufirst%3DA.%2BM.%26aulast%3DCapill%25C3%25A9%26aufirst%3DN.%2BV.%26aulast%3DSantos%26aufirst%3DG.%2BR.%26aulast%3DVairo%26aufirst%3DB.%2BC.%26aulast%3DOliveira%26aufirst%3DS.%2BN.%26aulast%3DFonseca%26aufirst%3DR.%2BJ.%26aulast%3DMour%25C3%25A3o%26aufirst%3DP.%2BA.%26atitle%3DHeparin%2520from%2520bovine%2520intestinal%2520mucosa%253A%2520glycans%2520with%2520multiple%2520sulfation%2520patterns%2520and%2520anticoagulant%2520effects%26jtitle%3DThromb.%2520Haemostasis%26date%3D2012%26volume%3D107%26spage%3D903%26epage%3D915%26doi%3D10.1160%2FTH-11-07-0518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Mauri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boccardi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karfunkle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macchi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keire, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, M. J.</span><span> </span><span class="NLM_article-title">Qualification of HSQC methods for quantitative composition of heparin and low molecular weight heparins</span> <span class="citation_source-journal">J. Pharm. Biomed. Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">92</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span><span class="refDoi"> DOI: 10.1016/j.jpba.2016.12.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1016%2Fj.jpba.2016.12.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=28068519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmsVyrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2017&pages=92-105&author=L.+Mauriauthor=G.+Boccardiauthor=G.+Torriauthor=M.+Karfunkleauthor=E.+Macchiauthor=L.+Muziauthor=D.+Keireauthor=M.+J.+Guerrini&title=Qualification+of+HSQC+methods+for+quantitative+composition+of+heparin+and+low+molecular+weight+heparins&doi=10.1016%2Fj.jpba.2016.12.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Qualification of HSQC methods for quantitative composition of heparin and low molecular weight heparins</span></div><div class="casAuthors">Mauri, Lucio; Boccardi, Giovanni; Torri, Giangiacomo; Karfunkle, Michael; Macchi, Eleonora; Muzi, Laura; Keire, David; Guerrini, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">92-105</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">An NMR HSQC method has recently been proposed for the quant. detn. of the mono- and disaccharide subunits of heparin and low mol. wt. heparins (LMWH).  The focus of the current study was the validation of this procedure to make the 2D-NMR method suitable for pharmaceutical quality control applications.  Pre-validation work investigated the effects of several exptl. parameters to assess robustness and to optimize crit. factors.  Important exptl. parameters were pulse sequence selection, equilibration interval between pulse trains and temp.  These observations were needed so that the NMR method was sufficiently understood to enable continuous improvement.  A std. validation study on heparin then examd. linearity, repeatability, intermediate precision and limits of detection and quantitation; selected validation parameters were also detd. for LMWH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5eysMbpVls7Vg90H21EOLACvtfcHk0liAnocaEBNisg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmsVyrtQ%253D%253D&md5=fec77c6fd579a70913d6b054a66f3d62</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2016.12.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2016.12.031%26sid%3Dliteratum%253Aachs%26aulast%3DMauri%26aufirst%3DL.%26aulast%3DBoccardi%26aufirst%3DG.%26aulast%3DTorri%26aufirst%3DG.%26aulast%3DKarfunkle%26aufirst%3DM.%26aulast%3DMacchi%26aufirst%3DE.%26aulast%3DMuzi%26aufirst%3DL.%26aulast%3DKeire%26aufirst%3DD.%26aulast%3DGuerrini%26aufirst%3DM.%2BJ.%26atitle%3DQualification%2520of%2520HSQC%2520methods%2520for%2520quantitative%2520composition%2520of%2520heparin%2520and%2520low%2520molecular%2520weight%2520heparins%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2017%26volume%3D136%26spage%3D92%26epage%3D105%26doi%3D10.1016%2Fj.jpba.2016.12.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Keire, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulloy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Hakim, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cairatti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogwood, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mourão, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DaLuz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szajek, A.</span><span> </span><span class="NLM_article-title">Diversifying the global heparin supply chain: reintroduction of bovine heparin in the United States?</span> <span class="citation_source-journal">Pharm. Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2015&pages=28-35&author=D.+Keireauthor=B.+Mulloyauthor=C.+Chaseauthor=A.+Al-Hakimauthor=D.+Cairattiauthor=E.+Grayauthor=J.+Hogwoodauthor=T.+Morrisauthor=P.+Mour%C3%A3oauthor=C.+DaLuzauthor=M.+Soaresauthor=A.+Szajek&title=Diversifying+the+global+heparin+supply+chain%3A+reintroduction+of+bovine+heparin+in+the+United+States%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKeire%26aufirst%3DD.%26aulast%3DMulloy%26aufirst%3DB.%26aulast%3DChase%26aufirst%3DC.%26aulast%3DAl-Hakim%26aufirst%3DA.%26aulast%3DCairatti%26aufirst%3DD.%26aulast%3DGray%26aufirst%3DE.%26aulast%3DHogwood%26aufirst%3DJ.%26aulast%3DMorris%26aufirst%3DT.%26aulast%3DMour%25C3%25A3o%26aufirst%3DP.%26aulast%3DDaLuz%26aufirst%3DC.%26aulast%3DSoares%26aufirst%3DM.%26aulast%3DSzajek%26aufirst%3DA.%26atitle%3DDiversifying%2520the%2520global%2520heparin%2520supply%2520chain%253A%2520reintroduction%2520of%2520bovine%2520heparin%2520in%2520the%2520United%2520States%253F%26jtitle%3DPharm.%2520Technol.%26date%3D2015%26volume%3D39%26spage%3D28%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Szajek, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chess, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gratzl, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keire, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulloy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shriver, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torralba, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viskov, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodcock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Hakim, A.</span><span> </span><span class="NLM_article-title">The US regulatory and pharmacopeia response to the global heparin contamination crisis</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">625</span><span class="NLM_x">–</span> <span class="NLM_lpage">630</span><span class="refDoi"> DOI: 10.1038/nbt.3606</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1038%2Fnbt.3606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=27281424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC28XpsFCltrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2016&pages=625-630&author=A.+Y.+Szajekauthor=E.+Chessauthor=K.+Johansenauthor=G.+Gratzlauthor=E.+Grayauthor=D.+Keireauthor=R.+J.+Linhardtauthor=J.+Liuauthor=T.+Morrisauthor=B.+Mulloyauthor=M.+Nasrauthor=Z.+Shriverauthor=P.+Torralbaauthor=C.+Viskovauthor=R.+Williamsauthor=J.+Woodcockauthor=W.+Workmanauthor=A.+Al-Hakim&title=The+US+regulatory+and+pharmacopeia+response+to+the+global+heparin+contamination+crisis&doi=10.1038%2Fnbt.3606"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The US regulatory and pharmacopeia response to the global heparin contamination crisis</span></div><div class="casAuthors">Szajek, Anita Y.; Chess, Edward; Johansen, Kristian; Gratzl, Gyongyi; Gray, Elaine; Keire, David; Linhardt, Robert J.; Liu, Jian; Morris, Tina; Mulloy, Barbara; Nasr, Moheb; Shriver, Zachary; Torralba, Pearle; Viskov, Christian; Williams, Roger; Woodcock, Janet; Workman, Wesley; Al-Hakim, Ali</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">625-630</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The contamination of the widely used lifesaving anticoagulant drug heparin in 2007 has drawn renewed attention to the challenges that are assocd. with the characterization, quality control and standardization of complex biol. medicines from natural sources.  Heparin is a linear, highly sulfated polysaccharide consisting of alternating glucosamine and uronic acid monosaccharide residues.  Heparin has been used successfully as an injectable antithrombotic medicine since the 1930s, and its isolation from animal sources (primarily porcine intestine) as well as its manufg. processes have not changed substantially since its introduction.  The 2007 heparin contamination crisis resulted in several deaths in the United States and hundreds of adverse reactions worldwide, revealing the vulnerability of a complex global supply chain to sophisticated adulteration.  This Perspective discusses how the US Food and Drug Administration (FDA), the United States Pharmacopeial Convention (USP) and international stakeholders collaborated to redefine quality expectations for heparin, thus making an important natural product better controlled and less susceptible to economically motivated adulteration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY0ESVJNOCH7Vg90H21EOLACvtfcHk0ljmTs_v_t3lEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpsFCltrk%253D&md5=b73afb1d503ad195c93e9492b73dd1c1</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnbt.3606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.3606%26sid%3Dliteratum%253Aachs%26aulast%3DSzajek%26aufirst%3DA.%2BY.%26aulast%3DChess%26aufirst%3DE.%26aulast%3DJohansen%26aufirst%3DK.%26aulast%3DGratzl%26aufirst%3DG.%26aulast%3DGray%26aufirst%3DE.%26aulast%3DKeire%26aufirst%3DD.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DMorris%26aufirst%3DT.%26aulast%3DMulloy%26aufirst%3DB.%26aulast%3DNasr%26aufirst%3DM.%26aulast%3DShriver%26aufirst%3DZ.%26aulast%3DTorralba%26aufirst%3DP.%26aulast%3DViskov%26aufirst%3DC.%26aulast%3DWilliams%26aufirst%3DR.%26aulast%3DWoodcock%26aufirst%3DJ.%26aulast%3DWorkman%26aufirst%3DW.%26aulast%3DAl-Hakim%26aufirst%3DA.%26atitle%3DThe%2520US%2520regulatory%2520and%2520pharmacopeia%2520response%2520to%2520the%2520global%2520heparin%2520contamination%2520crisis%26jtitle%3DNat.%2520Biotechnol.%26date%3D2016%26volume%3D34%26spage%3D625%26epage%3D630%26doi%3D10.1038%2Fnbt.3606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Lessons learned from the contamination of heparin</span> <span class="citation_source-journal">Nat. Prod. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">313</span><span class="NLM_x">–</span> <span class="NLM_lpage">321</span><span class="refDoi"> DOI: 10.1039/b819896a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1039%2Fb819896a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=19240943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisVGjsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2009&pages=313-321&author=H.+Liuauthor=Z.+Zhangauthor=R.+J.+Linhardt&title=Lessons+learned+from+the+contamination+of+heparin&doi=10.1039%2Fb819896a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons learned from the contamination of heparin</span></div><div class="casAuthors">Liu, Haiying; Zhang, Zhenqing; Linhardt, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Reports</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">313-321</span>CODEN:
                <span class="NLM_cas:coden">NPRRDF</span>;
        ISSN:<span class="NLM_cas:issn">0265-0568</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Heparin is unique as one of the oldest drugs currently still in widespread clin. use as an anticoagulant, a natural product, one of the first biopolymeric drugs, and one of the few carbohydrate drugs.  Recently, certain batches of heparin were assocd. with anaphylactoid-type reactions, some leading to hypotension and death.  These reactions were traced to contamination with a semi-synthetic oversulfated chondroitin sulfate (OSCS).  This Highlight reviews the heparin contamination crisis, its resoln., and the lessons learned.  Pharmaceutical scientists now must consider dozens of natural and synthetic heparinoids as potential heparin contaminants.  Effective assays, which can detect both known and unknown contaminants, are required to monitor the quality of heparin.  Safer and better-regulated processes are needed for heparin prodn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyeErJWeTMMLVg90H21EOLACvtfcHk0ljmTs_v_t3lEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisVGjsL8%253D&md5=bb640e69bd3e6940f6fc81758ab00e2f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1039%2Fb819896a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb819896a%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DLessons%2520learned%2520from%2520the%2520contamination%2520of%2520heparin%26jtitle%3DNat.%2520Prod.%2520Rep.%26date%3D2009%26volume%3D26%26spage%3D313%26epage%3D321%26doi%3D10.1039%2Fb819896a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Guerrini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beccati, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shriver, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naggi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viswanathan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capila, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lansing, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guglieri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Hakim, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunay, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhse, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodcock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkataraman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasisekharan, R.</span><span> </span><span class="NLM_article-title">Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">669</span><span class="NLM_x">–</span> <span class="NLM_lpage">675</span><span class="refDoi"> DOI: 10.1038/nbt1407</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1038%2Fnbt1407" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=18437154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmvVCisrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=669-675&author=M.+Guerriniauthor=D.+Beccatiauthor=Z.+Shriverauthor=A.+Naggiauthor=K.+Viswanathanauthor=A.+Bisioauthor=I.+Capilaauthor=J.+C.+Lansingauthor=S.+Guglieriauthor=B.+Fraserauthor=A.+Al-Hakimauthor=N.+S.+Gunayauthor=Z.+Zhangauthor=L.+Robinsonauthor=L.+Buhseauthor=M.+Nasrauthor=J.+Woodcockauthor=R.+Langerauthor=G.+Venkataramanauthor=R.+J.+Linhardtauthor=B.+Casuauthor=G.+Torriauthor=R.+Sasisekharan&title=Oversulfated+chondroitin+sulfate+is+a+contaminant+in+heparin+associated+with+adverse+clinical+events&doi=10.1038%2Fnbt1407"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events</span></div><div class="casAuthors">Guerrini, Marco; Beccati, Daniela; Shriver, Zachary; Naggi, Annamaria; Viswanathan, Karthik; Bisio, Antonella; Capila, Ishan; Lansing, Jonathan C.; Guglieri, Sara; Fraser, Blair; Al-Hakim, Ali; Gunay, Nur Sibel; Zhang, Zhenqing; Robinson, Luke; Buhse, Lucinda; Nasr, Moheb; Woodcock, Janet; Langer, Robert; Venkataraman, Ganesh; Linhardt, Robert J.; Casu, Benito; Torri, Giangiacomo; Sasisekharan, Ram</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">669-675</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Recently, certain lots of heparin have been assocd. with an acute, rapid onset of serious side effects indicative of an allergic-type reaction.  To identify potential causes for this sudden rise in side effects, we examd. lots of heparin that correlated with adverse events using orthogonal high-resoln. anal. techniques.  Through detailed structural anal., the contaminant was found to contain a disaccharide repeat unit of glucuronic acid linked β1 3 to a β-N-acetylgalactosamine.  The disaccharide unit has an unusual sulfation pattern and is sulfated at the 2-O and 3-O positions of the glucuronic acid as well as at the 4-O and 6-O positions of the galactosamine.  Given the nature of this contaminant, traditional screening tests cannot differentiate between affected and unaffected lots.  Our anal. suggests effective screening methods that can be used to det. whether or not heparin lots contain the contaminant reported here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX-IanwUPD4bVg90H21EOLACvtfcHk0liAmfzAo1CwAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmvVCisrY%253D&md5=42fa6cf94a3534ed36992977bb4985d9</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnbt1407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1407%26sid%3Dliteratum%253Aachs%26aulast%3DGuerrini%26aufirst%3DM.%26aulast%3DBeccati%26aufirst%3DD.%26aulast%3DShriver%26aufirst%3DZ.%26aulast%3DNaggi%26aufirst%3DA.%26aulast%3DViswanathan%26aufirst%3DK.%26aulast%3DBisio%26aufirst%3DA.%26aulast%3DCapila%26aufirst%3DI.%26aulast%3DLansing%26aufirst%3DJ.%2BC.%26aulast%3DGuglieri%26aufirst%3DS.%26aulast%3DFraser%26aufirst%3DB.%26aulast%3DAl-Hakim%26aufirst%3DA.%26aulast%3DGunay%26aufirst%3DN.%2BS.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DRobinson%26aufirst%3DL.%26aulast%3DBuhse%26aufirst%3DL.%26aulast%3DNasr%26aufirst%3DM.%26aulast%3DWoodcock%26aufirst%3DJ.%26aulast%3DLanger%26aufirst%3DR.%26aulast%3DVenkataraman%26aufirst%3DG.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26aulast%3DCasu%26aufirst%3DB.%26aulast%3DTorri%26aufirst%3DG.%26aulast%3DSasisekharan%26aufirst%3DR.%26atitle%3DOversulfated%2520chondroitin%2520sulfate%2520is%2520a%2520contaminant%2520in%2520heparin%2520associated%2520with%2520adverse%2520clinical%2520events%26jtitle%3DNat.%2520Biotechnol.%26date%3D2008%26volume%3D26%26spage%3D669%26epage%3D675%26doi%3D10.1038%2Fnbt1407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Maruyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imanari, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Conformational changes and anticoagulant activity of chondroitin sulfate following its O-sulfonation</span> <span class="citation_source-journal">Carbohydr. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">306</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span><span class="refDoi"> DOI: 10.1016/S0008-6215(97)10060-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1016%2FS0008-6215%2897%2910060-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=1998&pages=35-43&author=T.+Maruyamaauthor=T.+Toidaauthor=T.+Imanariauthor=G.+Yuauthor=R.+J.+Linhardt&title=Conformational+changes+and+anticoagulant+activity+of+chondroitin+sulfate+following+its+O-sulfonation&doi=10.1016%2FS0008-6215%2897%2910060-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0008-6215%2897%2910060-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0008-6215%252897%252910060-X%26sid%3Dliteratum%253Aachs%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DToida%26aufirst%3DT.%26aulast%3DImanari%26aufirst%3DT.%26aulast%3DYu%26aufirst%3DG.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DConformational%2520changes%2520and%2520anticoagulant%2520activity%2520of%2520chondroitin%2520sulfate%2520following%2520its%2520O-sulfonation%26jtitle%3DCarbohydr.%2520Res.%26date%3D1998%26volume%3D306%26spage%3D35%26epage%3D43%26doi%3D10.1016%2FS0008-6215%2897%2910060-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Harrich, V. D.; Mayer, P.; Turczynski, J.</span><span> </span><span class="NLM_article-title">Medikamentenskandal: Erneut probleme mit heparin (Medication scandal: Problems with heparin again)</span>. <a href="http://www.tagesschau.de/wirtschaft/pharmacrime/pharmacrime-heparin-103.html" class="extLink">http://www.tagesschau.de/wirtschaft/pharmacrime/pharmacrime-heparin-103.html</a> (accessed May 17, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Harrich%2C+V.+D.%3B+Mayer%2C+P.%3B+Turczynski%2C+J.+Medikamentenskandal%3A+Erneut+probleme+mit+heparin+%28Medication+scandal%3A+Problems+with+heparin+again%29.+http%3A%2F%2Fwww.tagesschau.de%2Fwirtschaft%2Fpharmacrime%2Fpharmacrime-heparin-103.html+%28accessed+May+17%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3DHarrich%26aufirst%3DV.%2BD.%26atitle%3DMedikamentenskandal%253A%2520Erneut%2520probleme%2520mit%2520heparin%2520%2528Medication%2520scandal%253A%2520Problems%2520with%2520heparin%2520again%2529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Fu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suflita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Bioengineered heparins and heparan sulfates</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">249</span><span class="refDoi"> DOI: 10.1016/j.addr.2015.11.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1016%2Fj.addr.2015.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=26555370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVSks7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2016&pages=237-249&author=L.+Fuauthor=M.+Suflitaauthor=R.+J.+Linhardt&title=Bioengineered+heparins+and+heparan+sulfates&doi=10.1016%2Fj.addr.2015.11.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Bioengineered heparins and heparan sulfates</span></div><div class="casAuthors">Fu, Li; Suflita, Matthew; Linhardt, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">237-249</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Heparin and heparan sulfates are closely related linear anionic polysaccharides, called glycosaminoglycans, which exhibit a no. of important biol. and pharmacol. activities.  These polysaccharides, having complex structures and polydispersity, are biosynthesized in the Golgi of animal cells.  While heparan sulfate is a widely distributed membrane and extracellular glycosaminoglycan, heparin is found primarily intracellularly in the granules of mast cells.  While heparin has historically received most of the scientific attention for its anticoagulant activity, interest has steadily grown in the multi-faceted role heparan sulfate plays in normal and pathophysiol.  The chem. synthesis of these glycosaminoglycans is largely precluded by their structural complexity.  Today, we depend on livestock animal tissues for the isolation and the annual com. prodn. of hundred ton quantities of heparin used in the manuf. of anticoagulant drugs and medical device coatings.  The variability of animal-sourced heparin and heparan sulfates, their inherent impurities, the limited availability of source tissues, the poor control of these source materials and their manufg. processes, suggest a need for new approaches for their prodn.  Over the past decade there have been major efforts in the biotechnol. prodn. of these glycosaminoglycans, driven by both therapeutic applications and as probes to study their natural functions.  This review focuses on the complex biol. of these glycosaminoglycans in human health and disease, and the use of recombinant technol. in the chemoenzymic synthesis and metabolic engineering of heparin and heparan sulfates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoicKOhyeX6ZLVg90H21EOLACvtfcHk0liAmfzAo1CwAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVSks7jI&md5=0ce99640a8b2ec3920cdca63aec3ebcd</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2015.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2015.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DL.%26aulast%3DSuflita%26aufirst%3DM.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DBioengineered%2520heparins%2520and%2520heparan%2520sulfates%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2016%26volume%3D97%26spage%3D237%26epage%3D249%26doi%3D10.1016%2Fj.addr.2015.11.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Chemoenzymatic synthesis of heparan sulfate and heparin</span> <span class="citation_source-journal">Nat. Prod. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1676</span><span class="NLM_x">–</span> <span class="NLM_lpage">1685</span><span class="refDoi"> DOI: 10.1039/C4NP00076E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1039%2FC4NP00076E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=25197032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFWjtLfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2014&pages=1676-1685&author=J.+Liuauthor=R.+J.+Linhardt&title=Chemoenzymatic+synthesis+of+heparan+sulfate+and+heparin&doi=10.1039%2FC4NP00076E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoenzymatic synthesis of heparan sulfate and heparin</span></div><div class="casAuthors">Liu, Jian; Linhardt, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1676-1685</span>CODEN:
                <span class="NLM_cas:coden">NPRRDF</span>;
        ISSN:<span class="NLM_cas:issn">0265-0568</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">This review covers recent development of chemoenzymic synthesis methodol. and its progress towards the synthesis of HS oligosaccharide targets having diverse sulfation patterns.  Heparan sulfate is a polysaccharide that plays essential physiol. functions in the animal kingdom.  Heparin, a highly sulfated form of heparan sulfate, is a widely prescribed anticoagulant drug worldwide.  The heparan sulfate and heparin isolated from natural sources are highly heterogeneous mixts. differing in their polysaccharide chain lengths and sulfation patterns.  The access to structurally defined heparan sulfate and heparin is crit. to probe the contribution of specific sulfated saccharide structures to the biol. functions as well as for the development of the next generation of heparin-based anticoagulant drugs.  The synthesis of heparan sulfate and heparin, using a purely chem. approach, has proven extremely difficult, esp. for targets larger than octasaccharides having a high degree of site-specific sulfation.  A new chemoenzymic method has emerged as an effective alternative approach.  This method uses recombinant heparan sulfate biosynthetic enzymes combined with unnatural uridine diphosphate-monosaccharide donors.  Recent examples demonstrate the successful synthesis of ultra-low mol. wt. heparin, low-mol. wt. heparin and bioengineered heparin with unprecedented efficiency.  The new method provides an opportunity to develop improved heparin-based therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbCgIXG0lkfrVg90H21EOLACvtfcHk0liZLmbKe8-W4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFWjtLfL&md5=7d1200967bbc7d0abaed4c89baa311ed</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1039%2FC4NP00076E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4NP00076E%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DChemoenzymatic%2520synthesis%2520of%2520heparan%2520sulfate%2520and%2520heparin%26jtitle%3DNat.%2520Prod.%2520Rep.%26date%3D2014%26volume%3D31%26spage%3D1676%26epage%3D1685%26doi%3D10.1039%2FC4NP00076E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Junqueira, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viana, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peixoto, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barros, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carvalho, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perini, E.</span><span> </span><span class="NLM_article-title">Heparin pharmacovigilance in Brazil</span> <span class="citation_source-journal">Rev. Assoc. Med. Bras. (1992)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">322</span><span class="NLM_x">–</span> <span class="NLM_lpage">326</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1016%2FS0104-4230%2811%2970067-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=21691698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A280%3ADC%252BC3MjksFaisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2011&pages=322-326&author=D.+R.+Junqueiraauthor=T.+G.+Vianaauthor=E.+R.+Peixotoauthor=F.+C.+Barrosauthor=M.+Carvalhoauthor=E.+Perini&title=Heparin+pharmacovigilance+in+Brazil"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Heparin pharmacovigilance in Brazil</span></div><div class="casAuthors">Junqueira Daniela Rezende Garcia; Viana Thercia Guedes; Peixoto Eliane R de M; Barros Fabiana C R de; Carvalho Maria das Gracas; Perini Edson</div><div class="citationInfo"><span class="NLM_cas:title">Revista da Associacao Medica Brasileira (1992)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">322-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To investigate the biological origin of injectable unfractioned heparin available in Brazilian market by discussing the impact of the profile of commercial products and the changes in heparin monograph on the drug safety.  METHODS:  The Anvisa data base for the Registered Products of Pharmaceutical Companies and the Dictionary of Pharmaceutical Specialties (DEF 2008/2009) were searched.  A survey with industries having an active permission for marketing the drug in Brazil was conducted.  RESULTS:  Five companies were granted a permission to market unfractioned heparin in Brazil.  Three of them are porcine in origin and two of them are bovine in origin, with only one explicitly showing this information in the package insert.  The effectiveness and safety of heparin studied in non-Brazilian populations may not represent the Brazilian reality, since most countries no longer produce bovine heparin.  The currently marketed heparin has approximately 10% less anticoagulant activity than that previously produced and this change may have clinical implications.  CONCLUSIONS:  Evidence about the lack of dose interchangeability between bovine and porcine heparins and the unique safety profile of these drugs indicates the need to follow the treatment and the patients' response.  Events threatening the patient's safety must be reported to the pharmacovigilance system in each particular country.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ6zi8ee1B0tLBItaL1WaVAfW6udTcc2eabgAujnlfsCLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MjksFaisA%253D%253D&md5=84ca2acb85a5c2d4526c087f5fbec74f</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS0104-4230%2811%2970067-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0104-4230%252811%252970067-7%26sid%3Dliteratum%253Aachs%26aulast%3DJunqueira%26aufirst%3DD.%2BR.%26aulast%3DViana%26aufirst%3DT.%2BG.%26aulast%3DPeixoto%26aufirst%3DE.%2BR.%26aulast%3DBarros%26aufirst%3DF.%2BC.%26aulast%3DCarvalho%26aufirst%3DM.%26aulast%3DPerini%26aufirst%3DE.%26atitle%3DHeparin%2520pharmacovigilance%2520in%2520Brazil%26jtitle%3DRev.%2520Assoc.%2520Med.%2520Bras.%2520%25281992%2529%26date%3D2011%26volume%3D57%26spage%3D322%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Warda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Turkey intestine as a commercial source of heparin? Comparative structural studies of intestinal avian and mammalian glycosaminoglycans</span> <span class="citation_source-journal">Comp. Biochem. Physiol., Part B: Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span><span class="refDoi"> DOI: 10.1016/S1096-4959(02)00250-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1016%2FS1096-4959%2802%2900250-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=12524047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1Wr" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2003&pages=189-197&author=M.+Wardaauthor=W.+Maoauthor=T.+Toidaauthor=R.+J.+Linhardt&title=Turkey+intestine+as+a+commercial+source+of+heparin%3F+Comparative+structural+studies+of+intestinal+avian+and+mammalian+glycosaminoglycans&doi=10.1016%2FS1096-4959%2802%2900250-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Turkey intestine as a commercial source of heparin? Comparative structural studies of intestinal avian and mammalian glycosaminoglycans</span></div><div class="casAuthors">Warda, Mohamad; Mao, Wenjun; Toida, Toshihiko; Linhardt, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Comparative Biochemistry and Physiology, Part B: Biochemistry & Molecular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">134B</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">189-197</span>CODEN:
                <span class="NLM_cas:coden">CBPBB8</span>;
        ISSN:<span class="NLM_cas:issn">1096-4959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Heparin is a glycosaminoglycan (GAG) that is extd. primarily from porcine intestinal tissues and is widely used as a clin. anticoagulant.  It is biosynthesized as a proteoglycan and stored exclusively in mast cells and is partially degraded to peptidoglycan and GAG upon immunol. activated mast cell degranulation.  In contrast, the structurally related heparan sulfate, is the polysaccharide portion of a ubiquitous proteoglycan, localized on cell surface and in the extracellular matrix of all animal tissues.  Heparin and heparan sulfate are made in the Golgi through a similar biosynthetic pathway.  The current study was undertaken in a search for alternative, non-mammalian, sources of anticoagulant heparin.  The heparin/heparan sulfate family of GAGs, prepd. and purified from turkey intestine, were assayed for anticoagulant activity and structurally characterized.  The resulting GAGs displayed a very low anticoagulant activity when compared to those obtained from porcine intestine using an identical procedure.  Structural characterization studies clearly demonstrate that heparan sulfate is the major GAG in the turkey intestine.  This observation is rationalized based on differences in the mammalian and avian coagulation and immune systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxLTQcG7peqrVg90H21EOLACvtfcHk0liZLmbKe8-W4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1Wr&md5=97011b80e9d003d310078f2f728b7161</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS1096-4959%2802%2900250-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1096-4959%252802%252900250-6%26sid%3Dliteratum%253Aachs%26aulast%3DWarda%26aufirst%3DM.%26aulast%3DMao%26aufirst%3DW.%26aulast%3DToida%26aufirst%3DT.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DTurkey%2520intestine%2520as%2520a%2520commercial%2520source%2520of%2520heparin%253F%2520Comparative%2520structural%2520studies%2520of%2520intestinal%2520avian%2520and%2520mammalian%2520glycosaminoglycans%26jtitle%3DComp.%2520Biochem.%2520Physiol.%252C%2520Part%2520B%253A%2520Biochem.%2520Mol.%2520Biol.%26date%3D2003%26volume%3D134%26spage%3D189%26epage%3D197%26doi%3D10.1016%2FS1096-4959%2802%2900250-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Guan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chi, L.</span><span> </span><span class="NLM_article-title">Comparison of low molecular weight heparins prepared using bovine lung heparin and porcine intestine heparin as starting materials</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">1843</span><span class="NLM_x">–</span> <span class="NLM_lpage">1850</span><span class="refDoi"> DOI: 10.1016/j.xphs.2016.03.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1016%2Fj.xphs.2016.03.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=27238483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtF2mtrvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2016&pages=1843-1850&author=Y.+Guanauthor=X.+Xuauthor=X.+Liuauthor=A.+Shengauthor=L.+Jinauthor=R.+J.+Linhardtauthor=L.+Chi&title=Comparison+of+low+molecular+weight+heparins+prepared+using+bovine+lung+heparin+and+porcine+intestine+heparin+as+starting+materials&doi=10.1016%2Fj.xphs.2016.03.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of Low-Molecular-Weight Heparins Prepared From Bovine Lung Heparin and Porcine Intestine Heparin</span></div><div class="casAuthors">Guan, Yudong; Xu, Xiaohui; Liu, Xinyue; Sheng, Anran; Jin, Lan; Linhardt, Robert J.; Chi, Lianli</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1843-1850</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Currently porcine intestine is the only approved source for producing pharmaceutical heparin in most countries.  Enoxaparin, prepd. by benzylation and alk. depolymn. from porcine intestine heparin, is prevalent in the anticoagulant drug market.  It is predicted that porcine intestine heparin-derived enoxaparin (PIE) will encounter shortage, and expanding its prodn. from heparins obtained from other animal tissues may, therefore, be inevitable.  Bovine lung heparin is a potential alternative source for producing enoxaparin.  Crit. processing parameters for producing bovine lung heparin-derived enoxaparin (BLE) are discussed.  Three batches of BLEs were prepd. and their detailed structures were compared with PIEs using modern anal. techniques, including disaccharide compn., intact chain mapping by liq. chromatog.-mass spectrometry and 2-dimensional NMR spectroscopy.  The results suggested that the differences between PIEs and BLEs mainly result from N-acetylation differences derived from the parent heparins.  In addn., bioactivities of BLEs were about 70% of PIEs based on anti-factor IIa and Xa chromogenic assays.  We conclude that BLE has the potential to be developed as an analog of PIE, although some challenges still remain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2sEKMSXf9VbVg90H21EOLACvtfcHk0li-FAitpNYh3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtF2mtrvI&md5=6d3fa91429735c023aba9551121a21a5</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.xphs.2016.03.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.xphs.2016.03.037%26sid%3Dliteratum%253Aachs%26aulast%3DGuan%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DSheng%26aufirst%3DA.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26aulast%3DChi%26aufirst%3DL.%26atitle%3DComparison%2520of%2520low%2520molecular%2520weight%2520heparins%2520prepared%2520using%2520bovine%2520lung%2520heparin%2520and%2520porcine%2520intestine%2520heparin%2520as%2520starting%2520materials%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2016%26volume%3D105%26spage%3D1843%26epage%3D1850%26doi%3D10.1016%2Fj.xphs.2016.03.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Ange, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fareed, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoppensteadt, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeske, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Comparison of low molecular weight heparins prepared from bovine heparins with enoxaparin</span> <span class="citation_source-journal">Clin. Appl. Thromb./Hemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">542</span><span class="refDoi"> DOI: 10.1177/1076029616686422</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1177%2F1076029616686422" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=28056526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVCisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=542&author=X.+Liuauthor=K.+St.+Angeauthor=J.+Fareedauthor=D.+Hoppensteadtauthor=W.+Jeskeauthor=A.+Koutaauthor=L.+Chiauthor=C.+Jinauthor=Y.+Jinauthor=Y.+Yaoauthor=R.+J.+Linhardt&title=Comparison+of+low+molecular+weight+heparins+prepared+from+bovine+heparins+with+enoxaparin&doi=10.1177%2F1076029616686422"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of Low-Molecular-Weight Heparins Prepared From Bovine Heparins With Enoxaparin</span></div><div class="casAuthors">Liu, Xinyue; St. Ange, Kalib; Fareed, Jawed; Hoppensteadt, Debra; Jeske, Walter; Kouta, Ahmed; Chi, Lianli; Jin, Caijuan; Jin, Yongsheng; Yao, Yiming; Linhardt, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Applied Thrombosis/Hemostasis</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">542-553</span>CODEN:
                <span class="NLM_cas:coden">CATHF9</span>;
        ISSN:<span class="NLM_cas:issn">1076-0296</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Heparin and its low-mol.-wt. heparin (LMWH) derivs. are widely used clin. anticoagulants.  These drugs are crit. for the practice of medicine in applications including kidney dialysis, cardiopulmonary bypass, and in the management of venous thromboembolism.  Currently, these drugs are derived from livestock, primarily porcine intestine.  The worldwide dependence on a single animal species has made the supply chain for this crit. drug quite fragile, leading to the search for other sources of these drugs, including bovine tissues such as bovine intestine or lung.  A no. of labs. are currently examg. the similarities and differences between heparins prepd. from porcine and bovine tissues.  The current study is designed to compare LMWH prepd. from bovine heparins through chem. β-elimination, a process currently used to prep. the LMWH, enoxaparin, from porcine heparin.  Using top-down, bottom-up, compositional anal. and bioassays, LMWHs, derived from bovine lung and intestine, are shown to closely resemble enoxaparin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7-IFPIM9yzrVg90H21EOLACvtfcHk0li-FAitpNYh3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVCisbc%253D&md5=18879b0dd0915d1bb7ce9cad980438e2</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1177%2F1076029616686422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1076029616686422%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DSt.%2BAnge%26aufirst%3DK.%26aulast%3DFareed%26aufirst%3DJ.%26aulast%3DHoppensteadt%26aufirst%3DD.%26aulast%3DJeske%26aufirst%3DW.%26aulast%3DKouta%26aufirst%3DA.%26aulast%3DChi%26aufirst%3DL.%26aulast%3DJin%26aufirst%3DC.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DComparison%2520of%2520low%2520molecular%2520weight%2520heparins%2520prepared%2520from%2520bovine%2520heparins%2520with%2520enoxaparin%26jtitle%3DClin.%2520Appl.%2520Thromb.%252FHemostasis%26date%3D2017%26volume%3D23%26spage%3D542%26doi%3D10.1177%2F1076029616686422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Mikhailov, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayo, K. H.</span><span> </span><span class="NLM_article-title">Heparin dodecasaccharide binding to platelet factor-4 and growth-related protein-a: Transition through a partially folded state and implications for heparin induced thrombocytopenia</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">25317</span><span class="NLM_x">–</span> <span class="NLM_lpage">25329</span><span class="refDoi"> DOI: 10.1074/jbc.274.36.25317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1074%2Fjbc.274.36.25317" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=25317-25329&author=D.+Mikhailovauthor=H.+C.+Youngauthor=R.+J.+Linhardtauthor=K.+H.+Mayo&title=Heparin+dodecasaccharide+binding+to+platelet+factor-4+and+growth-related+protein-a%3A+Transition+through+a+partially+folded+state+and+implications+for+heparin+induced+thrombocytopenia&doi=10.1074%2Fjbc.274.36.25317"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.36.25317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.36.25317%26sid%3Dliteratum%253Aachs%26aulast%3DMikhailov%26aufirst%3DD.%26aulast%3DYoung%26aufirst%3DH.%2BC.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26aulast%3DMayo%26aufirst%3DK.%2BH.%26atitle%3DHeparin%2520dodecasaccharide%2520binding%2520to%2520platelet%2520factor-4%2520and%2520growth-related%2520protein-a%253A%2520Transition%2520through%2520a%2520partially%2520folded%2520state%2520and%2520implications%2520for%2520heparin%2520induced%2520thrombocytopenia%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D25317%26epage%3D25329%26doi%3D10.1074%2Fjbc.274.36.25317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Arepally, G. M.</span><span> </span><span class="NLM_article-title">Heparin-induced thrombocytopenia</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">2864</span><span class="NLM_x">–</span> <span class="NLM_lpage">2872</span><span class="refDoi"> DOI: 10.1182/blood-2016-11-709873</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1182%2Fblood-2016-11-709873" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=28416511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1emtbjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2017&pages=2864-2872&author=G.+M.+Arepally&title=Heparin-induced+thrombocytopenia&doi=10.1182%2Fblood-2016-11-709873"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Heparin-induced thrombocytopenia</span></div><div class="casAuthors">Arepally, Gowthami M.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2864-2872</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">1528-0020</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Heparin-induced thrombocytopenia (HIT) is an immune complication of heparin therapy caused by antibodies to complexes of platelet factor 4 (PF4) and heparin.  Pathogenic antibodies to PF4/heparin bind and activate cellular FcgRIIA on platelets and monocytes to propagate ahypercoagulable state culminating in life-threatening thrombosis.  It is now recognized that anti-PF4/heparin antibodies develop commonly after heparin exposure, but only a subset of sensitized patients progress to lifethreatening complications of thrombocytopenia and thrombosis.  Recent scientific developments have clarified mechanisms underlying PF4/heparin immunogenicity, disease susceptibility, and clinicalmanifestations of disease.  Insights from clin. and lab. findings have also been recently harnessed for disease prevention.  This review will summarize our current understanding of HIT by reviewing pathogenesis, essential clin. and lab. features, and management.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj-0WEzMTzYrVg90H21EOLACvtfcHk0lgrIwRUG542bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1emtbjM&md5=d2e15cbe1028978e4c37e47324e1fa43</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1182%2Fblood-2016-11-709873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2016-11-709873%26sid%3Dliteratum%253Aachs%26aulast%3DArepally%26aufirst%3DG.%2BM.%26atitle%3DHeparin-induced%2520thrombocytopenia%26jtitle%3DBlood%26date%3D2017%26volume%3D129%26spage%3D2864%26epage%3D2872%26doi%3D10.1182%2Fblood-2016-11-709873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Bhaskar, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onishi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suflita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dordick, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Combinatorial one-pot chemoenzymatic synthesis of heparin</span> <span class="citation_source-journal">Carbohydr. Polym.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">407</span><span class="refDoi"> DOI: 10.1016/j.carbpol.2014.10.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1016%2Fj.carbpol.2014.10.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=25817684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFWitrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2015&pages=399-407&author=U.+Bhaskarauthor=G.+Liauthor=L.+Fuauthor=A.+Onishiauthor=M.+Suflitaauthor=J.+S.+Dordickauthor=R.+J.+Linhardt&title=Combinatorial+one-pot+chemoenzymatic+synthesis+of+heparin&doi=10.1016%2Fj.carbpol.2014.10.054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Combinatorial one-pot chemoenzymatic synthesis of heparin</span></div><div class="casAuthors">Bhaskar, Ujjwal; Li, Guoyun; Fu, Li; Onishi, Akihiro; Suflita, Mathew; Dordick, Jonathan S.; Linhardt, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Carbohydrate Polymers</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">399-407</span>CODEN:
                <span class="NLM_cas:coden">CAPOD8</span>;
        ISSN:<span class="NLM_cas:issn">0144-8617</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Contamination in heparin batches during early 2008 has resulted in a significant effort to develop a safer bioengineered heparin using bacterial capsular polysaccharide heparosan and recombinant enzymes derived from the heparin/heparan sulfate biosynthetic pathway.  This requires controlled chem. N-deacetylation/N-sulfonation of heparosan followed by epimerization of most of its glucuronic acid residues to iduronic acid and O-sulfation of the C2 position of iduronic acid and the C3 and C6 positions of the glucosamine residues.  A combinatorial study of multi-enzyme, one-pot, in vitro biocatalytic synthesis, carried out in tandem with sensitive anal. techniques, reveals controlled structural changes leading to heparin products similar to animal-derived heparin active pharmaceutical ingredients.  Liq. chromatog.-mass spectrometry and NMR spectroscopy anal. confirms an abundance of heparin's characteristic trisulfated disaccharide, as well as 3-O-sulfo contg. residues crit. for heparin binding to antithrombin III and its anticoagulant activity.  The bioengineered heparins prepd. using this simplified one-pot chemoenzymic synthesis also show in vitro anticoagulant activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriyerybtU4MLVg90H21EOLACvtfcHk0lgrIwRUG542bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFWitrrK&md5=58861efade1229ced35c1d92d357acae</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.carbpol.2014.10.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.carbpol.2014.10.054%26sid%3Dliteratum%253Aachs%26aulast%3DBhaskar%26aufirst%3DU.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DFu%26aufirst%3DL.%26aulast%3DOnishi%26aufirst%3DA.%26aulast%3DSuflita%26aufirst%3DM.%26aulast%3DDordick%26aufirst%3DJ.%2BS.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DCombinatorial%2520one-pot%2520chemoenzymatic%2520synthesis%2520of%2520heparin%26jtitle%3DCarbohydr.%2520Polym.%26date%3D2015%26volume%3D122%26spage%3D399%26epage%3D407%26doi%3D10.1016%2Fj.carbpol.2014.10.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Yang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weyers, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sterner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Disaccharide analysis of glycosaminoglycan mixtures by ultra-performance liquid chromatography-mass spectrometry</span> <span class="citation_source-journal">J. Chromatogr. A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">1225</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">98</span><span class="refDoi"> DOI: 10.1016/j.chroma.2011.12.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1016%2Fj.chroma.2011.12.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=22236563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFSitLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1225&publication_year=2012&pages=91-98&author=B.+Yangauthor=Y.+Changauthor=A.+M.+Weyersauthor=E.+Sternerauthor=R.+J.+Linhardt&title=Disaccharide+analysis+of+glycosaminoglycan+mixtures+by+ultra-performance+liquid+chromatography-mass+spectrometry&doi=10.1016%2Fj.chroma.2011.12.063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Disaccharide analysis of glycosaminoglycan mixtures by ultra-high-performance liquid chromatography-mass spectrometry</span></div><div class="casAuthors">Yang, Bo; Chang, Yuqing; Weyers, Amanda M.; Sterner, Eric; Linhardt, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatography A</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1225</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">91-98</span>CODEN:
                <span class="NLM_cas:coden">JCRAEY</span>;
        ISSN:<span class="NLM_cas:issn">0021-9673</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Glycosaminoglycans are a family of polysaccharides widely distributed in all eukaryotic cells.  These polyanionic, linear chain polysaccharides are composed of repeating disaccharide units that are often differentially substituted with sulfo groups.  The diversity of glycosaminoglycan structures in cells, tissues and among different organisms reflect their functional an evolutionary importance.  Glycosaminoglycan compn. and structure also changes in development, aging and in disease progression, making their accurate and reliable anal. a crit., albeit, challenging endeavor.  Quant. disaccharide compositional anal. is one of the primary ways to characterize glycosaminoglycan compn. and structure and has a direct relation with glycosaminoglycan biol. functions.  In this study, glycosaminoglycan disaccharides, prepd. from heparan sulfate/heparin, chondroitin sulfate/dermatan sulfate and neutral hyaluronic acid using multiple polysaccharide lyases, were fluorescently labeled with 2-aminoacridone, fractionated into 17 well-resolved components by reverse-phase ultra-performance liq. chromatog., and analyzed by electrospray ionization mass spectrometry.  This anal. was successfully applied to cell, tissue, and biol. fluid samples for the picomole level detection of glycosaminoglycan compn. and structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ0TFyREyzj7Vg90H21EOLACvtfcHk0lgrIwRUG542bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFSitLs%253D&md5=60751b81903f6bcfb9a06cc495c44c6a</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.chroma.2011.12.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chroma.2011.12.063%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DB.%26aulast%3DChang%26aufirst%3DY.%26aulast%3DWeyers%26aufirst%3DA.%2BM.%26aulast%3DSterner%26aufirst%3DE.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DDisaccharide%2520analysis%2520of%2520glycosaminoglycan%2520mixtures%2520by%2520ultra-performance%2520liquid%2520chromatography-mass%2520spectrometry%26jtitle%3DJ.%2520Chromatogr.%2520A%26date%3D2012%26volume%3D1225%26spage%3D91%26epage%3D98%26doi%3D10.1016%2Fj.chroma.2011.12.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Xiao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tappen, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ly, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canova, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Heparin mapping using heparin lyases and the generation of a novel low molecular weight heparin</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">610</span><span class="refDoi"> DOI: 10.1021/jm101381k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101381k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFOqt77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=603-610&author=Z.+Xiaoauthor=B.+R.+Tappenauthor=M.+Lyauthor=W.+Zhaoauthor=L.+P.+Canovaauthor=H.+Guanauthor=R.+J.+Linhardt&title=Heparin+mapping+using+heparin+lyases+and+the+generation+of+a+novel+low+molecular+weight+heparin&doi=10.1021%2Fjm101381k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Heparin mapping using heparin lyases and the generation of a novel low molecular weight heparin</span></div><div class="casAuthors">Xiao, Zhongping; Tappen, Britney R.; Ly, Mellisa; Zhao, Wenjing; Canova, Lauren P.; Guan, Huashi; Linhardt, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">603-610</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Seven pharmaceutical heparins were investigated by oligosaccharide mapping by digestion with heparin lyase 1, 2, or 3, followed by high performance liq. chromatog. anal.  The structure of one of the prepd. mapping stds., ΔUA-Gal-Gal-Xyl-O-CH2CONHCH2COOH (where ΔUA is 4-deoxy-α-L-threo-hex-4-eno-pyranosyluronic acid, Gal is β-D-galactopyranose, and Xyl is β-D-xylopyranose) released from the linkage region using either heparin lyase 2 or heparin lyase 3 digestion, is reported for the first time.  A size-dependent susceptibility of site cleaved by heparin lyase 3 was also obsd.  Heparin lyase 3 acts on the undersulfated domains of the heparin chain and does not cleave the linkages within heparin's antithrombin III binding site.  Thus, a novel low mol. wt. heparin (LMWH) is afforded on heparin lyase 3 digestion of heparin due to this unique substrate specificity, which has anticoagulant activity comparable to that of currently available LMWH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq-WextauHcrVg90H21EOLACvtfcHk0ljEYhUsM_5IaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFOqt77O&md5=618a944505e39aff3c44099bed0ae599</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm101381k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101381k%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DZ.%26aulast%3DTappen%26aufirst%3DB.%2BR.%26aulast%3DLy%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DCanova%26aufirst%3DL.%2BP.%26aulast%3DGuan%26aufirst%3DH.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DHeparin%2520mapping%2520using%2520heparin%2520lyases%2520and%2520the%2520generation%2520of%2520a%2520novel%2520low%2520molecular%2520weight%2520heparin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D603%26epage%3D610%26doi%3D10.1021%2Fjm101381k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Jones, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limtiaco, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langeslay, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larive, C. K.</span><span> </span><span class="NLM_article-title">Heparin characterization: challenges and solutions</span> <span class="citation_source-journal">Annu. Rev. Anal. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">65</span><span class="refDoi"> DOI: 10.1146/annurev-anchem-061010-113911</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1146%2Fannurev-anchem-061010-113911" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=21469955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVynsbfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=439-65&author=C.+J.+Jonesauthor=S.+Beniauthor=J.+F.+Limtiacoauthor=D.+J.+Langeslayauthor=C.+K.+Larive&title=Heparin+characterization%3A+challenges+and+solutions&doi=10.1146%2Fannurev-anchem-061010-113911"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Heparin characterization: challenges and solutions</span></div><div class="casAuthors">Jones, Christopher J.; Beni, Szabolcs; Limtiaco, John F. K.; Langeslay, Derek J.; Larive, Cynthia K.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Analytical Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">439-465</span>CODEN:
                <span class="NLM_cas:coden">ARACFU</span>;
        ISSN:<span class="NLM_cas:issn">1936-1327</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Although heparin is an important and widely prescribed pharmaceutical anticoagulant, its high degree of sequence microheterogeneity and size polydispersity make mol.-level characterization challenging.  Unlike nucleic acids and proteins that are biosynthesized through template-driven assembly processes, heparin and the related glycosaminoglycan heparan sulfate are actively remodeled during biosynthesis through a series of enzymic reactions that lead to variable levels of O- and N-sulfonation and uronic acid epimers.  As summarized in this review, heparin sequence information is detd. through a bottom-up approach that relies on depolymn. reactions, size- and charge-based sepns., and sensitive mass spectrometric and NMR expts. to det. the structural identity of component oligosaccharides.  The structure-elucidation process, along with its challenges and opportunities for future anal. improvements, is reviewed and illustrated for a heparin-derived hexasaccharide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptSehKDoGOJbVg90H21EOLACvtfcHk0ljEYhUsM_5IaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVynsbfI&md5=cae7fcdbee40cc22c09b7b7d3affd642</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1146%2Fannurev-anchem-061010-113911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-anchem-061010-113911%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DC.%2BJ.%26aulast%3DBeni%26aufirst%3DS.%26aulast%3DLimtiaco%26aufirst%3DJ.%2BF.%26aulast%3DLangeslay%26aufirst%3DD.%2BJ.%26aulast%3DLarive%26aufirst%3DC.%2BK.%26atitle%3DHeparin%2520characterization%253A%2520challenges%2520and%2520solutions%26jtitle%3DAnnu.%2520Rev.%2520Anal.%2520Chem.%26date%3D2011%26volume%3D4%26spage%3D439%26epage%3D65%26doi%3D10.1146%2Fannurev-anchem-061010-113911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Mauri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boccardi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karfunkle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macchi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keire, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrini, M.</span><span> </span><span class="NLM_article-title">Qualification of HSQC methods for quantitative composition of heparin and low molecular weight heparins</span> <span class="citation_source-journal">J. Pharm. Biomed. Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">92</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span><span class="refDoi"> DOI: 10.1016/j.jpba.2016.12.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1016%2Fj.jpba.2016.12.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=28068519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmsVyrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2017&pages=92-105&author=L.+Mauriauthor=G.+Boccardiauthor=G.+Torriauthor=M.+Karfunkleauthor=E.+Macchiauthor=L.+Muziauthor=D.+Keireauthor=M.+Guerrini&title=Qualification+of+HSQC+methods+for+quantitative+composition+of+heparin+and+low+molecular+weight+heparins&doi=10.1016%2Fj.jpba.2016.12.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Qualification of HSQC methods for quantitative composition of heparin and low molecular weight heparins</span></div><div class="casAuthors">Mauri, Lucio; Boccardi, Giovanni; Torri, Giangiacomo; Karfunkle, Michael; Macchi, Eleonora; Muzi, Laura; Keire, David; Guerrini, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">92-105</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">An NMR HSQC method has recently been proposed for the quant. detn. of the mono- and disaccharide subunits of heparin and low mol. wt. heparins (LMWH).  The focus of the current study was the validation of this procedure to make the 2D-NMR method suitable for pharmaceutical quality control applications.  Pre-validation work investigated the effects of several exptl. parameters to assess robustness and to optimize crit. factors.  Important exptl. parameters were pulse sequence selection, equilibration interval between pulse trains and temp.  These observations were needed so that the NMR method was sufficiently understood to enable continuous improvement.  A std. validation study on heparin then examd. linearity, repeatability, intermediate precision and limits of detection and quantitation; selected validation parameters were also detd. for LMWH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5eysMbpVls7Vg90H21EOLACvtfcHk0ljEYhUsM_5IaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmsVyrtQ%253D%253D&md5=fec77c6fd579a70913d6b054a66f3d62</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2016.12.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2016.12.031%26sid%3Dliteratum%253Aachs%26aulast%3DMauri%26aufirst%3DL.%26aulast%3DBoccardi%26aufirst%3DG.%26aulast%3DTorri%26aufirst%3DG.%26aulast%3DKarfunkle%26aufirst%3DM.%26aulast%3DMacchi%26aufirst%3DE.%26aulast%3DMuzi%26aufirst%3DL.%26aulast%3DKeire%26aufirst%3DD.%26aulast%3DGuerrini%26aufirst%3DM.%26atitle%3DQualification%2520of%2520HSQC%2520methods%2520for%2520quantitative%2520composition%2520of%2520heparin%2520and%2520low%2520molecular%2520weight%2520heparins%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2017%26volume%3D136%26spage%3D92%26epage%3D105%26doi%3D10.1016%2Fj.jpba.2016.12.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malhotra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Novel Method for Measurement of Heparin Anticoagulant Activity Using SPR</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">526</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span><span class="refDoi"> DOI: 10.1016/j.ab.2017.03.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1016%2Fj.ab.2017.03.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=28322799" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BC2sXksFSisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=526&publication_year=2017&pages=39-42&author=J.+Zhaoauthor=X.+Liuauthor=A.+Malhotraauthor=Q.+Liauthor=F.+Zhangauthor=R.+J.+Linhardt&title=Novel+Method+for+Measurement+of+Heparin+Anticoagulant+Activity+Using+SPR&doi=10.1016%2Fj.ab.2017.03.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Novel method for measurement of heparin anticoagulant activity using SPR</span></div><div class="casAuthors">Zhao, Jing; Liu, Xinyue; Malhotra, Anju; Li, Quanhong; Zhang, Fuming; Linhardt, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">526</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">39-42</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A novel method has been developed for the easy measurement of heparin's anticoagulant activity using surface plasmon resonance.  The anticoagulant activity of target heparin was evaluated by measuring the competitive antithrombin III binding of analyte heparin in the soln. phase and USP heparin immobilized on chip surface.  Heparins, obtained from different animal sources, and low mol. wt. heparins were analyzed.  The results were reproducible and correlated well with the results of chromogenic assays (correlation coeff. r = 0.98 for anti-Xa and r = 0.94 for anti-IIa).  This protocol provides many advantages, significantly minimizing time, cost and the complications of chromogenic assay methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaJe7ckmOfkLVg90H21EOLACvtfcHk0lg4XbZqdJ6vBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXksFSisb0%253D&md5=4e6037dfd7d6e5bc54ec0cfb1fcf81be</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2017.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2017.03.013%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DMalhotra%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DNovel%2520Method%2520for%2520Measurement%2520of%2520Heparin%2520Anticoagulant%2520Activity%2520Using%2520SPR%26jtitle%3DAnal.%2520Biochem.%26date%3D2017%26volume%3D526%26spage%3D39%26epage%3D42%26doi%3D10.1016%2Fj.ab.2017.03.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span> </span><span class="NLM_article-title">Heparin Sodium</span>. USP37 Official Monograph; <span class="NLM_publisher-name">United States Pharmacopeia</span>: <span class="NLM_publisher-loc">Rockville, MD</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Heparin+Sodium.+USP37+Official+Monograph%3B+United+States+Pharmacopeia%3A+Rockville%2C+MD%2C+2013."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26atitle%3DHeparin%2520Sodium%26pub%3DUnited%2520States%2520Pharmacopeia%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Mousa, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aljada, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takieddin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castelli, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhardt, R. J.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and pharmacodynamics of oral heparin solid dosage form in healthy human subjects</span> <span class="citation_source-journal">J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1508</span><span class="NLM_x">–</span> <span class="NLM_lpage">1520</span><span class="refDoi"> DOI: 10.1177/0091270007307242</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=10.1177%2F0091270007307242" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=18048572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVyjtr%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=1508-1520&author=S.+A.+Mousaauthor=F.+Zhangauthor=A.+Aljadaauthor=S.+Chaturvediauthor=M.+Takieddinauthor=H.+Zhangauthor=L.+Chiauthor=M.+C.+Castelliauthor=K.+Friedmanauthor=M.+M.+Goldbergauthor=R.+J.+Linhardt&title=Pharmacokinetics+and+pharmacodynamics+of+oral+heparin+solid+dosage+form+in+healthy+human+subjects&doi=10.1177%2F0091270007307242"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and pharmacodynamics of oral heparin solid dosage form in healthy human subjects</span></div><div class="casAuthors">Mousa, Shaker A.; Zhang, Fuming; Aljada, Ahmad; Chaturvedi, Seema; Takieddin, Majde; Zhang, Haifeng; Chi, Lianli; Castelli, M. Cristina; Friedman, Kristen; Goldberg, Michael M.; Linhardt, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1508-1520</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">The present investigation detd. the mol. structure and the pharmacokinetic and pharmacodynamic profiles of oral unfractionated heparin contg. oral absorption enhancer sodium N-[8-(2-hydroxybenzoyl) amino]caprylate, salcaprozate sodium (SNAC) and assessed the safety and tolerability of the orally dosed heparin solid dosage form vs. other routes.  Sixteen healthy men were included in this single-dose, 3-way crossover, randomized, open-label study.  Disaccharide compositional anal. was performed using capillary high-performance liq. chromatog. with electrospray ionization mass spectrometry detection.  The pharmacodynamics of heparin were obtained from anal. of plasma anti-factor Xa, anti-factor IIa, activated partial thromboplastin time, and total tissue factor pathway inhibitor data.  The mol. wt. properties and the disaccharide compn. of orally administered unfractionated heparin/SNAC and parenterally administered unfractionated heparin are identical and consistent with the starting pharmaceutical std. heparin.  Furthermore, the anti-factor Xa/anti-factor IIa ratio achieved is of approx. 1:1.  This is the first true pharmacokinetic study to measure the chem. compns. of heparin administered by different routes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwS6_f159JTrVg90H21EOLACvtfcHk0lg4XbZqdJ6vBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVyjtr%252FP&md5=aa4b3ee7291fba7a9b120e74bea53a17</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1177%2F0091270007307242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270007307242%26sid%3Dliteratum%253Aachs%26aulast%3DMousa%26aufirst%3DS.%2BA.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DAljada%26aufirst%3DA.%26aulast%3DChaturvedi%26aufirst%3DS.%26aulast%3DTakieddin%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DChi%26aufirst%3DL.%26aulast%3DCastelli%26aufirst%3DM.%2BC.%26aulast%3DFriedman%26aufirst%3DK.%26aulast%3DGoldberg%26aufirst%3DM.%2BM.%26aulast%3DLinhardt%26aufirst%3DR.%2BJ.%26atitle%3DPharmacokinetics%2520and%2520pharmacodynamics%2520of%2520oral%2520heparin%2520solid%2520dosage%2520form%2520in%2520healthy%2520human%2520subjects%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2007%26volume%3D47%26spage%3D1508%26epage%3D1520%26doi%3D10.1177%2F0091270007307242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i13"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01269">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_16077"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01269">10.1021/acs.jmedchem.7b01269</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Heparin sources, enzyme expression and immobilization, disaccharide and tetrasaccharide analysis, NMR spectroscopy, molecular weight and concentration determinations, surface plasmon resonance binding analysis, in vitro anticoagulant activity measurement, purity and quality analysis of modified bovine intestinal heparins, animal studies and determination of PD, PK studies, supplementary tables, and supplementary figures (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01269/suppl_file/jm7b01269_si_001.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01269/suppl_file/jm7b01269_si_001.pdf">jm7b01269_si_001.pdf (1.17 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01269&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-20%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01269%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01269" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679aba6c98503cb8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
